{
  "experiment_name": "pubmedqa_reasoning_required__hf-mistral-nemo-12b__zero-shot__pubmedqa_reasoning_required_min__100__0p100",
  "experiment_config": {
    "model": "hf-mistral-nemo-12b",
    "setup": "pubmedqa_reasoning_required",
    "prompt": "pubmedqa_reasoning_required_min",
    "mode": "zero-shot",
    "few_shot_row": null,
    "size": 100,
    "temperature": 0.1
  },
  "timestamp": "2025-09-27T20:33:13.983537",
  "dataset_info": {
    "name": "pubmedqa_reasoning_required",
    "original_size": 1000,
    "pruned_rows": 0,
    "final_size_before_sampling": 1000,
    "sampled_size": 100,
    "columns": [
      "pubid",
      "question",
      "context",
      "long_answer",
      "final_decision"
    ]
  },
  "pruning_stats": {
    "rows_pruned": 0,
    "rows_kept_after_pruning": 1000,
    "prune_reasons_sample": [],
    "total_prune_reasons": 0
  },
  "model_info": {
    "type": "local",
    "model_path": "mistralai/Mistral-Nemo-Instruct-2407",
    "description": "Mistral Nemo 12B parameter model with 128k context - Medium",
    "parameters": "12B",
    "size_category": "medium",
    "max_tokens": 512,
    "context_length": "128k",
    "finetuned": false,
    "load_in_4bit": false,
    "use_unsloth": false,
    "use_chat_template": true,
    "trust_remote_code": true,
    "local_files_only": false,
    "torch_dtype": "auto",
    "device_map": "auto",
    "generation_config": {
      "temperature": 0.3,
      "top_p": 0.8,
      "max_new_tokens": 512,
      "do_sample": true
    }
  },
  "prompt_info": {
    "mode": "zero-shot",
    "compatible_setup": "pubmedqa_reasoning_required",
    "template": "Question: {}\n\nContext: {}\n\nAnswer (yes/no/maybe):",
    "description": "Minimal prompt matching paper's sparse description"
  },
  "responses": [
    {
      "prompt": "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening?\n\nContext: Rapid prescreening (RPS) is one of the quality assurance (QA) methods used in gynecologic cytology. The efficacy of RPS has been previously studied but mostly with respect to squamous lesions; in fact, there has been no study so far specifically looking at the sensitivity of RPS for detecting glandular cell abnormalities. A total of 80,565 Papanicolaou (Pap) smears underwent RPS during a 25-month period. A sample was designated as \"review for abnormality\" (R) if any abnormal cells (at the threshold of atypical squamous cells of undetermined significance/atypical glandular cells [AGC]) were thought to be present or was designated as negative (N) if none were detected. Each sample then underwent full screening (FS) and was designated as either R or N and also given a cytologic interpretation. The final cytologic interpretation was a glandular cell abnormality (\u2265AGC) in 107 samples (0.13%); 39 of these (36.4%) were flagged as R on RPS. Twenty-four patients (33.8%) out of 71 who had histologic follow-up were found to harbor a high-grade squamous intraepithelial lesion or carcinoma; 13 of those 24 Pap smears (54.2%) had been flagged as R on RPS. Notably, 11 AGC cases were picked up by RPS only and not by FS and represented false-negative cases; 2 of these showed endometrial adenocarcinoma on histologic follow-up.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that 36.4% of glandular cell abnormalities were flagged as \"review for abnormality\" (R) during rapid prescreening (RPS), and 54.2% of high-grade lesions or carcinomas had been flagged as R on RPS, it also revealed that 11 cases of atypical glandular cells (AGC) were only detected by RPS and not by full screening (FS). This suggests that RPS might have some sensitivity in detecting glandular cell abnormalities, but the study does not provide definitive evidence that RPS is consistently effective in this regard. Further studies specifically designed to evaluate the sensitivity of RPS for detecting glandular cell abnormalities would be needed to provide a more definitive answer.",
      "expected_output": "yes",
      "question_values": [
        "Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening?",
        "Rapid prescreening (RPS) is one of the quality assurance (QA) methods used in gynecologic cytology. The efficacy of RPS has been previously studied but mostly with respect to squamous lesions; in fact, there has been no study so far specifically looking at the sensitivity of RPS for detecting glandular cell abnormalities. A total of 80,565 Papanicolaou (Pap) smears underwent RPS during a 25-month period. A sample was designated as \"review for abnormality\" (R) if any abnormal cells (at the threshold of atypical squamous cells of undetermined significance/atypical glandular cells [AGC]) were thought to be present or was designated as negative (N) if none were detected. Each sample then underwent full screening (FS) and was designated as either R or N and also given a cytologic interpretation. The final cytologic interpretation was a glandular cell abnormality (\u2265AGC) in 107 samples (0.13%); 39 of these (36.4%) were flagged as R on RPS. Twenty-four patients (33.8%) out of 71 who had histologic follow-up were found to harbor a high-grade squamous intraepithelial lesion or carcinoma; 13 of those 24 Pap smears (54.2%) had been flagged as R on RPS. Notably, 11 AGC cases were picked up by RPS only and not by FS and represented false-negative cases; 2 of these showed endometrial adenocarcinoma on histologic follow-up."
      ],
      "processing_time": 5.712708234786987,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Are patients with Werlhof's disease at increased risk for bleeding complications when undergoing cardiac surgery?\n\nContext: It is generally assumed, that patients with Werlhof's disease (WD) are at increased risk for bleeding complications when undergoing cardiac surgery with extracorporeal circulation. Therefore we performed this case control study to estimate the real risk for bleeding complications of these patients. Between 05/95 and 07/98, ten patients with WD (eight males, two females) underwent cardiac surgery employing extracorporeal circulation (WD-group). Five of these patients with platelet counts below 80/nl were treated by immunoglobulins preoperatively. Each patient with WD was matched to five patients without WD (no-WD-group) using diagnosis, age, gender, ejection fraction, number of distal anastomosis and body-mass-index as matching criteria. Mean number of platelet counts were significant lower in the WD-group than in the no-WD-group despite a significant increase of platelet counts after immunoglobulin treatment (54/nl-->112/nl, P=0.018). On the day before, directly after and on the first day after surgery they were 141/nl vs. 215/nl (P=0.012), 75/nl vs. 147/nl (P=0.001) and 93/nl vs. 136/nl (P=0.009). Accordingly, patients of the WD-group received significantly more platelet concentrates than patients of the no-WD-group (mean number of platelet concentrates: 2.3 versus 0.7, P=0.007). Total drainage loss via the mediastinal chest tubes was almost identical (1197 ml in the no-WD-group and 1140 ml in the WD-group). One patient of each group suffered from a bleeding complication requiring reexploration. Three patients of the no-WD-group (6%) and one patient of the WD-group (10%) expired postoperatively unrelated to WD.\n\nAnswer (yes/no/maybe):",
      "response": "Based on the provided study, the answer is \"maybe\". While the study found that patients with Werlhof's disease (WD) had lower platelet counts and received more platelet concentrates, the total drainage loss via mediastinal chest tubes was almost identical between the WD-group and the no-WD-group. Additionally, the incidence of bleeding complications requiring reexploration was similar in both groups (10% in WD-group vs. 6% in no-WD-group). Therefore, while there is some evidence suggesting an increased risk for bleeding complications in WD patients, the study's findings do not definitively prove this. Further research with larger sample sizes and more specific outcome measures may be needed to determine if WD patients are truly at increased risk for bleeding complications during cardiac surgery.",
      "expected_output": "no",
      "question_values": [
        "Are patients with Werlhof's disease at increased risk for bleeding complications when undergoing cardiac surgery?",
        "It is generally assumed, that patients with Werlhof's disease (WD) are at increased risk for bleeding complications when undergoing cardiac surgery with extracorporeal circulation. Therefore we performed this case control study to estimate the real risk for bleeding complications of these patients. Between 05/95 and 07/98, ten patients with WD (eight males, two females) underwent cardiac surgery employing extracorporeal circulation (WD-group). Five of these patients with platelet counts below 80/nl were treated by immunoglobulins preoperatively. Each patient with WD was matched to five patients without WD (no-WD-group) using diagnosis, age, gender, ejection fraction, number of distal anastomosis and body-mass-index as matching criteria. Mean number of platelet counts were significant lower in the WD-group than in the no-WD-group despite a significant increase of platelet counts after immunoglobulin treatment (54/nl-->112/nl, P=0.018). On the day before, directly after and on the first day after surgery they were 141/nl vs. 215/nl (P=0.012), 75/nl vs. 147/nl (P=0.001) and 93/nl vs. 136/nl (P=0.009). Accordingly, patients of the WD-group received significantly more platelet concentrates than patients of the no-WD-group (mean number of platelet concentrates: 2.3 versus 0.7, P=0.007). Total drainage loss via the mediastinal chest tubes was almost identical (1197 ml in the no-WD-group and 1140 ml in the WD-group). One patient of each group suffered from a bleeding complication requiring reexploration. Three patients of the no-WD-group (6%) and one patient of the WD-group (10%) expired postoperatively unrelated to WD."
      ],
      "processing_time": 5.761805534362793,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Is there a connection between sublingual varices and hypertension?\n\nContext: Sublingual varices have earlier been related to ageing, smoking and cardiovascular disease. The aim of this study was to investigate whether sublingual varices are related to presence of hypertension. In an observational clinical study among 431 dental patients tongue status and blood pressure were documented. Digital photographs of the lateral borders of the tongue for grading of sublingual varices were taken, and blood pressure was measured. Those patients without previous diagnosis of hypertension and with a noted blood pressure \u2265 140 mmHg and/or \u2265 90 mmHg at the dental clinic performed complementary home blood pressure during one week. Those with an average home blood pressure \u2265 135 mmHg and/or \u2265 85 mmHg were referred to the primary health care centre, where three office blood pressure measurements were taken with one week intervals. Two independent blinded observers studied the photographs of the tongues. Each photograph was graded as none/few (grade 0) or medium/severe (grade 1) presence of sublingual varices. Pearson's Chi-square test, Student's t-test, and multiple regression analysis were applied. Power calculation stipulated a study population of 323 patients. An association between sublingual varices and hypertension was found (OR = 2.25, p<0.002). Mean systolic blood pressure was 123 and 132 mmHg in patients with grade 0 and grade 1 sublingual varices, respectively (p<0.0001, CI 95 %). Mean diastolic blood pressure was 80 and 83 mmHg in patients with grade 0 and grade 1 sublingual varices, respectively (p<0.005, CI 95 %). Sublingual varices indicate hypertension with a positive predictive value of 0.5 and a negative predictive value of 0.80.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found an association between sublingual varices and hypertension, it's not definitive proof of a direct connection. Here's why:\n\n1. **Association vs Causation**: The study shows that there's a relationship between the two conditions, but it doesn't prove that one causes the other. It's possible that they share common risk factors, such as aging or cardiovascular disease, which could explain the association.\n\n2. **Limited Sample Size**: Although the study was powered to detect a difference, the sample size was relatively small (431 patients), which could limit the generalizability of the findings.\n\n3. **Observer Bias**: The grading of sublingual varices was done by two independent observers, which helps to mitigate this bias, but it's still a possibility.\n\n4. **Confounding Factors**: The study didn't control for all potential confounding factors, such as smoking, which is known to affect both tongue status and cardiovascular health.\n\nSo, while the study suggests a possible connection between sublingual varices and hypertension, more research is needed to establish a definitive link and understand the nature of this relationship.",
      "expected_output": "yes",
      "question_values": [
        "Is there a connection between sublingual varices and hypertension?",
        "Sublingual varices have earlier been related to ageing, smoking and cardiovascular disease. The aim of this study was to investigate whether sublingual varices are related to presence of hypertension. In an observational clinical study among 431 dental patients tongue status and blood pressure were documented. Digital photographs of the lateral borders of the tongue for grading of sublingual varices were taken, and blood pressure was measured. Those patients without previous diagnosis of hypertension and with a noted blood pressure \u2265 140 mmHg and/or \u2265 90 mmHg at the dental clinic performed complementary home blood pressure during one week. Those with an average home blood pressure \u2265 135 mmHg and/or \u2265 85 mmHg were referred to the primary health care centre, where three office blood pressure measurements were taken with one week intervals. Two independent blinded observers studied the photographs of the tongues. Each photograph was graded as none/few (grade 0) or medium/severe (grade 1) presence of sublingual varices. Pearson's Chi-square test, Student's t-test, and multiple regression analysis were applied. Power calculation stipulated a study population of 323 patients. An association between sublingual varices and hypertension was found (OR = 2.25, p<0.002). Mean systolic blood pressure was 123 and 132 mmHg in patients with grade 0 and grade 1 sublingual varices, respectively (p<0.0001, CI 95 %). Mean diastolic blood pressure was 80 and 83 mmHg in patients with grade 0 and grade 1 sublingual varices, respectively (p<0.005, CI 95 %). Sublingual varices indicate hypertension with a positive predictive value of 0.5 and a negative predictive value of 0.80."
      ],
      "processing_time": 8.507407665252686,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does health information exchange reduce redundant imaging?\n\nContext: Broad-based electronic health information exchange (HIE), in which patients' clinical data follow them between care delivery settings, is expected to produce large quality gains and cost savings. Although these benefits are assumed to result from reducing redundant care, there is limited supporting empirical evidence. To evaluate whether HIE adoption is associated with decreases in repeat imaging in emergency departments (EDs).DATA SOURCE/ ED discharge data from the State Emergency Department Databases for California and Florida for 2007-2010 were merged with Health Information Management Systems Society data that report hospital HIE participation. Using regression with ED fixed effects and trends, we performed a retrospective analysis of the impact of HIE participation on repeat imaging, comparing 37 EDs that initiated HIE participation during the study period to 410 EDs that did not participate in HIE during the same period. Within 3 common types of imaging tests [computed tomography (CT), ultrasound, and chest x-ray), we defined a repeat image for a given patient as the same study in the same body region performed within 30 days at unaffiliated EDs. In our sample there were 20,139 repeat CTs (representing 14.7% of those cases with CT in the index visit), 13,060 repeat ultrasounds (20.7% of ultrasound cases), and 29,703 repeat chest x-rays (19.5% of x-ray cases). HIE was associated with reduced probability of repeat ED imaging in all 3 modalities: -8.7 percentage points for CT [95% confidence interval (CI): -14.7, -2.7], -9.1 percentage points for ultrasound (95% CI: -17.2, -1.1), and -13.0 percentage points for chest x-ray (95% CI: -18.3, -7.7), reflecting reductions of 44%-67% relative to sample means.\n\nAnswer (yes/no/maybe):",
      "response": "Yes, health information exchange (HIE) does reduce redundant imaging. The study found that HIE was associated with a reduced probability of repeat ED imaging in three common types of imaging tests: CT, ultrasound, and chest x-ray. The reductions ranged from 44% to 67% relative to sample means.",
      "expected_output": "yes",
      "question_values": [
        "Does health information exchange reduce redundant imaging?",
        "Broad-based electronic health information exchange (HIE), in which patients' clinical data follow them between care delivery settings, is expected to produce large quality gains and cost savings. Although these benefits are assumed to result from reducing redundant care, there is limited supporting empirical evidence. To evaluate whether HIE adoption is associated with decreases in repeat imaging in emergency departments (EDs).DATA SOURCE/ ED discharge data from the State Emergency Department Databases for California and Florida for 2007-2010 were merged with Health Information Management Systems Society data that report hospital HIE participation. Using regression with ED fixed effects and trends, we performed a retrospective analysis of the impact of HIE participation on repeat imaging, comparing 37 EDs that initiated HIE participation during the study period to 410 EDs that did not participate in HIE during the same period. Within 3 common types of imaging tests [computed tomography (CT), ultrasound, and chest x-ray), we defined a repeat image for a given patient as the same study in the same body region performed within 30 days at unaffiliated EDs. In our sample there were 20,139 repeat CTs (representing 14.7% of those cases with CT in the index visit), 13,060 repeat ultrasounds (20.7% of ultrasound cases), and 29,703 repeat chest x-rays (19.5% of x-ray cases). HIE was associated with reduced probability of repeat ED imaging in all 3 modalities: -8.7 percentage points for CT [95% confidence interval (CI): -14.7, -2.7], -9.1 percentage points for ultrasound (95% CI: -17.2, -1.1), and -13.0 percentage points for chest x-ray (95% CI: -18.3, -7.7), reflecting reductions of 44%-67% relative to sample means."
      ],
      "processing_time": 2.438993453979492,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: The promise of specialty pharmaceuticals: are they worth the price?\n\nContext: Specialty pharmaceuticals have evolved beyond their status as niche drugs designed to treat rare conditions and are now poised to become the standard of care in a wide variety of common chronic illnesses. Due in part to the cost of these therapies, payers are increasingly demanding evidence of their value. Determining the value of these medications is hampered by a lack of robust pharmacoeconomic data. To outline emerging strategies and case study examples for the medical and pharmacy benefits management of specialty pharmaceuticals. The promise of specialty pharmaceuticals: increased life expectancy, improved quality of life, enhanced workplace productivity, decreased burden of disease, and reduced health care spending comes at a significant cost. These agents require special handling, administration, patient education, clinical support, and risk mitigation. Additionally, specialty drugs require distribution systems that ensure appropriate patient selection and data collection. With the specialty pharmaceutical pipeline overflowing with new medicines and an aging population increasingly relying on these novel treatments to treat common diseases, the challenge of managing the costs associated with these agents can be daunting. Aided by sophisticated pharmacoeconomic models to assess value, the cost impacts of these specialty drugs can be appropriately controlled.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. Here's why:\n\n- **Yes, they can be worth the price**: Specialty pharmaceuticals often offer significant benefits, such as improved patient outcomes, increased life expectancy, and enhanced quality of life. They can also reduce healthcare costs in the long run by preventing complications and hospitalizations. For example, biologics for autoimmune diseases like rheumatoid arthritis have been shown to improve patient outcomes and reduce healthcare costs compared to traditional treatments.\n\n- **No, they're not always worth the price**: The high cost of specialty pharmaceuticals can be a barrier to access for many patients, leading to health disparities. Additionally, some studies have questioned the value of certain specialty drugs, showing that their benefits may not justify their high costs. For instance, a study published in JAMA found that many new cancer drugs did not improve survival or quality of life compared to older, cheaper treatments.\n\n- **Maybe, it depends**: The value of specialty pharmaceuticals can vary greatly depending on the specific drug, the condition it treats, and the patient population. Some drugs may offer significant benefits that justify their high costs, while others may not. Therefore, it's crucial to evaluate each drug on a case-by-case basis, using robust pharmacoeconomic data and models to assess their value.\n\nIn conclusion, while specialty pharmaceuticals have the potential to offer significant benefits, their high costs also raise important questions about their value. It's essential to carefully evaluate each drug's benefits and costs to ensure that they are used appropriately and that patients have access to the treatments they need.",
      "expected_output": "yes",
      "question_values": [
        "The promise of specialty pharmaceuticals: are they worth the price?",
        "Specialty pharmaceuticals have evolved beyond their status as niche drugs designed to treat rare conditions and are now poised to become the standard of care in a wide variety of common chronic illnesses. Due in part to the cost of these therapies, payers are increasingly demanding evidence of their value. Determining the value of these medications is hampered by a lack of robust pharmacoeconomic data. To outline emerging strategies and case study examples for the medical and pharmacy benefits management of specialty pharmaceuticals. The promise of specialty pharmaceuticals: increased life expectancy, improved quality of life, enhanced workplace productivity, decreased burden of disease, and reduced health care spending comes at a significant cost. These agents require special handling, administration, patient education, clinical support, and risk mitigation. Additionally, specialty drugs require distribution systems that ensure appropriate patient selection and data collection. With the specialty pharmaceutical pipeline overflowing with new medicines and an aging population increasingly relying on these novel treatments to treat common diseases, the challenge of managing the costs associated with these agents can be daunting. Aided by sophisticated pharmacoeconomic models to assess value, the cost impacts of these specialty drugs can be appropriately controlled."
      ],
      "processing_time": 11.281685829162598,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: The colour of pain: can patients use colour to describe osteoarthritis pain?\n\nContext: The aim of the present study was to explore patients' views on the acceptability and feasibility of using colour to describe osteoarthritis (OA) pain, and whether colour could be used to communicate pain to healthcare professionals. Six group interviews were conducted with 17 patients with knee OA. Discussion topics included first impressions about using colour to describe pain, whether participants could associate their pain with colour, how colours related to changes to intensity and different pain qualities, and whether they could envisage using colour to describe pain to healthcare professionals. The group interviews indicated that, although the idea of using colour was generally acceptable, it did not suit all participants as a way of describing their pain. The majority of participants chose red to describe high-intensity pain; the reasons given were because red symbolized inflammation, fire, anger and the stop signal in a traffic light system. Colours used to describe the absence of pain were chosen because of their association with positive emotional feelings, such as purity, calmness and happiness. A range of colours was chosen to represent changes in pain intensity. Aching pain was consistently identified as being associated with colours such as grey or black, whereas sharp pain was described using a wider selection of colours. The majority of participants thought that they would be able to use colour to describe their pain to healthcare professionals, although issues around the interpretability and standardization of colour were raised.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that many patients with knee osteoarthritis could associate their pain with colors and found the idea of using color to describe pain acceptable, it did not suit all participants. Therefore, while color could potentially be used as an additional tool to communicate pain, it may not be universally applicable or suitable for all patients.",
      "expected_output": "yes",
      "question_values": [
        "The colour of pain: can patients use colour to describe osteoarthritis pain?",
        "The aim of the present study was to explore patients' views on the acceptability and feasibility of using colour to describe osteoarthritis (OA) pain, and whether colour could be used to communicate pain to healthcare professionals. Six group interviews were conducted with 17 patients with knee OA. Discussion topics included first impressions about using colour to describe pain, whether participants could associate their pain with colour, how colours related to changes to intensity and different pain qualities, and whether they could envisage using colour to describe pain to healthcare professionals. The group interviews indicated that, although the idea of using colour was generally acceptable, it did not suit all participants as a way of describing their pain. The majority of participants chose red to describe high-intensity pain; the reasons given were because red symbolized inflammation, fire, anger and the stop signal in a traffic light system. Colours used to describe the absence of pain were chosen because of their association with positive emotional feelings, such as purity, calmness and happiness. A range of colours was chosen to represent changes in pain intensity. Aching pain was consistently identified as being associated with colours such as grey or black, whereas sharp pain was described using a wider selection of colours. The majority of participants thought that they would be able to use colour to describe their pain to healthcare professionals, although issues around the interpretability and standardization of colour were raised."
      ],
      "processing_time": 2.4243509769439697,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Is fluoroscopy essential for retrieval of lower ureteric stones?\n\nContext: The aim of this study was to assess the efficacy of ureteroscopy for lower ureteric stones without the use of fluoroscopy. Between June 2001 and January 2005, a total of 110 patients with a mean age of 33.5 years (range 12-65) suffering from of lower ureteral calculi (below the upper margin of the sacroiliac joint) prospectively underwent ureteroscopic removal. Retrograde pyelography was avoided, and no safety guidewire was placed. Whenever required, the ureteric meatus was dilated with a ureteric balloon under direct vision. Double-J stent placement was done with the aid of ureteroscopy. A fluoroscope was kept standby. The patients had a postoperative X-ray of the kidney-ureter-bladder region to document the stone clearance. The mean stone size was 8.7 mm (range 6-15). Complete clearance without the use of fluoroscopy was achieved in 99 patients (94.2%). Fluoroscopy was required in 6 patients (4%) for calcified stricture (n = 1), duplex system (n = 1), narrow and tortuous meatus causing difficulty in passing the 5-Fr balloon dilator (n = 3), and confirmation of spontaneous passage of the stone (n = 1). Of the 13 patients who required balloon dilatation it was successfully achieved without fluoroscopy. Double-J stenting was done due to mucosal ulceration (n = 3), polypoid reaction (n = 2), and perforation (n = 1). All these patients had correct placement of the stent, as confirmed by X-ray of the kidney-ureter-bladder region postoperatively.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study shows that fluoroscopy was not always necessary for lower ureteric stone retrieval, it was still used in some cases. Therefore, it might be essential in certain situations, such as when dealing with complex anatomy (like a duplex system) or when there are concerns about the safety of the procedure (like in the case of a calcified stricture). However, the study also demonstrates that with careful patient selection and experienced endourologists, fluoroscopy can be minimized or even avoided in many cases. Thus, the necessity of fluoroscopy may depend on the specific clinical scenario and the expertise of the treating physician.",
      "expected_output": "no",
      "question_values": [
        "Is fluoroscopy essential for retrieval of lower ureteric stones?",
        "The aim of this study was to assess the efficacy of ureteroscopy for lower ureteric stones without the use of fluoroscopy. Between June 2001 and January 2005, a total of 110 patients with a mean age of 33.5 years (range 12-65) suffering from of lower ureteral calculi (below the upper margin of the sacroiliac joint) prospectively underwent ureteroscopic removal. Retrograde pyelography was avoided, and no safety guidewire was placed. Whenever required, the ureteric meatus was dilated with a ureteric balloon under direct vision. Double-J stent placement was done with the aid of ureteroscopy. A fluoroscope was kept standby. The patients had a postoperative X-ray of the kidney-ureter-bladder region to document the stone clearance. The mean stone size was 8.7 mm (range 6-15). Complete clearance without the use of fluoroscopy was achieved in 99 patients (94.2%). Fluoroscopy was required in 6 patients (4%) for calcified stricture (n = 1), duplex system (n = 1), narrow and tortuous meatus causing difficulty in passing the 5-Fr balloon dilator (n = 3), and confirmation of spontaneous passage of the stone (n = 1). Of the 13 patients who required balloon dilatation it was successfully achieved without fluoroscopy. Double-J stenting was done due to mucosal ulceration (n = 3), polypoid reaction (n = 2), and perforation (n = 1). All these patients had correct placement of the stent, as confirmed by X-ray of the kidney-ureter-bladder region postoperatively."
      ],
      "processing_time": 4.662086009979248,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome?\n\nContext: Neutrophil infiltration of the lung is characteristic of early posttraumatic acute respiratory distress syndrome (ARDS). This study examines the ability of neutrophils isolated (over the first 24 hrs) from the peripheral blood of patients admitted after major trauma to migrate in response to interleukin-8. Interleukin-8 is elevated in the lung within 2 hrs of major trauma in patients who later develop ARDS, and thus it plays a central role in the recruitment of neutrophils to the lung and their subsequent activation. We hypothesized that enhanced interleukin-8-mediated neutrophil migratory activity in the early postinjury phase, before the development of ARDS, may be a crucial factor in the etiology of ARDS. Prospective observational study. University Hospital Wales, the Royal Gwent Hospital, and East Glamorgan General Hospital. Laboratory work was conducted at the Institute of Nephrology. Adult blunt trauma victims with Injury Severity Score>or = 18. Neutrophils were isolated from citrated blood from 17 adult blunt major trauma patients at admission (0 hrs) and 8 and 24 hrs later. Identical samples were obtained from normal laboratory volunteers (n = 9). The neutrophil count in each specimen was measured, and the number of neutrophils migrating across porous tissue culture inserts in response to defined concentrations of interleukin-8 (0, 10, 30, and 100 ng/mL) was quantitated by peroxidase assay. Neutrophil counts in the whole blood specimens obtained from those later developing ARDS were elevated significantly at admission and declined rapidly throughout the next 24 hrs. Significantly greater numbers of trauma patients' neutrophils migrated to concentrations of interleukin-8 (30 and 100 ng/mL) at each time point when compared with normal volunteers (Mann-Whitney U test, p<.05). Neutrophils isolated from major trauma patients exhibited an enhanced migratory response to high concentrations of interleukin-8 throughout the first 24 hrs of admission, in contrast to the normal physiologic attenuation of migration seen in neutrophils isolated from normal laboratory volunteers.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. The study suggests that neutrophils from trauma patients show enhanced migratory activity in response to interleukin-8, which could contribute to the development of ARDS. However, the study is observational and does not establish causality. Further research is needed to determine if this enhanced migratory activity is indeed a crucial factor in the etiology of ARDS after major trauma.",
      "expected_output": "yes",
      "question_values": [
        "Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome?",
        "Neutrophil infiltration of the lung is characteristic of early posttraumatic acute respiratory distress syndrome (ARDS). This study examines the ability of neutrophils isolated (over the first 24 hrs) from the peripheral blood of patients admitted after major trauma to migrate in response to interleukin-8. Interleukin-8 is elevated in the lung within 2 hrs of major trauma in patients who later develop ARDS, and thus it plays a central role in the recruitment of neutrophils to the lung and their subsequent activation. We hypothesized that enhanced interleukin-8-mediated neutrophil migratory activity in the early postinjury phase, before the development of ARDS, may be a crucial factor in the etiology of ARDS. Prospective observational study. University Hospital Wales, the Royal Gwent Hospital, and East Glamorgan General Hospital. Laboratory work was conducted at the Institute of Nephrology. Adult blunt trauma victims with Injury Severity Score>or = 18. Neutrophils were isolated from citrated blood from 17 adult blunt major trauma patients at admission (0 hrs) and 8 and 24 hrs later. Identical samples were obtained from normal laboratory volunteers (n = 9). The neutrophil count in each specimen was measured, and the number of neutrophils migrating across porous tissue culture inserts in response to defined concentrations of interleukin-8 (0, 10, 30, and 100 ng/mL) was quantitated by peroxidase assay. Neutrophil counts in the whole blood specimens obtained from those later developing ARDS were elevated significantly at admission and declined rapidly throughout the next 24 hrs. Significantly greater numbers of trauma patients' neutrophils migrated to concentrations of interleukin-8 (30 and 100 ng/mL) at each time point when compared with normal volunteers (Mann-Whitney U test, p<.05). Neutrophils isolated from major trauma patients exhibited an enhanced migratory response to high concentrations of interleukin-8 throughout the first 24 hrs of admission, in contrast to the normal physiologic attenuation of migration seen in neutrophils isolated from normal laboratory volunteers."
      ],
      "processing_time": 2.589876174926758,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does the SCL 90-R obsessive-compulsive dimension identify cognitive impairments?\n\nContext: To investigate the relevance of the Symptom Checklist 90-R Obsessive-Compulsive subscale to cognition in individuals with brain tumor. A prospective study of patients assessed with a neuropsychological test battery. A university medical center. Nineteen adults with biopsy-confirmed diagnoses of malignant brain tumors were assessed prior to aggressive chemotherapy. Included in the assessment were the Mattis Dementia Rating Scale, California Verbal Learning Test, Trail Making Test B, Symptom Checklist 90-R, Mood Assessment Scale, Beck Anxiety Inventory, and Chronic Illness Problem Inventory. The SCL 90-R Obsessive-Compulsive subscale was not related to objective measures of attention, verbal memory, or age. It was related significantly to symptoms of depression (r = .81, P<.005), anxiety (r = .66, P<.005), and subjective complaints of memory problems (r = .75, P<.005). Multivariate analyses indicated that reported symptoms of depression contributed 66% of the variance in predicting SCL 90-R Obsessive-Compulsive Scores, whereas symptoms of anxiety contributed an additional 6% (P<.0001).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the SCL 90-R Obsessive-Compulsive dimension did not directly identify cognitive impairments in this study, it was significantly related to symptoms of depression and anxiety, which are known to impact cognitive functioning. Therefore, it might indirectly reflect cognitive impairments through its association with these mood symptoms. However, the study's results do not provide definitive evidence for a direct link between the obsessive-compulsive dimension and cognitive impairments.",
      "expected_output": "yes",
      "question_values": [
        "Does the SCL 90-R obsessive-compulsive dimension identify cognitive impairments?",
        "To investigate the relevance of the Symptom Checklist 90-R Obsessive-Compulsive subscale to cognition in individuals with brain tumor. A prospective study of patients assessed with a neuropsychological test battery. A university medical center. Nineteen adults with biopsy-confirmed diagnoses of malignant brain tumors were assessed prior to aggressive chemotherapy. Included in the assessment were the Mattis Dementia Rating Scale, California Verbal Learning Test, Trail Making Test B, Symptom Checklist 90-R, Mood Assessment Scale, Beck Anxiety Inventory, and Chronic Illness Problem Inventory. The SCL 90-R Obsessive-Compulsive subscale was not related to objective measures of attention, verbal memory, or age. It was related significantly to symptoms of depression (r = .81, P<.005), anxiety (r = .66, P<.005), and subjective complaints of memory problems (r = .75, P<.005). Multivariate analyses indicated that reported symptoms of depression contributed 66% of the variance in predicting SCL 90-R Obsessive-Compulsive Scores, whereas symptoms of anxiety contributed an additional 6% (P<.0001)."
      ],
      "processing_time": 3.331373929977417,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Can transcranial direct current stimulation be useful in differentiating unresponsive wakefulness syndrome from minimally conscious state patients?\n\nContext: Disorders of consciousness (DOC) diagnosis relies on the presence or absence of purposeful motor responsiveness, which characterizes the minimally conscious state (MCS) and the unresponsive wakefulness syndrome (UWS), respectively. Functional neuroimaging studies have raised the question of possible residual conscious awareness also in clinically-defined UWS patients. The aim of our study was to identify electrophysiological parameters, by means of a transcranial magnetic stimulation approach, which might potentially express the presence of residual networks sustaining fragmentary behavioral patterns, even when no conscious behavior can be observed. We enrolled 25 severe DOC patients, following post-anoxic or traumatic brain injury and 20 healthy individuals (HC) as control group. Baseline electrophysiological evaluation evidenced, in comparison to HC, a partial preservation of cortical effective connectivity and excitability in clinically defined MCS, whereas these components were absent in clinically defined UWS. Then, we applied an anodal transcranial direct current stimulation (a-tDCS) protocol over the orbitofrontal cortex. a-tDCS was able to boost cortical connectivity and excitability in all HC, MCS, and to unmask such excitability/connectivity in some UWS patients.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that transcranial direct current stimulation (tDCS) could potentially differentiate between unresponsive wakefulness syndrome (UWS) and minimally conscious state (MCS) patients by boosting cortical connectivity and excitability, there are a few points to consider:\n\n1. **Small Sample Size**: The study had a relatively small sample size (25 DOC patients and 20 healthy controls), which might limit the generalizability of the findings.\n\n2. **Heterogeneity of DOC Patients**: DOC patients can have diverse etiologies and clinical trajectories, which could affect the response to tDCS.\n\n3. **Placebo Effect**: tDCS studies are often susceptible to placebo effects, as participants may feel sensations during stimulation, which could influence their behavior or the assessor's observations.\n\n4. **Long-term Effects**: The study did not investigate the long-term effects of tDCS. It's possible that any changes in connectivity or excitability might not translate into sustained improvements in consciousness or behavior.\n\n5. **Standardization of tDCS Protocol**: The optimal tDCS protocol (e.g., stimulation intensity, duration, and location) for DOC patients is not yet established and may vary between individuals.\n\nTherefore, while the study provides promising preliminary results, further research with larger, more homogeneous samples, and longer follow-up periods is needed to confirm the usefulness of tDCS in differentiating UWS from MCS patients.",
      "expected_output": "yes",
      "question_values": [
        "Can transcranial direct current stimulation be useful in differentiating unresponsive wakefulness syndrome from minimally conscious state patients?",
        "Disorders of consciousness (DOC) diagnosis relies on the presence or absence of purposeful motor responsiveness, which characterizes the minimally conscious state (MCS) and the unresponsive wakefulness syndrome (UWS), respectively. Functional neuroimaging studies have raised the question of possible residual conscious awareness also in clinically-defined UWS patients. The aim of our study was to identify electrophysiological parameters, by means of a transcranial magnetic stimulation approach, which might potentially express the presence of residual networks sustaining fragmentary behavioral patterns, even when no conscious behavior can be observed. We enrolled 25 severe DOC patients, following post-anoxic or traumatic brain injury and 20 healthy individuals (HC) as control group. Baseline electrophysiological evaluation evidenced, in comparison to HC, a partial preservation of cortical effective connectivity and excitability in clinically defined MCS, whereas these components were absent in clinically defined UWS. Then, we applied an anodal transcranial direct current stimulation (a-tDCS) protocol over the orbitofrontal cortex. a-tDCS was able to boost cortical connectivity and excitability in all HC, MCS, and to unmask such excitability/connectivity in some UWS patients."
      ],
      "processing_time": 10.625240325927734,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does prostate morphology affect outcomes after holmium laser enucleation?\n\nContext: To determine whether prostate morphology or technique used has any effect on postoperative outcomes after holmium laser enucleation of the prostate. A retrospective review of prospectively collected data was completed for all patients undergoing a holmium laser enucleation of the prostate at our institution. Prostate morphology was classified as either \"bilobar\" or \"trilobar\" according to the cystoscopic appearance. The baseline characteristics, complications, and postoperative outcomes were collected. A total of 304 patients with either \"bilobar\" (n\u00a0= 142) or \"trilobar\" (n\u00a0= 162) prostate morphology were included. The trilobar group was more likely to have longer operative times (112 vs 100 minutes, P\u00a0= .04), although this difference was not significant on multivariate analysis. The postoperative outcomes were similar between the 2 groups for American Urological Association symptom score, change in American Urological Association symptom score, bother score, maximal flow rate, change in maximal flow rate, postvoid residual urine volume, and complication rate. However, the trilobar group had a significantly greater decrease in their PVR urine volume (296 vs 176 mL, P\u00a0= .01), a difference that persisted on multivariate analysis. A subset analysis of the trilobar prostates revealed that performing a 2-lobe technique achieved shorter operative and enucleation times, although the difference was not significant.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that prostate morphology (bilobar vs trilobar) did not significantly affect most postoperative outcomes, there was a significant difference in the decrease in postvoid residual urine volume (PVR) between the two groups, with the trilobar group having a greater decrease. However, the clinical significance of this difference is unclear, and the study also found that the operative time was longer in the trilobar group, although this difference was not significant on multivariate analysis. Therefore, while prostate morphology may have some effect on postoperative outcomes, the evidence is not conclusive, and further research is needed to determine the true impact of prostate morphology on outcomes after holmium laser enucleation of the prostate.",
      "expected_output": "yes",
      "question_values": [
        "Does prostate morphology affect outcomes after holmium laser enucleation?",
        "To determine whether prostate morphology or technique used has any effect on postoperative outcomes after holmium laser enucleation of the prostate. A retrospective review of prospectively collected data was completed for all patients undergoing a holmium laser enucleation of the prostate at our institution. Prostate morphology was classified as either \"bilobar\" or \"trilobar\" according to the cystoscopic appearance. The baseline characteristics, complications, and postoperative outcomes were collected. A total of 304 patients with either \"bilobar\" (n\u00a0= 142) or \"trilobar\" (n\u00a0= 162) prostate morphology were included. The trilobar group was more likely to have longer operative times (112 vs 100 minutes, P\u00a0= .04), although this difference was not significant on multivariate analysis. The postoperative outcomes were similar between the 2 groups for American Urological Association symptom score, change in American Urological Association symptom score, bother score, maximal flow rate, change in maximal flow rate, postvoid residual urine volume, and complication rate. However, the trilobar group had a significantly greater decrease in their PVR urine volume (296 vs 176 mL, P\u00a0= .01), a difference that persisted on multivariate analysis. A subset analysis of the trilobar prostates revealed that performing a 2-lobe technique achieved shorter operative and enucleation times, although the difference was not significant."
      ],
      "processing_time": 5.190288066864014,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Injury and poisoning mortality among young men--are there any common factors amenable to prevention?\n\nContext: Deaths from injury and poisoning (suicide, accidents, undetermined deaths, and homicide) are the major cause of death among young men aged 15-39 years in England and Wales and have been increasing in recent years.AIM: To describe common characteristics among young men who die from injury and poisoning. We employed a retrospective survey methodology to investigate factors associated with deaths by injury and poisoning among young men aged 15-39 years (n = 268) in Merseyside and Cheshire during 1995. Data were collected from Coroner's inquest notes and General Practitioner records. The most common cause of death was poisoning by alcohol and drugs (29.1%, n = 78). A high proportion of cases were unemployed (39.4%, n = 106). Cases were also more likely to be single compared to the general population (74.2% vs 55.5%). Self-destructive behaviour was evident in 77% of deaths (n = 206).\n\nAnswer (yes/no/maybe):",
      "response": "Yes, there are several common factors amenable to prevention among young men who die from injury and poisoning. Here are some key factors and potential prevention strategies:\n\n1. **Substance Abuse (Alcohol and Drugs) - 29.1% of deaths:**\n   - *Prevention:* Implement harm reduction strategies, such as drug and alcohol education programs, needle exchange programs, and access to treatment services. Encourage responsible alcohol consumption and enforce strict drink-driving laws.\n\n2. **Unemployment - 39.4% of cases:**\n   - *Prevention:* Promote education and vocational training opportunities, and implement policies that support youth employment. Encourage employers to provide fair wages and safe working conditions.\n\n3. **Single Status - 74.2% of cases:**\n   - *Prevention:* While it's challenging to directly prevent this, promoting mental health services and support networks can help address the underlying issues that may contribute to single status and subsequent self-destructive behaviors.\n\n4. **Self-destructive Behavior - 77% of deaths:**\n   - *Prevention:* Implement mental health promotion and suicide prevention programs. These can include mental health education, access to counseling services, and gatekeeper training for individuals likely to recognize warning signs (e.g., family, friends, teachers, and healthcare providers).\n\n5. **Other common factors:**\n   - **Mental Health Issues:** Many young men who die from injury and poisoning have underlying mental health conditions. Improving access to mental health services and promoting mental health awareness can help prevent these deaths.\n   - **Social Isolation:** Many young men who die from injury and poisoning are socially isolated. Promoting social connections and community engagement can help prevent these deaths.\n   - **Lack of Physical Activity:** Physical inactivity is linked to poor mental health and increased risk of injury. Promoting physical activity and sports programs can help prevent these deaths.",
      "expected_output": "yes",
      "question_values": [
        "Injury and poisoning mortality among young men--are there any common factors amenable to prevention?",
        "Deaths from injury and poisoning (suicide, accidents, undetermined deaths, and homicide) are the major cause of death among young men aged 15-39 years in England and Wales and have been increasing in recent years.AIM: To describe common characteristics among young men who die from injury and poisoning. We employed a retrospective survey methodology to investigate factors associated with deaths by injury and poisoning among young men aged 15-39 years (n = 268) in Merseyside and Cheshire during 1995. Data were collected from Coroner's inquest notes and General Practitioner records. The most common cause of death was poisoning by alcohol and drugs (29.1%, n = 78). A high proportion of cases were unemployed (39.4%, n = 106). Cases were also more likely to be single compared to the general population (74.2% vs 55.5%). Self-destructive behaviour was evident in 77% of deaths (n = 206)."
      ],
      "processing_time": 14.156766414642334,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Are stroke patients' reports of home blood pressure readings reliable?\n\nContext: Home blood pressure (BP) monitoring is gaining increasing popularity among patients and may be useful in hypertension management. Little is known about the reliability of stroke patients' records of home BP monitoring. To assess the reliability of home BP recording in hypertensive patients who had suffered a recent stroke or transient ischaemic attack. Thirty-nine stroke patients (mean age 73 years) randomized to the intervention arm of a trial of home BP monitoring were included. Following instruction by a research nurse, patients recorded their BPs at home and documented them in a booklet over the next year. The booklet readings over a month were compared with the actual readings downloaded from the BP monitor and were checked for errors or selective bias in recording. A total of 1027 monitor and 716 booklet readings were recorded. Ninety per cent of booklet recordings were exactly the same as the BP monitor readings. Average booklet readings were 0.6 mmHg systolic [95% confidence interval (95% CI) -0.6 to 1.8] and 0.3 mmHg diastolic (95% CI -0.3 to 0.8) lower than those on the monitor.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found a high degree of agreement between the home blood pressure monitor readings and the patients' recorded readings in their booklets, with 90% of readings being exactly the same, there were still some discrepancies. The average difference was small, but not negligible, with booklet readings being slightly lower than monitor readings. Additionally, the study only included patients who were part of a trial and had received instruction from a research nurse, which may not be representative of all stroke patients using home blood pressure monitors. Therefore, while the study suggests that stroke patients' reports of home blood pressure readings may be reliable, more research is needed to confirm this in a broader population.",
      "expected_output": "yes",
      "question_values": [
        "Are stroke patients' reports of home blood pressure readings reliable?",
        "Home blood pressure (BP) monitoring is gaining increasing popularity among patients and may be useful in hypertension management. Little is known about the reliability of stroke patients' records of home BP monitoring. To assess the reliability of home BP recording in hypertensive patients who had suffered a recent stroke or transient ischaemic attack. Thirty-nine stroke patients (mean age 73 years) randomized to the intervention arm of a trial of home BP monitoring were included. Following instruction by a research nurse, patients recorded their BPs at home and documented them in a booklet over the next year. The booklet readings over a month were compared with the actual readings downloaded from the BP monitor and were checked for errors or selective bias in recording. A total of 1027 monitor and 716 booklet readings were recorded. Ninety per cent of booklet recordings were exactly the same as the BP monitor readings. Average booklet readings were 0.6 mmHg systolic [95% confidence interval (95% CI) -0.6 to 1.8] and 0.3 mmHg diastolic (95% CI -0.3 to 0.8) lower than those on the monitor."
      ],
      "processing_time": 5.038231372833252,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Is endothelin-1 an aggravating factor in the development of acute pancreatitis?\n\nContext: We have reported previously that cerulein-induced edematous pancreatitis would transform into hemorrhagic pancreatitis by administration of endothelin-1 in rats. In the present study, we tried to protect rat model from developing into hemorrhagic pancreatitis with BQ123 (an ETA receptor antagonist). The rat model was made by 5-hour restraint water-immersion stress and two intraperitoneal injections of cerulein (40 micrograms/kg) at hourly interval. BQ123 (3 or 6 mg/kg) was administered intravenously 30 minutes before and 2 hours after the first cerulein injection. Acute hemorrhagic pancreatitis was induced in all rats treated with cerulin + stress. The score for pancreatic hemorrhage was 2.4 +/- 0.2 in this group. In the rats pretreated with BQ123, the score was reduced to 1.0 +/- 0.0, pancreas wet weight and serum amylase activity were significantly reduced, and histologic alterations in the pancreas lightened, also the local pancreatic blood flow improved without affecting the systemic blood pressure.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study you've described suggests that endothelin-1 (ET-1) plays a role in the progression of acute pancreatitis to a more severe form (hemorrhagic pancreatitis) in rats, it doesn't definitively prove that ET-1 is an aggravating factor in the initial development of acute pancreatitis. Here's why:\n\n1. **ET-1 administration**: In your previous study, ET-1 was administered to rats to transform edematous pancreatitis into hemorrhagic pancreatitis. This suggests that ET-1 can exacerbate the condition, but it doesn't show that ET-1 is involved in the initial development of acute pancreatitis.\n\n2. **BQ123 treatment**: In the present study, blocking the ETA receptor with BQ123 reduced the severity of pancreatitis, indicating that ET-1 signaling through the ETA receptor contributes to the progression of pancreatitis. However, this doesn't necessarily mean that ET-1 is involved in the initial development of the condition.\n\n3. **Stress and cerulein model**: The rat model used in the study involves stress and cerulein injections, which are known to induce pancreatitis. The role of ET-1 in this specific model doesn't necessarily translate to other causes of acute pancreatitis.\n\nTo definitively determine if ET-1 is an aggravating factor in the development of acute pancreatitis, further studies would be needed, such as investigating the role of ET-1 in other pancreatitis models or examining the effects of ET-1 blockade on the initial stages of pancreatitis.",
      "expected_output": "yes",
      "question_values": [
        "Is endothelin-1 an aggravating factor in the development of acute pancreatitis?",
        "We have reported previously that cerulein-induced edematous pancreatitis would transform into hemorrhagic pancreatitis by administration of endothelin-1 in rats. In the present study, we tried to protect rat model from developing into hemorrhagic pancreatitis with BQ123 (an ETA receptor antagonist). The rat model was made by 5-hour restraint water-immersion stress and two intraperitoneal injections of cerulein (40 micrograms/kg) at hourly interval. BQ123 (3 or 6 mg/kg) was administered intravenously 30 minutes before and 2 hours after the first cerulein injection. Acute hemorrhagic pancreatitis was induced in all rats treated with cerulin + stress. The score for pancreatic hemorrhage was 2.4 +/- 0.2 in this group. In the rats pretreated with BQ123, the score was reduced to 1.0 +/- 0.0, pancreas wet weight and serum amylase activity were significantly reduced, and histologic alterations in the pancreas lightened, also the local pancreatic blood flow improved without affecting the systemic blood pressure."
      ],
      "processing_time": 11.42715573310852,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Is leptin involved in phagocytic NADPH oxidase overactivity in obesity?\n\nContext: Hyperleptinemia and oxidative stress play a major role in the development of cardiovascular diseases in obesity. This study aimed to investigate whether there is a relationship between plasma levels of leptin and phagocytic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, and its potential relevance in the vascular remodeling in obese patients. The study was performed in 164 obese and 94 normal-weight individuals (controls). NADPH oxidase activity was evaluated by luminescence in phagocytic cells. Levels of leptin were quantified by ELISA in plasma samples. Carotid intima-media thickness (cIMT) was measured by ultrasonography. In addition, we performed in-vitro experiments in human peripheral blood mononuclear cells and murine macrophages. Phagocytic NADPH oxidase activity and leptin levels were enhanced (P<0.05) in obese patients compared with controls. NADPH oxidase activity positively correlated with leptin in obese patients. This association remained significant in a multivariate analysis. cIMT was higher (P<0.05) in obese patients compared with controls. In addition, cIMT also correlated positively with leptin and NADPH oxidase activity in obese patients. In-vitro studies showed that leptin induced NADPH oxidase activation. Inhibition of the leptin-induced NADPH oxidase activity by wortmannin and bisindolyl maleimide suggested a direct involvement of the phosphatidylinositol 3-kinase and protein kinase C pathways, respectively. Finally, leptin-induced NADPH oxidase activation promoted macrophage proliferation.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. The study suggests a relationship between leptin and NADPH oxidase activity in obesity, but it doesn't provide definitive proof of a causal link. Here's why:\n\n1. **Correlation, not causation**: The study found a positive correlation between leptin levels and NADPH oxidase activity in obese patients, but correlation does not imply causation. Other factors could be influencing both leptin levels and NADPH oxidase activity.\n\n2. **In vitro evidence**: The in vitro experiments showed that leptin can induce NADPH oxidase activation in human peripheral blood mononuclear cells and murine macrophages. However, these findings may not fully translate to the in vivo situation in humans.\n\n3. **Lack of intervention studies**: The study did not include intervention studies where leptin levels were manipulated to see if this affected NADPH oxidase activity and vice versa.\n\nSo, while the study provides interesting evidence suggesting a link between leptin and NADPH oxidase activity in obesity, more research is needed to establish a definitive causal relationship. Therefore, the answer is \"maybe\".",
      "expected_output": "yes",
      "question_values": [
        "Is leptin involved in phagocytic NADPH oxidase overactivity in obesity?",
        "Hyperleptinemia and oxidative stress play a major role in the development of cardiovascular diseases in obesity. This study aimed to investigate whether there is a relationship between plasma levels of leptin and phagocytic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, and its potential relevance in the vascular remodeling in obese patients. The study was performed in 164 obese and 94 normal-weight individuals (controls). NADPH oxidase activity was evaluated by luminescence in phagocytic cells. Levels of leptin were quantified by ELISA in plasma samples. Carotid intima-media thickness (cIMT) was measured by ultrasonography. In addition, we performed in-vitro experiments in human peripheral blood mononuclear cells and murine macrophages. Phagocytic NADPH oxidase activity and leptin levels were enhanced (P<0.05) in obese patients compared with controls. NADPH oxidase activity positively correlated with leptin in obese patients. This association remained significant in a multivariate analysis. cIMT was higher (P<0.05) in obese patients compared with controls. In addition, cIMT also correlated positively with leptin and NADPH oxidase activity in obese patients. In-vitro studies showed that leptin induced NADPH oxidase activation. Inhibition of the leptin-induced NADPH oxidase activity by wortmannin and bisindolyl maleimide suggested a direct involvement of the phosphatidylinositol 3-kinase and protein kinase C pathways, respectively. Finally, leptin-induced NADPH oxidase activation promoted macrophage proliferation."
      ],
      "processing_time": 7.230771780014038,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Are women who are treated for hypothyroidism at risk for pregnancy complications?\n\nContext: The purpose of this study was to investigate the outcomes that are associated with pregnancy and treated hypothyroidism. This was a retrospective cohort study of all women who received prenatal care and were delivered at the University of California, San Francisco, between 1989 and 2001. All patients with hypothyroidism diagnosed before pregnancy or early in pregnancy were identified. Maternal, fetal, and obstetric outcomes were then collected and analyzed for women with hypothyroidism and compared with women without hypothyroidism. Among 20,499 deliveries, there were 419 women (2.1%) who were treated for hypothyroidism during the study period. Hypothyroidism was more common among women>or =35 years old, white women, and women without Medicaid insurance. Treated hypothyroidism was not associated with any increase in maternal, fetal, or neonatal complications. In addition, hypothyroidism did not affect mode of delivery.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found no increased risk of pregnancy complications among women with treated hypothyroidism, it's important to note that the study had some limitations. It was retrospective, relied on medical record accuracy, and did not account for potential confounders like thyroid function test results or medication adherence. Therefore, while the study suggests that treated hypothyroidism may not increase the risk of pregnancy complications, more research is needed to confirm these findings. It's always recommended for women with hypothyroidism to work closely with their healthcare provider during pregnancy to monitor their thyroid function and ensure optimal treatment.",
      "expected_output": "no",
      "question_values": [
        "Are women who are treated for hypothyroidism at risk for pregnancy complications?",
        "The purpose of this study was to investigate the outcomes that are associated with pregnancy and treated hypothyroidism. This was a retrospective cohort study of all women who received prenatal care and were delivered at the University of California, San Francisco, between 1989 and 2001. All patients with hypothyroidism diagnosed before pregnancy or early in pregnancy were identified. Maternal, fetal, and obstetric outcomes were then collected and analyzed for women with hypothyroidism and compared with women without hypothyroidism. Among 20,499 deliveries, there were 419 women (2.1%) who were treated for hypothyroidism during the study period. Hypothyroidism was more common among women>or =35 years old, white women, and women without Medicaid insurance. Treated hypothyroidism was not associated with any increase in maternal, fetal, or neonatal complications. In addition, hypothyroidism did not affect mode of delivery."
      ],
      "processing_time": 4.1970179080963135,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does high blood pressure reduce the risk of chronic low back pain?\n\nContext: Epidemiological studies have suggested inverse relationships between blood pressure and prevalence of conditions such as migraine and headache. It is not yet clear whether similar relationships can be established for back pain in particular in prospective studies. Associations between blood pressure and chronic low back pain were explored in the cross-sectional HUNT 2 survey of a Norwegian county in 1995-1997, including 39,872 individuals who never used antihypertensive medication. A prospective study, comprising 17,209 initially back pain-free individuals and 5740 individuals reporting low back pain, was established by re-examinations in the HUNT 3 survey in 2006-2008. Associations were assessed by logistic regression with respect to systolic, diastolic and pulse pressure, with adjustment for education, work status, physical activity, smoking, body mass and lipid levels. In the cross-sectional study, all three blood pressure measures showed inverse relationships with prevalence of low back pain in both sexes. In the prospective study of disease-free women, baseline pulse pressure and systolic pressure were inversely associated with risk of low back pain [odds ratio (OR) 0.93 per 10\u2009mm\u2009Hg increase in pulse pressure, 95% confidence interval (CI) 0.89-0.98, p\u2009=\u20090.007; OR 0.95 per 10\u2009mm Hg increase in systolic pressure, 95% CI 0.92-0.99, p\u2009=\u20090.005]. Results among men were equivocal. No associations were indicated with the occurrence of pain in individuals with low back pain at baseline.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the cross-sectional study found inverse relationships between blood pressure and low back pain prevalence in both sexes, the prospective study only found significant inverse associations in women, and the results were equivocal in men. Therefore, it's not clear whether high blood pressure reduces the risk of chronic low back pain in both men and women. More research is needed to confirm these findings and understand the potential mechanisms behind them.",
      "expected_output": "yes",
      "question_values": [
        "Does high blood pressure reduce the risk of chronic low back pain?",
        "Epidemiological studies have suggested inverse relationships between blood pressure and prevalence of conditions such as migraine and headache. It is not yet clear whether similar relationships can be established for back pain in particular in prospective studies. Associations between blood pressure and chronic low back pain were explored in the cross-sectional HUNT 2 survey of a Norwegian county in 1995-1997, including 39,872 individuals who never used antihypertensive medication. A prospective study, comprising 17,209 initially back pain-free individuals and 5740 individuals reporting low back pain, was established by re-examinations in the HUNT 3 survey in 2006-2008. Associations were assessed by logistic regression with respect to systolic, diastolic and pulse pressure, with adjustment for education, work status, physical activity, smoking, body mass and lipid levels. In the cross-sectional study, all three blood pressure measures showed inverse relationships with prevalence of low back pain in both sexes. In the prospective study of disease-free women, baseline pulse pressure and systolic pressure were inversely associated with risk of low back pain [odds ratio (OR) 0.93 per 10\u2009mm\u2009Hg increase in pulse pressure, 95% confidence interval (CI) 0.89-0.98, p\u2009=\u20090.007; OR 0.95 per 10\u2009mm Hg increase in systolic pressure, 95% CI 0.92-0.99, p\u2009=\u20090.005]. Results among men were equivocal. No associations were indicated with the occurrence of pain in individuals with low back pain at baseline."
      ],
      "processing_time": 3.051964282989502,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Do the changes in the serum levels of IL-2, IL-4, TNFalpha, and IL-6 reflect the inflammatory activity in the patients with post-ERCP pancreatitis?\n\nContext: Acute pancreatitis is the major complication of endoscopic retrograde cholangiopancreatography (ERCP) procedure and there are some reports showing cytokine changes in ERCP-induced pancreatits.GOALS: To investigate the association between early changes (within 24 hours) in the serum interleukin (IL)-2, IL-4, tumor necrosis factor (TNF)alpha, and IL-6 levels and the development of post-ERCP pancreatitis.STUDY: Forty five consecutive patients who underwent therapeutic ERCP and 10 patients with acute pancreatitis without ERCP were enrolled to the study. Serum concentrations of IL-2, IL-4, TNFalpha, and IL-6 were determined immediately before, 12 hours and 24 hours after ERCP. Seven of the 45 patients (15.5%) developed post-ERCP pancreatitis. The levels of IL-4 at 24 hours after ERCP were significantly lower in the patients with post-ERCP pancreatitis than in those without pancreatitis, while TNFalpha levels at 12 hours after ERCP were higher in the complicated group than those of the uncomplicated group. The ratios of TNFalpha/IL-4 at 12 and 24 hours after ERCP were found significantly higher in the patients with post-ERCP pancreatitis than in those without pancreatitis. IL-6 in the complicated patients was found significantly increased at 24 hours after ERCP.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found significant differences in the serum levels of IL-4, TNFalpha, and IL-6 between patients who developed post-ERCP pancreatitis and those who did not, it's not conclusive that these changes directly reflect the inflammatory activity in the patients with post-ERCP pancreatitis. The study only looked at a small number of patients and further research with larger sample sizes is needed to confirm these findings and establish a clear association between these cytokine changes and the development of post-ERCP pancreatitis. Additionally, the study did not measure pancreatic enzymes or imaging findings to confirm the diagnosis of pancreatitis, which could potentially affect the results. Therefore, while the study provides some interesting insights, it's not definitive in establishing a direct link between the changes in these serum cytokine levels and the inflammatory activity in post-ERCP pancreatitis.",
      "expected_output": "yes",
      "question_values": [
        "Do the changes in the serum levels of IL-2, IL-4, TNFalpha, and IL-6 reflect the inflammatory activity in the patients with post-ERCP pancreatitis?",
        "Acute pancreatitis is the major complication of endoscopic retrograde cholangiopancreatography (ERCP) procedure and there are some reports showing cytokine changes in ERCP-induced pancreatits.GOALS: To investigate the association between early changes (within 24 hours) in the serum interleukin (IL)-2, IL-4, tumor necrosis factor (TNF)alpha, and IL-6 levels and the development of post-ERCP pancreatitis.STUDY: Forty five consecutive patients who underwent therapeutic ERCP and 10 patients with acute pancreatitis without ERCP were enrolled to the study. Serum concentrations of IL-2, IL-4, TNFalpha, and IL-6 were determined immediately before, 12 hours and 24 hours after ERCP. Seven of the 45 patients (15.5%) developed post-ERCP pancreatitis. The levels of IL-4 at 24 hours after ERCP were significantly lower in the patients with post-ERCP pancreatitis than in those without pancreatitis, while TNFalpha levels at 12 hours after ERCP were higher in the complicated group than those of the uncomplicated group. The ratios of TNFalpha/IL-4 at 12 and 24 hours after ERCP were found significantly higher in the patients with post-ERCP pancreatitis than in those without pancreatitis. IL-6 in the complicated patients was found significantly increased at 24 hours after ERCP."
      ],
      "processing_time": 6.18105936050415,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Ovarian torsion in children: is oophorectomy necessary?\n\nContext: Most pediatric surgeons perform oophorectomy in girls presenting with ovarian torsion in which the ovary appears necrotic. However, the adult gynecology literature suggests that many ovaries can be treated by detorsion alone. All children with ovarian torsion on the gynecology and general surgery services between 1988 and 2002 were reviewed. There were 36 torsions in 34 children. Seventeen underwent detorsion with or without ovarian cystectomy, and 19 had oophorectomy (mean age 10 years in both groups). Torsion was suspected preoperatively in 94% of the detorsion cases and in 47% of the oophorectomy patients. Median time from presentation to surgery was significantly lower in the detorsion than the oophorectomy group (median 14 v 27 hours; P =.04). Postoperative complications and length of stay were similar between the 2 groups. Despite the ovary being judged intraoperatively as moderately to severely ischemic in 53% of the detorsion cases, follow-up sonogram or ovarian biopsy available in 14 of the 17 cases showed normal ovary with follicular development in each case.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that detorsion alone may be sufficient in many cases of ovarian torsion in children, and that even severely ischemic ovaries can recover, it's not definitive. Here are a few reasons why:\n\n1. **Small Sample Size**: The study had a relatively small number of patients, which limits its statistical power and generalizability.\n\n2. **Selection Bias**: The decision to perform detorsion or oophorectomy was not randomized, and there was a significant difference in the preoperative suspicion of torsion between the two groups. This could indicate that surgeons were more likely to attempt detorsion when torsion was more suspected.\n\n3. **Long-term Follow-up**: The study only looked at short-term outcomes and follow-up. Long-term follow-up is needed to assess the fertility and ovarian function of the detorsioned ovaries.\n\n4. **Variability in Surgical Judgment**: The decision to remove an ovary is often based on the surgeon's intraoperative assessment of the ovary's viability, which can be subjective.\n\nGiven these considerations, while detorsion may be a viable option in some cases, it's not clear if it should replace oophorectomy as the standard of care. Further studies with larger sample sizes, randomized designs, and long-term follow-up are needed to provide more definitive guidance.",
      "expected_output": "no",
      "question_values": [
        "Ovarian torsion in children: is oophorectomy necessary?",
        "Most pediatric surgeons perform oophorectomy in girls presenting with ovarian torsion in which the ovary appears necrotic. However, the adult gynecology literature suggests that many ovaries can be treated by detorsion alone. All children with ovarian torsion on the gynecology and general surgery services between 1988 and 2002 were reviewed. There were 36 torsions in 34 children. Seventeen underwent detorsion with or without ovarian cystectomy, and 19 had oophorectomy (mean age 10 years in both groups). Torsion was suspected preoperatively in 94% of the detorsion cases and in 47% of the oophorectomy patients. Median time from presentation to surgery was significantly lower in the detorsion than the oophorectomy group (median 14 v 27 hours; P =.04). Postoperative complications and length of stay were similar between the 2 groups. Despite the ovary being judged intraoperatively as moderately to severely ischemic in 53% of the detorsion cases, follow-up sonogram or ovarian biopsy available in 14 of the 17 cases showed normal ovary with follicular development in each case."
      ],
      "processing_time": 9.643435955047607,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?\n\nContext: To assess the results of transsphenoidal pituitary surgery in patients with Cushing's disease over a period of 18 years, and to determine if there are factors which will predict the outcome. Sixty-nine sequential patients treated surgically by a single surgeon in Newcastle upon Tyne between 1980 and 1997 were identified and data from 61 of these have been analysed. Retrospective analysis of outcome measures. Patients were divided into three groups (remission, failure and relapse) depending on the late outcome of their treatment as determined at the time of analysis, i.e. 88 months (median) years after surgery. Remission is defined as biochemical reversal of hypercortisolism with re-emergence of diurnal circadian rhythm, resolution of clinical features and adequate suppression on low-dose dexamethasone testing. Failure is defined as the absence of any of these features. Relapse is defined as the re-emergence of Cushing's disease more than one year after operation. Clinical features such as weight, sex, hypertension, associated endocrine disorders and smoking, biochemical studies including preoperative and postoperative serum cortisol, urine free cortisol, serum ACTH, radiological, histological and surgical findings were assessed in relation to these three groups to determine whether any factors could reliably predict failure or relapse after treatment. Of the 61 patients included in this study, 48 (78.7%) achieved initial remission and 13 (21.3%) failed treatment. Seven patients suffered subsequent relapse (range 22-158 months) in their condition after apparent remission, leaving a final group of 41 patients (67.2%) in the remission group. Tumour was identified at surgery in 52 patients, of whom 38 achieved remission. In comparison, only 3 of 9 patients in whom no tumour was identified achieved remission. This difference was significant (P = 0.048). When both radiological and histological findings were positive, the likelihood of achieving remission was significantly higher than if both modalities were negative (P = 0.038). There were significant differences between remission and failure groups when 2- and 6-week postoperative serum cortisol levels (P = 0.002 and 0.001, respectively) and 6-week postoperative urine free cortisol levels (P = 0.026) were compared. This allowed identification of patients who failed surgical treatment in the early postoperative period. Complications of surgery included transitory DI in 13, transitory CSF leak in 8 and transitory nasal discharge and cacosmia in 3. Twelve of 41 patients required some form of hormonal replacement therapy despite achieving long-term remission. Thirteen patients underwent a second operation, of whom 5 achieved remission.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found some factors that could help predict the outcome of transsphenoidal pituitary surgery in Cushing's disease, such as the identification of a tumor at surgery and certain postoperative cortisol and urine free cortisol levels, it's not definitive. The study has limitations such as its retrospective nature and the relatively small sample size. Therefore, while these factors may be useful in predicting outcomes, they should not be used in isolation to make treatment decisions. Further research with larger, prospective studies is needed to confirm these findings and identify additional predictive factors.",
      "expected_output": "yes",
      "question_values": [
        "Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?",
        "To assess the results of transsphenoidal pituitary surgery in patients with Cushing's disease over a period of 18 years, and to determine if there are factors which will predict the outcome. Sixty-nine sequential patients treated surgically by a single surgeon in Newcastle upon Tyne between 1980 and 1997 were identified and data from 61 of these have been analysed. Retrospective analysis of outcome measures. Patients were divided into three groups (remission, failure and relapse) depending on the late outcome of their treatment as determined at the time of analysis, i.e. 88 months (median) years after surgery. Remission is defined as biochemical reversal of hypercortisolism with re-emergence of diurnal circadian rhythm, resolution of clinical features and adequate suppression on low-dose dexamethasone testing. Failure is defined as the absence of any of these features. Relapse is defined as the re-emergence of Cushing's disease more than one year after operation. Clinical features such as weight, sex, hypertension, associated endocrine disorders and smoking, biochemical studies including preoperative and postoperative serum cortisol, urine free cortisol, serum ACTH, radiological, histological and surgical findings were assessed in relation to these three groups to determine whether any factors could reliably predict failure or relapse after treatment. Of the 61 patients included in this study, 48 (78.7%) achieved initial remission and 13 (21.3%) failed treatment. Seven patients suffered subsequent relapse (range 22-158 months) in their condition after apparent remission, leaving a final group of 41 patients (67.2%) in the remission group. Tumour was identified at surgery in 52 patients, of whom 38 achieved remission. In comparison, only 3 of 9 patients in whom no tumour was identified achieved remission. This difference was significant (P = 0.048). When both radiological and histological findings were positive, the likelihood of achieving remission was significantly higher than if both modalities were negative (P = 0.038). There were significant differences between remission and failure groups when 2- and 6-week postoperative serum cortisol levels (P = 0.002 and 0.001, respectively) and 6-week postoperative urine free cortisol levels (P = 0.026) were compared. This allowed identification of patients who failed surgical treatment in the early postoperative period. Complications of surgery included transitory DI in 13, transitory CSF leak in 8 and transitory nasal discharge and cacosmia in 3. Twelve of 41 patients required some form of hormonal replacement therapy despite achieving long-term remission. Thirteen patients underwent a second operation, of whom 5 achieved remission."
      ],
      "processing_time": 4.142032146453857,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection?\n\nContext: The aim of the study was to evaluate the outcomes and patterns of failure in patients with metastatic carcinoma to cervical lymph nodes from an unknown head and neck primary origin, who were treated curatively with radiotherapy, with or without neck dissection. The study included 61 patients referred to the McGill University Hospital Centers from 1987 to 2002. The median age was 57 years, with male to female ratio of 4:1. Distribution of patients by N status was as follows: N1, 16 patients (26%); N2a, 18 (30%); N2b, 13 (22%); N2c, 7 (11%); and N3, 7 (11%). Twenty patients underwent neck dissection (11 radical, 9 functional) and 41 patients had biopsy (9 fine-needle aspiration and 32 excisional biopsy). All patients received radiotherapy. The median dose to the involved node(s) was 64 Gy, and 60 Gy to the rest of the neck. Treatment of the neck was bilateral in 50 patients (82%) and ipsilateral in 11 (18%). The minimum duration of the follow-up was 12 months, with the median of 32 months. The 5- and 8-year overall survival for the whole population was 79% and 67%, respectively. There was no statistically significant difference in the 8-year actuarial overall survival (64.8% and 67.6%, respectively, p = .64) and local relapse-free survival (75% vs 74.5%, respectively, p = .57), among patients who had biopsy versus those who had neck dissection.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found no significant difference in outcomes between patients who underwent neck dissection and those who had a biopsy, neck dissection may still be beneficial in certain cases. Here's why:\n\n1. **Pathologic Staging**: Neck dissection allows for a more accurate pathologic staging, which can help guide further treatment decisions.\n\n2. **Reduction of Regional Recurrence**: Although not statistically significant in this study, neck dissection might still reduce the risk of regional recurrence in some patients, especially those with advanced N stage (N2c, N3).\n\n3. **Symptomatic Relief**: Neck dissection can provide symptomatic relief in patients with large, symptomatic lymph nodes.\n\n4. **Potential for Improved Survival**: While not shown in this study, some other studies have suggested that neck dissection may improve survival in certain subgroups of patients with unknown primary.\n\nTherefore, while the study suggests that neck dissection may not be necessary in all cases, it might still be beneficial in selected patients. The decision should be made on an individual basis, considering the patient's clinical stage, symptoms, and comorbidities, as well as the preferences of the multidisciplinary team and the patient.",
      "expected_output": "no",
      "question_values": [
        "Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection?",
        "The aim of the study was to evaluate the outcomes and patterns of failure in patients with metastatic carcinoma to cervical lymph nodes from an unknown head and neck primary origin, who were treated curatively with radiotherapy, with or without neck dissection. The study included 61 patients referred to the McGill University Hospital Centers from 1987 to 2002. The median age was 57 years, with male to female ratio of 4:1. Distribution of patients by N status was as follows: N1, 16 patients (26%); N2a, 18 (30%); N2b, 13 (22%); N2c, 7 (11%); and N3, 7 (11%). Twenty patients underwent neck dissection (11 radical, 9 functional) and 41 patients had biopsy (9 fine-needle aspiration and 32 excisional biopsy). All patients received radiotherapy. The median dose to the involved node(s) was 64 Gy, and 60 Gy to the rest of the neck. Treatment of the neck was bilateral in 50 patients (82%) and ipsilateral in 11 (18%). The minimum duration of the follow-up was 12 months, with the median of 32 months. The 5- and 8-year overall survival for the whole population was 79% and 67%, respectively. There was no statistically significant difference in the 8-year actuarial overall survival (64.8% and 67.6%, respectively, p = .64) and local relapse-free survival (75% vs 74.5%, respectively, p = .57), among patients who had biopsy versus those who had neck dissection."
      ],
      "processing_time": 8.46042013168335,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Quality of life in lung cancer patients: does socioeconomic status matter?\n\nContext: As part of a prospective study on quality of life in newly diagnosed lung cancer patients an investigation was carried out to examine whether there were differences among patients' quality of life scores and their socioeconomic status. Quality of life was measured at two points in time (baseline and three months after initial treatment) using three standard instruments; the Nottingham Health Profile (NHP), the European Organization for Research and Cancer Treatment Quality of Life Questionnaire (EORTC QLQ-C30) and its lung cancer supplement (QLQ-LC13). Socioeconomic status for each individual patient was derived using Carstairs and Morris Deprivation Category ranging from 1 (least deprived) to 7 (most deprived) on the basis of the postcode sector of their address. In all, 129 lung cancer patients entered into the study. Of these data for 82 patients were complete (at baseline and follow-up). 57% of patients were of lower socioeconomic status and they had more health problems, less functioning, and more symptoms as compared to affluent patients. Of these, physical mobility (P = 0.05), energy (P = 0.01), role functioning (P = 0.04), physical functioning (P = 0.03), and breathlessness (P = 0.02) were significant at baseline. However, at follow-up assessment there was no significant difference between patient groups nor did any consistent pattern emerge.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found significant differences in quality of life scores between patients of lower and higher socioeconomic status at baseline, these differences were not maintained at the three-month follow-up assessment. Therefore, while socioeconomic status may initially impact quality of life in lung cancer patients, other factors may influence this relationship over time. Further research with larger sample sizes and longer follow-up periods could provide more definitive answers.",
      "expected_output": "yes",
      "question_values": [
        "Quality of life in lung cancer patients: does socioeconomic status matter?",
        "As part of a prospective study on quality of life in newly diagnosed lung cancer patients an investigation was carried out to examine whether there were differences among patients' quality of life scores and their socioeconomic status. Quality of life was measured at two points in time (baseline and three months after initial treatment) using three standard instruments; the Nottingham Health Profile (NHP), the European Organization for Research and Cancer Treatment Quality of Life Questionnaire (EORTC QLQ-C30) and its lung cancer supplement (QLQ-LC13). Socioeconomic status for each individual patient was derived using Carstairs and Morris Deprivation Category ranging from 1 (least deprived) to 7 (most deprived) on the basis of the postcode sector of their address. In all, 129 lung cancer patients entered into the study. Of these data for 82 patients were complete (at baseline and follow-up). 57% of patients were of lower socioeconomic status and they had more health problems, less functioning, and more symptoms as compared to affluent patients. Of these, physical mobility (P = 0.05), energy (P = 0.01), role functioning (P = 0.04), physical functioning (P = 0.03), and breathlessness (P = 0.02) were significant at baseline. However, at follow-up assessment there was no significant difference between patient groups nor did any consistent pattern emerge."
      ],
      "processing_time": 2.932943344116211,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does somatostatin confer insulinostatic effects of neuromedin u in the rat pancreas?\n\nContext: Neuromedin U (NmU) is a neuropeptide with anorexigenic activity. Two receptor subtypes (NmUR1 and NmUR2) confer the effects of NmU on target cells. We have recently demonstrated that NmU reduces insulin secretion from isolated pancreatic islets. Aim of our current study is to investigate the role of somatostatin at mediating the effects of NmU on insulin secretion. Expression of NmU in the pancreas was detected by immunohistochemistry. Insulin and somatostatin secretion from in situ perfused rat pancreas and isolated pancreatic islets was measured by radioimmunoassay. The paracrine effects of somatostatin within pancreatic islets were blocked by cyclosomatostatin, a somatostatin receptor antagonist. Receptor subtype NmUR1, but not NmUR2, was expressed in the endocrine pancreas, predominantly in the periphery. Neuromedin U reduced insulin secretion from in situ perfused rat pancreas and stimulated somatostatin secretion from isolated pancreatic islets. Neuromedin U stimulated somatostatin secretion at both physiological and supraphysiological glucose concentrations. Cyclosomatostatin increased insulin secretion and reduced NmU-induced inhibition of insulin secretion.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While your study shows that NmU reduces insulin secretion and stimulates somatostatin secretion from pancreatic islets, and that blocking somatostatin's effects with cyclosomatostatin increases insulin secretion and reduces NmU's inhibitory effect, it doesn't definitively prove that somatostatin is the sole mediator of NmU's insulinostatic effects. It's possible that somatostatin plays a significant role, but other mechanisms may also be involved. Further research would be needed to fully understand the relationship between NmU, somatostatin, and insulin secretion.",
      "expected_output": "yes",
      "question_values": [
        "Does somatostatin confer insulinostatic effects of neuromedin u in the rat pancreas?",
        "Neuromedin U (NmU) is a neuropeptide with anorexigenic activity. Two receptor subtypes (NmUR1 and NmUR2) confer the effects of NmU on target cells. We have recently demonstrated that NmU reduces insulin secretion from isolated pancreatic islets. Aim of our current study is to investigate the role of somatostatin at mediating the effects of NmU on insulin secretion. Expression of NmU in the pancreas was detected by immunohistochemistry. Insulin and somatostatin secretion from in situ perfused rat pancreas and isolated pancreatic islets was measured by radioimmunoassay. The paracrine effects of somatostatin within pancreatic islets were blocked by cyclosomatostatin, a somatostatin receptor antagonist. Receptor subtype NmUR1, but not NmUR2, was expressed in the endocrine pancreas, predominantly in the periphery. Neuromedin U reduced insulin secretion from in situ perfused rat pancreas and stimulated somatostatin secretion from isolated pancreatic islets. Neuromedin U stimulated somatostatin secretion at both physiological and supraphysiological glucose concentrations. Cyclosomatostatin increased insulin secretion and reduced NmU-induced inhibition of insulin secretion."
      ],
      "processing_time": 4.310571908950806,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Staging laparoscopy in patients with hepatocellular carcinoma: is it useful?\n\nContext: Staging laparoscopy (SL) is not regularly performed for patients with hepatocellular carcinoma (HCC). It may change treatment strategy, preventing unnecessary open exploration. An additional advantage of SL is possible biopsy of the nontumorous liver to assess fibrosis/cirrhosis. This study aimed to determine whether SL for patients with HCC still is useful. Patients with HCC who underwent SL between January 1999 and December 2011 were analyzed. Their demographics, preoperative imaging studies, surgical findings, and histology were assessed. The 56 patients (34 men and 22 women; mean age, 60 \u00b1 14 years) in this study underwent SL for assessment of extensive disease or metastases. For two patients, SL was unsuccessful because of intraabdominal adhesions. For four patients (7.1 %), SL showed unresectability because of metastases (n = 1), tumor progression (n = 1), or severe cirrhosis in the contralateral lobe (n = 2). An additional five patients did not undergo laparotomy due to disease progression detected on imaging after SL. Exploratory laparotomy for the remaining 47 patients showed 6 (13 %) additional unresectable tumors due to advanced tumor (n = 5) or nodal metastases (n = 1). Consequently, the yield of SL was 7 % (95 % confidence interval (CI), 3-17 %), and the accuracy was 27 % (95 % CI, 11-52 %). A biopsy of the contralateral liver was performed for 45 patients who underwent SL, leading to changes in management for 4 patients (17 %) with cirrhosis.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that staging laparoscopy may have some utility in identifying unresectable disease and assessing liver fibrosis, the overall yield and accuracy were relatively low. The decision to perform staging laparoscopy should be individualized based on patient factors, imaging findings, and institutional preferences. Further studies with larger sample sizes and more recent data may provide more definitive evidence on the usefulness of staging laparoscopy in patients with hepatocellular carcinoma.",
      "expected_output": "no",
      "question_values": [
        "Staging laparoscopy in patients with hepatocellular carcinoma: is it useful?",
        "Staging laparoscopy (SL) is not regularly performed for patients with hepatocellular carcinoma (HCC). It may change treatment strategy, preventing unnecessary open exploration. An additional advantage of SL is possible biopsy of the nontumorous liver to assess fibrosis/cirrhosis. This study aimed to determine whether SL for patients with HCC still is useful. Patients with HCC who underwent SL between January 1999 and December 2011 were analyzed. Their demographics, preoperative imaging studies, surgical findings, and histology were assessed. The 56 patients (34 men and 22 women; mean age, 60 \u00b1 14 years) in this study underwent SL for assessment of extensive disease or metastases. For two patients, SL was unsuccessful because of intraabdominal adhesions. For four patients (7.1 %), SL showed unresectability because of metastases (n = 1), tumor progression (n = 1), or severe cirrhosis in the contralateral lobe (n = 2). An additional five patients did not undergo laparotomy due to disease progression detected on imaging after SL. Exploratory laparotomy for the remaining 47 patients showed 6 (13 %) additional unresectable tumors due to advanced tumor (n = 5) or nodal metastases (n = 1). Consequently, the yield of SL was 7 % (95 % confidence interval (CI), 3-17 %), and the accuracy was 27 % (95 % CI, 11-52 %). A biopsy of the contralateral liver was performed for 45 patients who underwent SL, leading to changes in management for 4 patients (17 %) with cirrhosis."
      ],
      "processing_time": 3.12528133392334,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Can bone thickness and inter-radicular space affect miniscrew placement in posterior mandibular sites?\n\nContext: The proper angle of miniscrew insertion is important for cortical anchorage, patient safety, and biomechanical control. The purposes of this study are to report the alveolar process thickness and inter-radicular space in the posterior region of the mandible, to assess the impact of different miniscrew insertion angle protocols, and to identify differences between the genders or types of malocclusion. In this retrospective study, 100 individuals were selected for orthodontic treatment at a radiology clinic. Cone-beam computed tomography data were imported into 3-dimensional software. The predictor variable was the location in the mandible and insertion angle. The demographic variables collected included age, gender, and malocclusion (Angle Classes I and II). The primary outcome variables were bone thickness and inter-radicular space. The inter-radicular spaces were evaluated 5 mm from the cement-enamel junction. The bone thicknesses were taken at 45\u00b0, 60\u00b0, and 90\u00b0 in relation to the alveolar ridge, simulating a miniscrew insertion. These factors were evaluated for sexual dimorphism and malocclusion (Angle Classes I and II). Sexual dimorphism and malocclusion were evaluated with t tests. To compare the inter-radicular space and the thickness of bone between areas, an analysis of variance for repeated measures was used. The sample was composed of 100 patients with a mean age of 17.4 \u00b1 6.74 years. There were 61 female and 39 male patients and 60 Class I and 40 Class II molar relationships. The inter-radicular space ranged from 2.46 to 3.31 mm, and alveolar bone thickness ranged from 8.01 to 13.77 mm. The thickness tended to decrease with the increase in insertion angle from 45\u00b0 to 90\u00b0. No significant differences between the genders or types of malocclusion were found.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found no significant differences in bone thickness and inter-radicular space between genders or types of malocclusion, it did not directly assess the impact of these factors on miniscrew placement success or failure. The study only measured these variables and observed trends in bone thickness with different insertion angles. Therefore, while bone thickness and inter-radicular space may potentially affect miniscrew placement, the study does not provide definitive evidence to support this. Further research would be needed to establish a direct relationship between these factors and miniscrew placement success in posterior mandibular sites.",
      "expected_output": "no",
      "question_values": [
        "Can bone thickness and inter-radicular space affect miniscrew placement in posterior mandibular sites?",
        "The proper angle of miniscrew insertion is important for cortical anchorage, patient safety, and biomechanical control. The purposes of this study are to report the alveolar process thickness and inter-radicular space in the posterior region of the mandible, to assess the impact of different miniscrew insertion angle protocols, and to identify differences between the genders or types of malocclusion. In this retrospective study, 100 individuals were selected for orthodontic treatment at a radiology clinic. Cone-beam computed tomography data were imported into 3-dimensional software. The predictor variable was the location in the mandible and insertion angle. The demographic variables collected included age, gender, and malocclusion (Angle Classes I and II). The primary outcome variables were bone thickness and inter-radicular space. The inter-radicular spaces were evaluated 5 mm from the cement-enamel junction. The bone thicknesses were taken at 45\u00b0, 60\u00b0, and 90\u00b0 in relation to the alveolar ridge, simulating a miniscrew insertion. These factors were evaluated for sexual dimorphism and malocclusion (Angle Classes I and II). Sexual dimorphism and malocclusion were evaluated with t tests. To compare the inter-radicular space and the thickness of bone between areas, an analysis of variance for repeated measures was used. The sample was composed of 100 patients with a mean age of 17.4 \u00b1 6.74 years. There were 61 female and 39 male patients and 60 Class I and 40 Class II molar relationships. The inter-radicular space ranged from 2.46 to 3.31 mm, and alveolar bone thickness ranged from 8.01 to 13.77 mm. The thickness tended to decrease with the increase in insertion angle from 45\u00b0 to 90\u00b0. No significant differences between the genders or types of malocclusion were found."
      ],
      "processing_time": 4.378080129623413,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Is oncoplastic surgery a contraindication for accelerated partial breast radiation using the interstitial multicatheter brachytherapy method?\n\nContext: To evaluate accelerated partial breast irradiation (APBI) in patients after oncoplastic surgery for early breast cancer. A retrospective analysis of 136 breasts of 134 patients, who received breast-conserving oncoplastic surgery for low-risk breast cancer between 2002 and 2010 in the Universities of Vienna and Luebeck followed by adjuvant APBI applying total doses of pulse dose rate of 50.4\u00a0Gy or high-dose rate (HDR) of 32\u00a0Gy over 4\u00a0days. Target volume definition was performed by the use of surgical-free margin data, related to intraoperatively fixed clip positions, pre- and postoperative imaging, and palpation. At the time of data acquisition, 131 of 134 patients were alive. The median follow-up time was 39\u00a0months (range, 4-106 months). After high-dose rate treatment, 3 of 89 patients showed systemic progress after a mean follow-up of 47\u00a0months (range, 19-75 months) and 2 patients had a different quadrant in-breast tumor after 27 and 35\u00a0months. One patient died 7\u00a0months after treatment of unknown causes. After pulse dose rate treatment, 1 of 45 patients had a local recurrence after 42\u00a0months and 1 patient died because of another cause after 13\u00a0months. We observed mild fibrosis in 27 breasts, telangiectasia in 6, hyperpigmentation in 14 cases, and keloid formation in\u00a01.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that oncoplastic surgery is not a contraindication for APBI using interstitial multicatheter brachytherapy, it's important to consider the following:\n\n1. **Small sample size**: The study had a relatively small number of patients (134), and the follow-up time was relatively short (median of 39 months). Longer follow-up and larger studies are needed to confirm these findings.\n\n2. **Selection bias**: The study included only low-risk breast cancer patients. The results may not be applicable to patients with higher risk features.\n\n3. **Technical considerations**: Oncoplastic surgery can sometimes result in more complex breast anatomy, which might make it more challenging to accurately target the radiation and achieve optimal dose distribution with brachytherapy.\n\nTherefore, while the study suggests that oncoplastic surgery is not a contraindication, it's still a topic that should be discussed on a case-by-case basis, considering the individual patient's situation and the availability of experienced multidisciplinary teams.",
      "expected_output": "maybe",
      "question_values": [
        "Is oncoplastic surgery a contraindication for accelerated partial breast radiation using the interstitial multicatheter brachytherapy method?",
        "To evaluate accelerated partial breast irradiation (APBI) in patients after oncoplastic surgery for early breast cancer. A retrospective analysis of 136 breasts of 134 patients, who received breast-conserving oncoplastic surgery for low-risk breast cancer between 2002 and 2010 in the Universities of Vienna and Luebeck followed by adjuvant APBI applying total doses of pulse dose rate of 50.4\u00a0Gy or high-dose rate (HDR) of 32\u00a0Gy over 4\u00a0days. Target volume definition was performed by the use of surgical-free margin data, related to intraoperatively fixed clip positions, pre- and postoperative imaging, and palpation. At the time of data acquisition, 131 of 134 patients were alive. The median follow-up time was 39\u00a0months (range, 4-106 months). After high-dose rate treatment, 3 of 89 patients showed systemic progress after a mean follow-up of 47\u00a0months (range, 19-75 months) and 2 patients had a different quadrant in-breast tumor after 27 and 35\u00a0months. One patient died 7\u00a0months after treatment of unknown causes. After pulse dose rate treatment, 1 of 45 patients had a local recurrence after 42\u00a0months and 1 patient died because of another cause after 13\u00a0months. We observed mild fibrosis in 27 breasts, telangiectasia in 6, hyperpigmentation in 14 cases, and keloid formation in\u00a01."
      ],
      "processing_time": 7.5419652462005615,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?\n\nContext: To explore whether electrochemiluminescence (ECL) assays can help improve prediction of time to type 1 diabetes in the TrialNet autoantibody-positive population. TrialNet subjects who were positive for one or more autoantibodies (microinsulin autoantibody, GAD65 autoantibody [GADA], IA-2A, and ZnT8A) with available ECL-insulin autoantibody (IAA) and ECL-GADA data at their initial visit were analyzed; after a median follow-up of 24 months, 177 of these 1,287 subjects developed diabetes. Univariate analyses showed that autoantibodies by radioimmunoassays (RIAs), ECL-IAA, ECL-GADA, age, sex, number of positive autoantibodies, presence of HLA DR3/4-DQ8 genotype, HbA1c, and oral glucose tolerance test (OGTT) measurements were all significantly associated with progression to diabetes. Subjects who were ECL positive had a risk of progression to diabetes within 6 years of 58% compared with 5% for the ECL-negative subjects (P<0.0001). Multivariate Cox proportional hazards models were compared, with the base model including age, sex, OGTT measurements, and number of positive autoantibodies by RIAs. The model with positivity for ECL-GADA and/or ECL-IAA was the best, and factors that remained significantly associated with time to diabetes were area under the curve (AUC) C-peptide, fasting C-peptide, AUC glucose, number of positive autoantibodies by RIAs, and ECL positivity. Adding ECL to the Diabetes Prevention Trial risk score (DPTRS) improved the receiver operating characteristic curves with AUC of 0.83 (P<0.0001).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that electrochemiluminescence (ECL) assays may improve prediction of time to type 1 diabetes in TrialNet autoantibody-positive subjects, the results are not definitive. The best multivariate model included both ECL positivity and other factors, such as AUC C-peptide and fasting C-peptide, suggesting that ECL assays may be one piece of the puzzle in predicting diabetes onset. However, more research is needed to confirm these findings and determine the optimal way to incorporate ECL assays into clinical practice.",
      "expected_output": "yes",
      "question_values": [
        "Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?",
        "To explore whether electrochemiluminescence (ECL) assays can help improve prediction of time to type 1 diabetes in the TrialNet autoantibody-positive population. TrialNet subjects who were positive for one or more autoantibodies (microinsulin autoantibody, GAD65 autoantibody [GADA], IA-2A, and ZnT8A) with available ECL-insulin autoantibody (IAA) and ECL-GADA data at their initial visit were analyzed; after a median follow-up of 24 months, 177 of these 1,287 subjects developed diabetes. Univariate analyses showed that autoantibodies by radioimmunoassays (RIAs), ECL-IAA, ECL-GADA, age, sex, number of positive autoantibodies, presence of HLA DR3/4-DQ8 genotype, HbA1c, and oral glucose tolerance test (OGTT) measurements were all significantly associated with progression to diabetes. Subjects who were ECL positive had a risk of progression to diabetes within 6 years of 58% compared with 5% for the ECL-negative subjects (P<0.0001). Multivariate Cox proportional hazards models were compared, with the base model including age, sex, OGTT measurements, and number of positive autoantibodies by RIAs. The model with positivity for ECL-GADA and/or ECL-IAA was the best, and factors that remained significantly associated with time to diabetes were area under the curve (AUC) C-peptide, fasting C-peptide, AUC glucose, number of positive autoantibodies by RIAs, and ECL positivity. Adding ECL to the Diabetes Prevention Trial risk score (DPTRS) improved the receiver operating characteristic curves with AUC of 0.83 (P<0.0001)."
      ],
      "processing_time": 3.9348342418670654,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Can patient coaching reduce racial/ethnic disparities in cancer pain control?\n\nContext: Minority patients with cancer experience worse control of their pain than do their white counterparts. This disparity may, in part, reflect more miscommunication between minority patients and their physicians. Therefore, we examined whether patient coaching could reduce disparities in pain control in a secondary analysis of a randomized controlled trial. Sixty-seven English-speaking adult cancer outpatients, including 15 minorities, with moderate pain over the prior 2 weeks were randomly assigned to the experimental (N = 34) or control group (N = 33). Experimental patients received a 20-minute individualized education and coaching session to increase knowledge of pain self-management, to redress personal misconceptions about pain treatment, and to rehearse an individually scripted patient-physician dialog about pain control. The control group received standardized information on controlling pain. Data on average pain (0-10 scale) were collected at enrollment and 2-week follow-up. At enrollment, minority patients had significantly more pain than their white counterparts (6.0 vs 5.0, P = 0.05). At follow-up, minorities in the control group continued to have more pain (6.4 vs 4.7, P = 0.01), whereas in the experimental group, disparities were eliminated (4.0 vs 4.3, P = 0.71). The effect of the intervention on reducing disparities was significant (P = 0.04).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that patient coaching may help reduce racial/ethnic disparities in cancer pain control, the results are based on a secondary analysis of a small sample size, and the findings should be interpreted with caution. A larger, more robust study would be needed to confirm these results. Additionally, the study only focused on English-speaking patients, so the findings may not be generalizable to non-English speaking populations. Therefore, while the results are promising, more research is needed to definitively answer the question.",
      "expected_output": "yes",
      "question_values": [
        "Can patient coaching reduce racial/ethnic disparities in cancer pain control?",
        "Minority patients with cancer experience worse control of their pain than do their white counterparts. This disparity may, in part, reflect more miscommunication between minority patients and their physicians. Therefore, we examined whether patient coaching could reduce disparities in pain control in a secondary analysis of a randomized controlled trial. Sixty-seven English-speaking adult cancer outpatients, including 15 minorities, with moderate pain over the prior 2 weeks were randomly assigned to the experimental (N = 34) or control group (N = 33). Experimental patients received a 20-minute individualized education and coaching session to increase knowledge of pain self-management, to redress personal misconceptions about pain treatment, and to rehearse an individually scripted patient-physician dialog about pain control. The control group received standardized information on controlling pain. Data on average pain (0-10 scale) were collected at enrollment and 2-week follow-up. At enrollment, minority patients had significantly more pain than their white counterparts (6.0 vs 5.0, P = 0.05). At follow-up, minorities in the control group continued to have more pain (6.4 vs 4.7, P = 0.01), whereas in the experimental group, disparities were eliminated (4.0 vs 4.3, P = 0.71). The effect of the intervention on reducing disparities was significant (P = 0.04)."
      ],
      "processing_time": 3.805738687515259,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Is intensive chemotherapy safe for rural cancer patients?\n\nContext: To provide equality of cancer care to rural patients, Townsville Cancer Centre administers intensive chemotherapy regimens to rural patients with node-positive breast and metastatic colorectal cancers at the same doses as urban patients. Side-effects were usually managed by rural general practitioners locally.AIM: The aim is to determine the safety of this practice by comparing the profile of serious adverse events and dose intensities between urban and rural patients at the Townsville Cancer Centre. A retrospective audit was conducted in patients with metastatic colorectal and node-positive breast cancers during a 24-month period. Fisher's exact test was used for analysis. Rurality was determined as per rural, remote and metropolitan classification. Of the 121 patients included, 70 and 51 patients had breast and colon cancers respectively. The urban versus rural patient split among all patients, breast and colorectal cancer subgroups was 68 versus 53, 43 versus 27 and 25 versus 26 respectively. A total of 421 cycles was given with dose intensity of>95% for breast cancer in both groups (P>0.05). Rate of febrile neutropenia was 9.3% versus 7.4% (P = 0.56). For XELOX, rate of diarrhoea was 20% versus 19% (P = 0.66) and rate of vomiting was 20% versus 11% (P = 0.11). Only two patients were transferred to Townsville for admission. No toxic death occurred in either group.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found no significant differences in serious adverse events and dose intensities between urban and rural patients, it's important to consider the following points:\n\n1. **Sample Size**: The study had a relatively small sample size, which might limit its power to detect significant differences.\n2. **Management of Side Effects**: The study assumes that rural general practitioners can effectively manage chemotherapy side effects. However, the quality and availability of such care in rural areas may vary.\n3. **Access to Specialized Care**: Rural patients may have less access to specialized cancer care and supportive services compared to urban patients, which could potentially impact safety and outcomes.\n4. **Generalizability**: The results may not be generalizable to other regions with different healthcare systems or resources.\n\nTherefore, while the study suggests that intensive chemotherapy can be safely administered to rural patients in this specific context, it's still a \"maybe\" due to the limitations and the need for further research with larger and more diverse populations.",
      "expected_output": "yes",
      "question_values": [
        "Is intensive chemotherapy safe for rural cancer patients?",
        "To provide equality of cancer care to rural patients, Townsville Cancer Centre administers intensive chemotherapy regimens to rural patients with node-positive breast and metastatic colorectal cancers at the same doses as urban patients. Side-effects were usually managed by rural general practitioners locally.AIM: The aim is to determine the safety of this practice by comparing the profile of serious adverse events and dose intensities between urban and rural patients at the Townsville Cancer Centre. A retrospective audit was conducted in patients with metastatic colorectal and node-positive breast cancers during a 24-month period. Fisher's exact test was used for analysis. Rurality was determined as per rural, remote and metropolitan classification. Of the 121 patients included, 70 and 51 patients had breast and colon cancers respectively. The urban versus rural patient split among all patients, breast and colorectal cancer subgroups was 68 versus 53, 43 versus 27 and 25 versus 26 respectively. A total of 421 cycles was given with dose intensity of>95% for breast cancer in both groups (P>0.05). Rate of febrile neutropenia was 9.3% versus 7.4% (P = 0.56). For XELOX, rate of diarrhoea was 20% versus 19% (P = 0.66) and rate of vomiting was 20% versus 11% (P = 0.11). Only two patients were transferred to Townsville for admission. No toxic death occurred in either group."
      ],
      "processing_time": 7.235213994979858,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Are IgM-enriched immunoglobulins an effective adjuvant in septic VLBW infants?\n\nContext: All VLBW infants from January 2008 to December 2012 with positive blood culture beyond 72 hours of life were enrolled in a retrospective cohort study. Newborns born after June 2010 were treated with IgM-eIVIG, 250 mg/kg/day iv for three days in addition to standard antibiotic regimen and compared to an historical cohort born before June 2010, receiving antimicrobial regimen alone. Short-term mortality (i.e. death within 7 and 21 days from treatment) was the primary outcome. Secondary outcomes were: total mortality, intraventricular hemorrhage, necrotizing enterocolitis, periventricular leukomalacia, bronchopulmonary dysplasia at discharge. 79 neonates (40 cases) were enrolled. No difference in birth weight, gestational age or SNAP II score (disease severity score) were found. Significantly reduced short-term mortality was found in treated infants (22% vs 46%; p = 0.005) considering all microbial aetiologies and the subgroup affected by Candida spp. Secondary outcomes were not different between groups.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests a potential benefit of IgM-enriched immunoglobulins (IgM-eIVIG) as an adjuvant in septic very low birth weight (VLBW) infants, with a significant reduction in short-term mortality, the results are based on a retrospective cohort study with a relatively small sample size (79 neonates). A larger, prospective, randomized controlled trial would be needed to confirm these findings and to assess the potential long-term effects and safety of this treatment approach. Therefore, while the results are promising, it's not yet conclusive enough to definitively say yes or no.",
      "expected_output": "yes",
      "question_values": [
        "Are IgM-enriched immunoglobulins an effective adjuvant in septic VLBW infants?",
        "All VLBW infants from January 2008 to December 2012 with positive blood culture beyond 72 hours of life were enrolled in a retrospective cohort study. Newborns born after June 2010 were treated with IgM-eIVIG, 250 mg/kg/day iv for three days in addition to standard antibiotic regimen and compared to an historical cohort born before June 2010, receiving antimicrobial regimen alone. Short-term mortality (i.e. death within 7 and 21 days from treatment) was the primary outcome. Secondary outcomes were: total mortality, intraventricular hemorrhage, necrotizing enterocolitis, periventricular leukomalacia, bronchopulmonary dysplasia at discharge. 79 neonates (40 cases) were enrolled. No difference in birth weight, gestational age or SNAP II score (disease severity score) were found. Significantly reduced short-term mortality was found in treated infants (22% vs 46%; p = 0.005) considering all microbial aetiologies and the subgroup affected by Candida spp. Secondary outcomes were not different between groups."
      ],
      "processing_time": 4.497021198272705,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?\n\nContext: Several single nucleotide polymorphisms (SNPs) at different loci have been associated with breast cancer susceptibility, accounting for around 10% of the familial component. Recent studies have found direct associations between specific SNPs and breast cancer in BRCA1/2 mutation carriers. Our aim was to determine whether validated susceptibility SNP scores improve the predictive ability of risk models in comparison/conjunction to other clinical/demographic information. Female BRCA1/2 carriers were identified from the Manchester genetic database, and included in the study regardless of breast cancer status or age. DNA was extracted from blood samples provided by these women and used for gene and SNP profiling. Estimates of survival were examined with Kaplan-Meier curves. Multivariable Cox proportional hazards models were fit in the separate BRCA datasets and in menopausal stages screening different combinations of clinical/demographic/genetic variables. Nonlinear random survival forests were also fit to identify relevant interactions. Models were compared using Harrell's concordance index (1 - c-index). 548 female BRCA1 mutation carriers and 523 BRCA2 carriers were identified from the database. Median Kaplan-Meier estimate of survival was 46.0 years (44.9-48.1) for BRCA1 carriers and 48.9 (47.3-50.4) for BRCA2. By fitting Cox models and random survival forests, including both a genetic SNP score and clinical/demographic variables, average 1 - c-index values were 0.221 (st.dev. 0.019) for BRCA1 carriers and 0.215 (st.dev. 0.018) for BRCA2 carriers.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that incorporating validated susceptibility SNP scores into risk models along with clinical and demographic information may improve predictive ability, the improvement is modest. The average 1 - c-index values of 0.221 for BRCA1 carriers and 0.215 for BRCA2 carriers indicate that the models have limited predictive power. Therefore, while multiple SNP testing in BRCA2 and BRCA1 female carriers might contribute to improving risk prediction models, it may not significantly enhance the predictive ability on its own. Further research is needed to explore the potential of combining SNP scores with other biomarkers, genetic factors, or more advanced modeling techniques to achieve better risk prediction.",
      "expected_output": "no",
      "question_values": [
        "Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?",
        "Several single nucleotide polymorphisms (SNPs) at different loci have been associated with breast cancer susceptibility, accounting for around 10% of the familial component. Recent studies have found direct associations between specific SNPs and breast cancer in BRCA1/2 mutation carriers. Our aim was to determine whether validated susceptibility SNP scores improve the predictive ability of risk models in comparison/conjunction to other clinical/demographic information. Female BRCA1/2 carriers were identified from the Manchester genetic database, and included in the study regardless of breast cancer status or age. DNA was extracted from blood samples provided by these women and used for gene and SNP profiling. Estimates of survival were examined with Kaplan-Meier curves. Multivariable Cox proportional hazards models were fit in the separate BRCA datasets and in menopausal stages screening different combinations of clinical/demographic/genetic variables. Nonlinear random survival forests were also fit to identify relevant interactions. Models were compared using Harrell's concordance index (1 - c-index). 548 female BRCA1 mutation carriers and 523 BRCA2 carriers were identified from the database. Median Kaplan-Meier estimate of survival was 46.0 years (44.9-48.1) for BRCA1 carriers and 48.9 (47.3-50.4) for BRCA2. By fitting Cox models and random survival forests, including both a genetic SNP score and clinical/demographic variables, average 1 - c-index values were 0.221 (st.dev. 0.019) for BRCA1 carriers and 0.215 (st.dev. 0.018) for BRCA2 carriers."
      ],
      "processing_time": 4.950155735015869,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy?\n\nContext: Nd:YAG laser-induced thermo therapy (LITT) of rat brains is associated with blood-brain barrier (BBB) permeability changes. We address the question of whether LITT-induced locoregional disruption of the BBB could possibly allow a locoregional passage of chemotherapeutic agents into brain tissue to treat malignant glioma.STUDY DESIGN/ CD Fischer rats were subject to LITT of the left forebrain. Disruption of the BBB was analyzed using Evans blue and immunohistochemistry (IH). Animals were perfused with paclitaxel, and high-pressure liquid chromatography (HPLC) was employed to analyze the content of paclitaxel in brain and plasma samples. LITT induces an opening of the BBB as demonstrated by locoregional extravasation of Evans blue, C3C, fibrinogen, and IgM. HPLC proved the passage of paclitaxel across the disrupted BBB.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study does show that LITT can induce a temporary opening of the blood-brain barrier and that paclitaxel can pass through this disrupted barrier, it's not conclusive about whether this would be an effective or safe approach for treating malignant glioma. Here are a few reasons why:\n\n1. **Temporary Opening**: The BBB disruption is temporary, and it's not clear if it lasts long enough for a therapeutic effect.\n2. **Local Concentration**: Even if paclitaxel enters the brain, it's not certain that it will reach the tumor in high enough concentrations to be effective.\n3. **Safety**: Disrupting the BBB could potentially allow other harmful substances to enter the brain, and there could be other unforeseen side effects.\n4. **Clinical Relevance**: The study was conducted on rats, and the results may not translate directly to humans.\n\nSo, while the study suggests that LITT could potentially be used as an adjuvant therapy for glioma by allowing chemotherapeutic agents to pass the BBB, more research is needed to determine if this approach is safe and effective in clinical settings.",
      "expected_output": "yes",
      "question_values": [
        "Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy?",
        "Nd:YAG laser-induced thermo therapy (LITT) of rat brains is associated with blood-brain barrier (BBB) permeability changes. We address the question of whether LITT-induced locoregional disruption of the BBB could possibly allow a locoregional passage of chemotherapeutic agents into brain tissue to treat malignant glioma.STUDY DESIGN/ CD Fischer rats were subject to LITT of the left forebrain. Disruption of the BBB was analyzed using Evans blue and immunohistochemistry (IH). Animals were perfused with paclitaxel, and high-pressure liquid chromatography (HPLC) was employed to analyze the content of paclitaxel in brain and plasma samples. LITT induces an opening of the BBB as demonstrated by locoregional extravasation of Evans blue, C3C, fibrinogen, and IgM. HPLC proved the passage of paclitaxel across the disrupted BBB."
      ],
      "processing_time": 8.204091787338257,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Is coeliac disease screening in risk groups justified?\n\nContext: The benefits of serologic screening for coeliac disease in asymptomatic individuals are debatable.AIM: To investigate dietary compliance, quality of life and bone mineral density after long-term treatment in coeliac disease patients found by screening in risk groups. The study comprised 53 consecutive screen-detected coeliac patients diagnosed 14 years (median) ago. Dietary compliance was assessed by interview, 4-day food record and serology. Quality of life was evaluated by the Psychological General Well-Being and SF-36 questionnaires, gastrointestinal symptoms by the Gastrointestinal Symptom Rating Scale and bone mineral density by dual-energy x-ray absorptiometry. Comparisons were made to 44 symptom-detected-treated coeliac patients, 110 non-coeliac subjects and the general population. A total of 96% of screen-detected and 93% of symptom-detected coeliac patients adhered to a strict or fairly strict gluten-free diet. In screen-detected patients, quality of life and gastrointestinal symptoms were similar to those in symptom-detected patients or non-coeliac controls and bone mineral density was similar to that in the general population.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study shows that screen-detected coeliac patients had good dietary compliance, similar quality of life, and normal bone mineral density after long-term treatment, it's important to consider the following:\n\n1. **Ethical implications**: Screening asymptomatic individuals for coeliac disease may lead to overdiagnosis and overtreatment, causing potential harm and anxiety.\n\n2. **Cost-effectiveness**: The benefits of screening need to be weighed against the costs, including the resources required for screening, follow-up, and treatment.\n\n3. **Uncertainty about long-term benefits**: Although the study shows positive outcomes after 14 years, the long-term benefits of screening and early treatment are not yet fully established.\n\n4. **Individual risk assessment**: The decision to screen should consider individual risk factors, such as family history or associated conditions.\n\nTherefore, while the study suggests that screening in risk groups may be justified, the decision should be made on an individual basis, considering the potential benefits, harms, and uncertainties, and taking into account the patient's preferences and values.",
      "expected_output": "yes",
      "question_values": [
        "Is coeliac disease screening in risk groups justified?",
        "The benefits of serologic screening for coeliac disease in asymptomatic individuals are debatable.AIM: To investigate dietary compliance, quality of life and bone mineral density after long-term treatment in coeliac disease patients found by screening in risk groups. The study comprised 53 consecutive screen-detected coeliac patients diagnosed 14 years (median) ago. Dietary compliance was assessed by interview, 4-day food record and serology. Quality of life was evaluated by the Psychological General Well-Being and SF-36 questionnaires, gastrointestinal symptoms by the Gastrointestinal Symptom Rating Scale and bone mineral density by dual-energy x-ray absorptiometry. Comparisons were made to 44 symptom-detected-treated coeliac patients, 110 non-coeliac subjects and the general population. A total of 96% of screen-detected and 93% of symptom-detected coeliac patients adhered to a strict or fairly strict gluten-free diet. In screen-detected patients, quality of life and gastrointestinal symptoms were similar to those in symptom-detected patients or non-coeliac controls and bone mineral density was similar to that in the general population."
      ],
      "processing_time": 7.883803606033325,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does loss of consciousness predict neuropsychological decrements after concussion?\n\nContext: To investigate the importance of loss of consciousness (LOC) in predicting neuropsychological test performance in a large sample of patients with head injury. Retrospective comparison of neuropsychological test results for patients who suffered traumatic LOC, no LOC, or uncertain LOC. Allegheny General Hospital, Pittsburgh, Pennsylvania. The total number of patients included in this study was 383. Neuropsychological test measures, including the visual reproduction, digit span, and logical memory subtests of the Wechsler memory scale (revised), the Trail Making test, Wisconsin Card Sorting test, Hopkins Verbal Learning test, Controlled Oral Word Association, and the Galveston Orientation and Amnesia test (GOAT). No significant differences were found between the LOC, no LOC, or uncertain LOC groups for any of the neuropsychological measures used. Patients who had experienced traumatic LOC did not perform more poorly on neuropsychological testing than those with no LOC or uncertain LOC. All three groups demonstrated mildly decreased performance on formal tests of speed of information processing, attentional process, and memory.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found no significant differences between the groups with and without loss of consciousness (LOC) on neuropsychological tests, it's important to consider the following:\n\n1. **Sample Size**: The study had a large sample size (n=383), which increases the likelihood of detecting significant differences if they exist.\n\n2. **Test Sensitivity**: The neuropsychological tests used might not have been sensitive enough to detect subtle differences between the groups.\n\n3. **Other Factors**: Loss of consciousness is just one factor among many that can influence neuropsychological outcomes after a concussion. Other factors like duration of post-traumatic amnesia, duration of loss of consciousness, and other clinical variables might also play significant roles.\n\n4. **Clinical Implications**: Even if LOC doesn't predict neuropsychological decrements, it's still a clinically important sign that should be considered in the overall assessment and management of concussion patients.\n\nSo, while the study suggests that LOC may not be a strong predictor of neuropsychological decrements, it's still a complex issue that might depend on various factors and the sensitivity of the tests used. Therefore, the answer is \"maybe\".",
      "expected_output": "no",
      "question_values": [
        "Does loss of consciousness predict neuropsychological decrements after concussion?",
        "To investigate the importance of loss of consciousness (LOC) in predicting neuropsychological test performance in a large sample of patients with head injury. Retrospective comparison of neuropsychological test results for patients who suffered traumatic LOC, no LOC, or uncertain LOC. Allegheny General Hospital, Pittsburgh, Pennsylvania. The total number of patients included in this study was 383. Neuropsychological test measures, including the visual reproduction, digit span, and logical memory subtests of the Wechsler memory scale (revised), the Trail Making test, Wisconsin Card Sorting test, Hopkins Verbal Learning test, Controlled Oral Word Association, and the Galveston Orientation and Amnesia test (GOAT). No significant differences were found between the LOC, no LOC, or uncertain LOC groups for any of the neuropsychological measures used. Patients who had experienced traumatic LOC did not perform more poorly on neuropsychological testing than those with no LOC or uncertain LOC. All three groups demonstrated mildly decreased performance on formal tests of speed of information processing, attentional process, and memory."
      ],
      "processing_time": 8.502309083938599,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Marital status, living arrangement and mortality: does the association vary by gender?\n\nContext: Men appear to benefit more from being married than women with respect to mortality in middle age. However, there is some uncertainty about gender differences in mortality risks in older individuals, widowed, divorced and single individuals and about the impact of living arrangements. Longitudinal data with 1990 census records being linked to mortality data up to 2005 were used (Swiss National Cohort). The sample comprised all residents over age 44 years in Switzerland (n=2,440,242). All-cause mortality HRs for marital status and living arrangements were estimated by Cox regression for men and women and different age groups with adjustment for education and socio-professional category. The benefit of being married was stronger for men than for women; however, mortality patterns were similar, with higher mortality in divorced and single individuals compared with widowed individuals (<80 years). After adjustment for living arrangements, the gender difference by marital status disappeared. Stratification by living arrangement revealed that mortality risks were highest for 45-64-year-old divorced (HR 1.72 (95% CI 1.67 to 1.76)) and single men (HR 1.67 (95% CI 1.63 to 1.71)) who lived alone. In women of the same age, the highest mortality risk was observed for those who were single and living with a partner (HR 1.70 (95% CI 1.58 to 1.82)). In older age groups, the impact of marital status decreased.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that the benefit of being married was stronger for men than for women, the association between marital status and mortality varied by living arrangements and age group. Therefore, it's not entirely clear whether the association varies by gender in a consistent way across all age groups and living arrangements.",
      "expected_output": "yes",
      "question_values": [
        "Marital status, living arrangement and mortality: does the association vary by gender?",
        "Men appear to benefit more from being married than women with respect to mortality in middle age. However, there is some uncertainty about gender differences in mortality risks in older individuals, widowed, divorced and single individuals and about the impact of living arrangements. Longitudinal data with 1990 census records being linked to mortality data up to 2005 were used (Swiss National Cohort). The sample comprised all residents over age 44 years in Switzerland (n=2,440,242). All-cause mortality HRs for marital status and living arrangements were estimated by Cox regression for men and women and different age groups with adjustment for education and socio-professional category. The benefit of being married was stronger for men than for women; however, mortality patterns were similar, with higher mortality in divorced and single individuals compared with widowed individuals (<80 years). After adjustment for living arrangements, the gender difference by marital status disappeared. Stratification by living arrangement revealed that mortality risks were highest for 45-64-year-old divorced (HR 1.72 (95% CI 1.67 to 1.76)) and single men (HR 1.67 (95% CI 1.63 to 1.71)) who lived alone. In women of the same age, the highest mortality risk was observed for those who were single and living with a partner (HR 1.70 (95% CI 1.58 to 1.82)). In older age groups, the impact of marital status decreased."
      ],
      "processing_time": 2.249337911605835,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Transesophageal echocardiographic assessment of left ventricular function in brain-dead patients: are marginally acceptable hearts suitable for transplantation?\n\nContext: The brain-dead donor supply has become one of the criteria limiting the performance of heart transplantation. Conventional screening criteria are too limiting and exclude suitable heart donors. Echocardiography is now widely available and is a reliable tool to assess left ventricular dysfunction in brain-dead donors. Yet few data are available on the degree of left ventricular dysfunction where a transplantation is possible. Fifty-five potential brain-dead heart donors (age 38 +/- 11 years) were prospectively evaluated by transesophageal echocardiography (TEE) before harvesting. Fractional area change (FAC) was used to assess left ventricular function in potential brain-dead donors. Transplanted hearts were evaluated on the fifth postoperative day. The transplantation was considered a success if the recipient was alive, not retransplanted, without an assistance device or an epinephrine infusion of more than 1 mg/h and showed an ejection fraction above 40%. Of the 55 potential heart donors, 20 exhibited an FAC of less than 50%. Forty hearts were harvested, 36 of which were successfully transplanted. Nine patients had an FAC below 50% (group H2) and 27 had an FAC over 50% (group H1). Four patients died: 2 from hemorrhage (FAC>50% in donors); 1 from right and one from left ventricular dysfunction (FAC<50% in donors). The FAC increased significantly from 51 +/- 15% to 57 +/- 11% in 18 hearts that underwent TEE in donors and afterwards in recipients. Overall actuarial survival was 86.2% versus 64.6% at 1 and 2 years in group H1 and group H2, respectively (p = NS).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that hearts with marginal left ventricular function (FAC < 50%) can be successfully transplanted, the difference in survival rates between the two groups was not statistically significant. Therefore, while it's possible that these hearts could be suitable for transplantation, more data is needed to confirm this. Additionally, the decision to use a heart for transplantation should consider multiple factors, not just left ventricular function.",
      "expected_output": "yes",
      "question_values": [
        "Transesophageal echocardiographic assessment of left ventricular function in brain-dead patients: are marginally acceptable hearts suitable for transplantation?",
        "The brain-dead donor supply has become one of the criteria limiting the performance of heart transplantation. Conventional screening criteria are too limiting and exclude suitable heart donors. Echocardiography is now widely available and is a reliable tool to assess left ventricular dysfunction in brain-dead donors. Yet few data are available on the degree of left ventricular dysfunction where a transplantation is possible. Fifty-five potential brain-dead heart donors (age 38 +/- 11 years) were prospectively evaluated by transesophageal echocardiography (TEE) before harvesting. Fractional area change (FAC) was used to assess left ventricular function in potential brain-dead donors. Transplanted hearts were evaluated on the fifth postoperative day. The transplantation was considered a success if the recipient was alive, not retransplanted, without an assistance device or an epinephrine infusion of more than 1 mg/h and showed an ejection fraction above 40%. Of the 55 potential heart donors, 20 exhibited an FAC of less than 50%. Forty hearts were harvested, 36 of which were successfully transplanted. Nine patients had an FAC below 50% (group H2) and 27 had an FAC over 50% (group H1). Four patients died: 2 from hemorrhage (FAC>50% in donors); 1 from right and one from left ventricular dysfunction (FAC<50% in donors). The FAC increased significantly from 51 +/- 15% to 57 +/- 11% in 18 hearts that underwent TEE in donors and afterwards in recipients. Overall actuarial survival was 86.2% versus 64.6% at 1 and 2 years in group H1 and group H2, respectively (p = NS)."
      ],
      "processing_time": 3.1312742233276367,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Delayed diagnosis of anorectal malformations: are current guidelines sufficient?\n\nContext: Infants referred to our institution with a final diagnosis of ARM were retrospectively reviewed between 2001 and 2009. The first cohort consisted of patients that were referred between November 2001 and November 2006 with the diagnosis of an ARM that had been delayed for more than 48 h. The second cohort was those referred between December 2006 and May 2009 with whom the diagnosis of ARM had not been made within 24 h of birth. Nineteen infants were referred with delayed diagnosis of an ARM over the 7.5 years of the study. Of 44 patients referred to our institution between December 2006 and May 2009, diagnosis of an ARM was delayed more than 24 h in 14 (32%). There was no difference in gender, birth weight, prematurity, type of malformation or presence of associated anomalies between those with timely and delayed diagnosis of their ARM. A significantly greater proportion of those with a delayed diagnosis presented with obstructive symptoms (86% vs. 27%, P<0.001), including abdominal distension (57%) and delayed passage of meconium or stool (29%). Despite undergoing neonatal examination, the diagnosis of ARM was missed in 12 patients overall.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study highlights the importance of timely diagnosis of anorectal malformations (ARMs) and suggests that current guidelines may not be sufficient, it also shows that even with guidelines in place, missed diagnoses can still occur. Here's why it's a \"maybe\":\n\n1. **Yes, current guidelines may not be sufficient**: The high rate of delayed diagnosis (32% in the second cohort) suggests that current guidelines or their implementation may not be adequate. This is further supported by the fact that even with a neonatal examination, the diagnosis was missed in 12 patients.\n\n2. **Maybe, other factors may be involved**: The study found that a significantly greater proportion of delayed diagnoses presented with obstructive symptoms. This could suggest that the severity of symptoms or the presence of certain symptoms might influence the time to diagnosis, regardless of guidelines. Additionally, human error and lack of awareness among healthcare providers could also contribute to missed diagnoses.\n\nTo improve the situation, it might be necessary to review and update guidelines, improve healthcare provider education and awareness, and consider additional diagnostic tools or protocols. However, more research is needed to determine the most effective ways to reduce the rate of delayed diagnosis of ARMs.",
      "expected_output": "no",
      "question_values": [
        "Delayed diagnosis of anorectal malformations: are current guidelines sufficient?",
        "Infants referred to our institution with a final diagnosis of ARM were retrospectively reviewed between 2001 and 2009. The first cohort consisted of patients that were referred between November 2001 and November 2006 with the diagnosis of an ARM that had been delayed for more than 48 h. The second cohort was those referred between December 2006 and May 2009 with whom the diagnosis of ARM had not been made within 24 h of birth. Nineteen infants were referred with delayed diagnosis of an ARM over the 7.5 years of the study. Of 44 patients referred to our institution between December 2006 and May 2009, diagnosis of an ARM was delayed more than 24 h in 14 (32%). There was no difference in gender, birth weight, prematurity, type of malformation or presence of associated anomalies between those with timely and delayed diagnosis of their ARM. A significantly greater proportion of those with a delayed diagnosis presented with obstructive symptoms (86% vs. 27%, P<0.001), including abdominal distension (57%) and delayed passage of meconium or stool (29%). Despite undergoing neonatal examination, the diagnosis of ARM was missed in 12 patients overall."
      ],
      "processing_time": 8.842343091964722,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Are higher rates of depression in women accounted for by differential symptom reporting?\n\nContext: The gender difference in prevalence and incidence rates of depression is one of the most consistent findings in psychiatric epidemiology. We sought to examine whether any gender differences in symptom profile might account for this difference in rates. This study was a population-based 13-year follow-up survey of community-dwelling adults living in East Baltimore in 1981. Subjects were the continuing participants of the Baltimore Epidemiologic Catchment Area Program. Participants interviewed between 1993 and 1996 with complete data on depressive symptoms and covariates were included (n = 1727). We applied structural equations with a measurement model for dichotomous data (the MIMIC-multiple indicators, multiple causes-model) to compare symptoms between women and men, in relation to the nine symptom groups comprising the diagnostic criteria for major depression, adjusting for several potentially influential characteristics (namely, age, self-reported ethnicity, educational attainment, marital status, and employment). There were no significant gender differences in the self-report of depression symptoms even taking into account the higher level of depressive symptoms of women and the influence of other covariates. For example, women were no more likely to endorse sadness than were men, as evidenced by a direct effect coefficient that was not significantly different from the null [adjusted estimated direct effect of gender on report of sadness = 0.105, 95% confidence interval (-0.113, 0.323)].\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found no significant gender differences in the self-report of depression symptoms after adjusting for various factors, it's important to consider a few points:\n\n1. **Measurement**: The study used self-reported symptoms, which could still be influenced by gender differences in reporting styles or willingness to disclose certain symptoms.\n\n2. **Symptom interpretation**: Some symptoms might be interpreted or experienced differently by men and women. For instance, irritability might be more likely to be reported by men due to societal expectations of male behavior.\n\n3. **Help-seeking behavior**: Women are more likely to seek help for mental health issues, which could lead to higher reported rates of depression. However, this study adjusted for help-seeking behavior by including mental health service use as a covariate.\n\n4. **Cultural and societal factors**: Gender differences in depression rates could also be influenced by societal expectations, stress, and life experiences, which were not fully accounted for in this study.\n\nSo, while the study suggests that differential symptom reporting might not fully account for the higher rates of depression in women, it's still a possibility that needs to be considered. Further research using different methods and considering more nuanced factors could provide more insight.",
      "expected_output": "no",
      "question_values": [
        "Are higher rates of depression in women accounted for by differential symptom reporting?",
        "The gender difference in prevalence and incidence rates of depression is one of the most consistent findings in psychiatric epidemiology. We sought to examine whether any gender differences in symptom profile might account for this difference in rates. This study was a population-based 13-year follow-up survey of community-dwelling adults living in East Baltimore in 1981. Subjects were the continuing participants of the Baltimore Epidemiologic Catchment Area Program. Participants interviewed between 1993 and 1996 with complete data on depressive symptoms and covariates were included (n = 1727). We applied structural equations with a measurement model for dichotomous data (the MIMIC-multiple indicators, multiple causes-model) to compare symptoms between women and men, in relation to the nine symptom groups comprising the diagnostic criteria for major depression, adjusting for several potentially influential characteristics (namely, age, self-reported ethnicity, educational attainment, marital status, and employment). There were no significant gender differences in the self-report of depression symptoms even taking into account the higher level of depressive symptoms of women and the influence of other covariates. For example, women were no more likely to endorse sadness than were men, as evidenced by a direct effect coefficient that was not significantly different from the null [adjusted estimated direct effect of gender on report of sadness = 0.105, 95% confidence interval (-0.113, 0.323)]."
      ],
      "processing_time": 8.876354455947876,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Laparoscopic myomectomy: do size, number, and location of the myomas form limiting factors for laparoscopic myomectomy?\n\nContext: To assess whether it is possible for an experienced laparoscopic surgeon to perform efficient laparoscopic myomectomy regardless of the size, number, and location of the myomas. Prospective observational study (Canadian Task Force classification II-1). Tertiary endoscopy center. A total of 505 healthy nonpregnant women with symptomatic myomas underwent laparoscopic myomectomy at our center. No exclusion criteria were based on the size, number, or location of myomas. Laparoscopic myomectomy and modifications of the technique: enucleation of the myoma by morcellation while it is still attached to the uterus with and without earlier devascularization. In all, 912 myomas were removed in these 505 patients laparoscopically. The mean number of myomas removed was 1.85 +/- 5.706 (95% CI 1.72-1.98). In all, 184 (36.4%) patients had multiple myomectomy. The mean size of the myomas removed was 5.86 +/- 3.300 cm in largest diameter (95% CI 5.56-6.16 cm). The mean weight of the myomas removed was 227.74 +/- 325.801 g (95% CI 198.03-257.45 g) and median was 100 g. The median operating time was 60 minutes (range 30-270 minutes). The median blood loss was 90 mL (range 40-2000 mL). Three comparisons were performed on the basis of size of the myomas (<10 cm and>or=10 cm in largest diameter), number of myomas removed (<or=4 and>or=5 myomas), and the technique (enucleation of the myomas by morcellation while the myoma is still attached to the uterus and the conventional technique). In all these comparisons, although the mean blood loss, duration of surgery, and hospital stay were greater in the groups in which larger myomas or more myomas were removed or the modified technique was performed as compared with their corresponding study group, the weight and size of removed myomas were also proportionately larger in these groups. Two patients were given the diagnosis of leiomyosarcoma in their histopathology and 1 patient developed a diaphragmatic parasitic myoma followed by a leiomyoma of the sigmoid colon. Six patients underwent laparoscopic hysterectomy 4 to 6 years after the surgery for recurrent myomas. One conversion to laparotomy occurred and 1 patient underwent open subtotal hysterectomy for dilutional coagulopathy.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that an experienced laparoscopic surgeon can perform efficient laparoscopic myomectomy on a wide range of myoma sizes, numbers, and locations, there are still some limitations and considerations to keep in mind:\n\n1. **Size**: The study found that larger myomas (>10 cm) were associated with longer operating times and more blood loss, although the difference was not statistically significant. Therefore, while it's possible to remove large myomas laparoscopically, it may be more challenging and risky.\n\n2. **Number**: Multiple myomas were also associated with longer operating times and more blood loss. However, the study didn't find a significant difference between removing 4 or fewer myomas versus 5 or more.\n\n3. **Location**: The study doesn't provide specific data on the location of the myomas. Some locations, like the broad ligament or the cornual region, may still pose challenges and increase the risk of complications.\n\n4. **Experience of the surgeon**: The study was conducted in a tertiary endoscopy center by experienced surgeons. The results may not be generalizable to less experienced surgeons or centers.\n\n5. **Risks and complications**: Although rare, the study reported cases of leiomyosarcoma, diaphragmatic parasitic myoma, and recurrent myomas requiring hysterectomy, highlighting the potential risks and long-term considerations.\n\nIn conclusion, while an experienced laparoscopic surgeon can perform myomectomy on a wide range of myoma sizes, numbers, and locations, it's important to consider the potential challenges, risks, and individual patient factors on a case-by-case basis.",
      "expected_output": "no",
      "question_values": [
        "Laparoscopic myomectomy: do size, number, and location of the myomas form limiting factors for laparoscopic myomectomy?",
        "To assess whether it is possible for an experienced laparoscopic surgeon to perform efficient laparoscopic myomectomy regardless of the size, number, and location of the myomas. Prospective observational study (Canadian Task Force classification II-1). Tertiary endoscopy center. A total of 505 healthy nonpregnant women with symptomatic myomas underwent laparoscopic myomectomy at our center. No exclusion criteria were based on the size, number, or location of myomas. Laparoscopic myomectomy and modifications of the technique: enucleation of the myoma by morcellation while it is still attached to the uterus with and without earlier devascularization. In all, 912 myomas were removed in these 505 patients laparoscopically. The mean number of myomas removed was 1.85 +/- 5.706 (95% CI 1.72-1.98). In all, 184 (36.4%) patients had multiple myomectomy. The mean size of the myomas removed was 5.86 +/- 3.300 cm in largest diameter (95% CI 5.56-6.16 cm). The mean weight of the myomas removed was 227.74 +/- 325.801 g (95% CI 198.03-257.45 g) and median was 100 g. The median operating time was 60 minutes (range 30-270 minutes). The median blood loss was 90 mL (range 40-2000 mL). Three comparisons were performed on the basis of size of the myomas (<10 cm and>or=10 cm in largest diameter), number of myomas removed (<or=4 and>or=5 myomas), and the technique (enucleation of the myomas by morcellation while the myoma is still attached to the uterus and the conventional technique). In all these comparisons, although the mean blood loss, duration of surgery, and hospital stay were greater in the groups in which larger myomas or more myomas were removed or the modified technique was performed as compared with their corresponding study group, the weight and size of removed myomas were also proportionately larger in these groups. Two patients were given the diagnosis of leiomyosarcoma in their histopathology and 1 patient developed a diaphragmatic parasitic myoma followed by a leiomyoma of the sigmoid colon. Six patients underwent laparoscopic hysterectomy 4 to 6 years after the surgery for recurrent myomas. One conversion to laparotomy occurred and 1 patient underwent open subtotal hysterectomy for dilutional coagulopathy."
      ],
      "processing_time": 11.87667465209961,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Can predilatation in transcatheter aortic valve implantation be omitted?\n\nContext: The use of a balloon expandable stent valve includes balloon predilatation of the aortic stenosis before valve deployment. The aim of the study was to see whether or not balloon predilatation is necessary in transcatheter aortic valve replacement (TAVI). Sixty consecutive TAVI patients were randomized to the standard procedure or to a protocol where balloon predilatation was omitted. There were no significant differences between the groups regarding early hemodynamic results or complication rates.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found no significant differences in early hemodynamic results or complication rates between the group that underwent balloon predilatation and the group that did not, it's important to note that this was a small study with a limited follow-up period. Larger, longer-term studies are needed to confirm these findings and determine the long-term safety and efficacy of omitting balloon predilatation in TAVI. Additionally, the decision to omit balloon predilatation may depend on individual patient characteristics and the specific type of valve being used. Therefore, it's not yet clear whether balloon predilatation can be universally omitted in TAVI.",
      "expected_output": "yes",
      "question_values": [
        "Can predilatation in transcatheter aortic valve implantation be omitted?",
        "The use of a balloon expandable stent valve includes balloon predilatation of the aortic stenosis before valve deployment. The aim of the study was to see whether or not balloon predilatation is necessary in transcatheter aortic valve replacement (TAVI). Sixty consecutive TAVI patients were randomized to the standard procedure or to a protocol where balloon predilatation was omitted. There were no significant differences between the groups regarding early hemodynamic results or complication rates."
      ],
      "processing_time": 4.849465608596802,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Volume change of uterine myomas during pregnancy: do myomas really grow?\n\nContext: To estimate changes in uterine myoma volume during pregnancy. Review of departmental electronic perinatal database and medical records. Canadian Task Force Classification II-3. Obstetrical ultrasound unit in an academic tertiary care center. One hundred-seven patients diagnosed with uterine myomas during pregnancy and who had two or more obstetrical ultrasounds in different periods of pregnancy. We analyzed the change in volume of uterine myomas between the first half of pregnancy (up until 19 weeks), third quarter (20-30 weeks), and last quarter (31 weeks to term). The volume of largest uterine myoma was calculated using the formula Volume (mm3)=Pi/6x(length mm)x(width mm)x(height mm). The mean age of the population was 31+/-6 years. Between the first and the second study periods, the percentage of uterine myomas that decreased in size was 55.1% (95% CI: 43-66), with a mean decrease in volume of 35%+/-4%; while the percentage of uterine myomas that enlarged was 44.9% (95% CI: 34-56), with a mean increase in volume of 69%+/-11%. Between the second and the third study periods, 75% (95% CI: 56-87) became smaller, with a mean decrease in volume of 30%+/-3%; while 25% (95% CI: 13-43) enlarged, with a mean increase in volume of 102%+/-62%.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that a significant number of uterine myomas decreased in size during pregnancy, it also found that a substantial minority (44.9% between the first and second periods, and 25% between the second and third periods) did enlarge. Therefore, it's not accurate to say that uterine myomas \"really grow\" during pregnancy, as the changes in size are variable and not universal. Some myomas may grow, while others may shrink or remain stable.",
      "expected_output": "no",
      "question_values": [
        "Volume change of uterine myomas during pregnancy: do myomas really grow?",
        "To estimate changes in uterine myoma volume during pregnancy. Review of departmental electronic perinatal database and medical records. Canadian Task Force Classification II-3. Obstetrical ultrasound unit in an academic tertiary care center. One hundred-seven patients diagnosed with uterine myomas during pregnancy and who had two or more obstetrical ultrasounds in different periods of pregnancy. We analyzed the change in volume of uterine myomas between the first half of pregnancy (up until 19 weeks), third quarter (20-30 weeks), and last quarter (31 weeks to term). The volume of largest uterine myoma was calculated using the formula Volume (mm3)=Pi/6x(length mm)x(width mm)x(height mm). The mean age of the population was 31+/-6 years. Between the first and the second study periods, the percentage of uterine myomas that decreased in size was 55.1% (95% CI: 43-66), with a mean decrease in volume of 35%+/-4%; while the percentage of uterine myomas that enlarged was 44.9% (95% CI: 34-56), with a mean increase in volume of 69%+/-11%. Between the second and the third study periods, 75% (95% CI: 56-87) became smaller, with a mean decrease in volume of 30%+/-3%; while 25% (95% CI: 13-43) enlarged, with a mean increase in volume of 102%+/-62%."
      ],
      "processing_time": 3.707148790359497,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Vertical lines in distal esophageal mucosa (VLEM): a true endoscopic manifestation of esophagitis in children?\n\nContext: We observed an endoscopic abnormally in a group of children with histological esophagitis. We termed this finding \"vertical lines in esophageal mucosa\" (VLEM). We examined the relationship between the presence of VLEM and significant histologic changes in esophageal mucosal biopsies. Between January 1, 1992, and August 31, 1994, the senior author (JFF) performed 255 esophageal biopsies. The procedure reports, available endoscopic photographs, and histology reports were reviewed to establish the endoscopic and histologic appearance of the esophageal mucosa. Intraepithelial cells were counted in a blind review of 42 randomly selected biopsies. The esophageal mucosa had a normal appearance on 160 endoscopic studies (Group 1) and VLEM were the only mucosal abnormalities in 41 endoscopies (Group 2). Histology was normal in 92 of 160 biopsies (57.5%) from Group 1, and 1 of 41 biopsies (2.4%) from Group 2. Most patients in Group 2 had eosinophilic esophagitis (34 of 41, 83%, specificity 0.85, sensitivity 0.5, p>0.001) which was of moderate to severe intensity (31 of 34, 91.2%, specificity 0.88, sensitivity 0.73, p<0.001).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests a strong association between vertical lines in distal esophageal mucosa (VLEM) and eosinophilic esophagitis (EoE) in children, it does not provide definitive evidence that VLEM is a true endoscopic manifestation of esophagitis. The study has some limitations, such as a relatively small sample size and lack of a control group without esophageal symptoms. Additionally, the study did not compare VLEM to other endoscopic findings of esophagitis, such as mucosal breaks or erosions. Therefore, while VLEM may be a useful endoscopic finding suggestive of EoE in children, further studies are needed to confirm its specificity and sensitivity as a true manifestation of esophagitis.",
      "expected_output": "yes",
      "question_values": [
        "Vertical lines in distal esophageal mucosa (VLEM): a true endoscopic manifestation of esophagitis in children?",
        "We observed an endoscopic abnormally in a group of children with histological esophagitis. We termed this finding \"vertical lines in esophageal mucosa\" (VLEM). We examined the relationship between the presence of VLEM and significant histologic changes in esophageal mucosal biopsies. Between January 1, 1992, and August 31, 1994, the senior author (JFF) performed 255 esophageal biopsies. The procedure reports, available endoscopic photographs, and histology reports were reviewed to establish the endoscopic and histologic appearance of the esophageal mucosa. Intraepithelial cells were counted in a blind review of 42 randomly selected biopsies. The esophageal mucosa had a normal appearance on 160 endoscopic studies (Group 1) and VLEM were the only mucosal abnormalities in 41 endoscopies (Group 2). Histology was normal in 92 of 160 biopsies (57.5%) from Group 1, and 1 of 41 biopsies (2.4%) from Group 2. Most patients in Group 2 had eosinophilic esophagitis (34 of 41, 83%, specificity 0.85, sensitivity 0.5, p>0.001) which was of moderate to severe intensity (31 of 34, 91.2%, specificity 0.88, sensitivity 0.73, p<0.001)."
      ],
      "processing_time": 5.450488328933716,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Is half-dose contrast-enhanced three-dimensional MR angiography sufficient for the abdominal aorta and pelvis?\n\nContext: To evaluate the usefulness of half-dose contrast-enhanced magnetic resonance (MR) angiography for depicting the abdominal aorta and its major branches. A total of 72 consecutive patients were randomly assigned to one of four groups that underwent MR angiography after receiving different concentrations (original or diluted to 50%) and total amounts (single or half-dose) of gadolinium chelate injected at different rates (1 or 0.5 mL/second). The signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of the abdominal aorta and of the common and external iliac arteries were calculated, and two blinded readers rated the respective image qualities. The SNR and CNR of the abdominal aorta and the common iliac artery in the 0.5 mL/second groups were statistically significantly lower than those in the 1 mL/second groups. The differences in overall image quality across the four groups were not statistically significant.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that half-dose contrast-enhanced MR angiography resulted in lower signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) for the abdominal aorta and common iliac artery when the contrast was injected at a slower rate (0.5 mL/second), the overall image quality was not significantly different across the four groups. Therefore, half-dose contrast-enhanced MR angiography might be sufficient for depicting the abdominal aorta and its major branches, but the injection rate could be a crucial factor. Further studies might be needed to confirm these findings and determine the optimal injection rate for half-dose contrast-enhanced MR angiography.",
      "expected_output": "yes",
      "question_values": [
        "Is half-dose contrast-enhanced three-dimensional MR angiography sufficient for the abdominal aorta and pelvis?",
        "To evaluate the usefulness of half-dose contrast-enhanced magnetic resonance (MR) angiography for depicting the abdominal aorta and its major branches. A total of 72 consecutive patients were randomly assigned to one of four groups that underwent MR angiography after receiving different concentrations (original or diluted to 50%) and total amounts (single or half-dose) of gadolinium chelate injected at different rates (1 or 0.5 mL/second). The signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of the abdominal aorta and of the common and external iliac arteries were calculated, and two blinded readers rated the respective image qualities. The SNR and CNR of the abdominal aorta and the common iliac artery in the 0.5 mL/second groups were statistically significantly lower than those in the 1 mL/second groups. The differences in overall image quality across the four groups were not statistically significant."
      ],
      "processing_time": 4.675435543060303,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Malnutrition, a new inducer for arterial calcification in hemodialysis patients?\n\nContext: Arterial calcification is a significant cardiovascular risk factor in hemodialysis patients. A series of factors are involved in the process of arterial calcification; however, the relationship between malnutrition and arterial calcification is still unclear. 68 hemodialysis patients were enrolled in this study. Nutrition status was evaluated using modified quantitative subjective global assessment (MQSGA). Related serum biochemical parameters were measured. And the radial artery samples were collected during the arteriovenous fistula surgeries. Hematoxylin/eosin stain was used to observe the arterial structures while Alizarin red stain to observe calcified depositions and classify calcified degree. The expressions of bone morphogenetic protein 2 (BMP2) and matrix Gla protein (MGP) were detected by immunohistochemistry and western blot methods. 66.18% hemodialysis patients were malnutrition. In hemodialysis patients, the calcified depositions were mainly located in the medial layer of the radial arteries and the expressions of BMP2 and MGP were both increased in the calcified areas. The levels of serum albumin were negatively associated with calcification score and the expressions of BMP2 and MGP. While MQSGA score, serum phosphorus and calcium\u2009\u00d7\u2009phosphorus product showed positive relationships with calcification score and the expressions of BMP2 and MGP.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. The study suggests a potential relationship between malnutrition, as assessed by MQSGA and serum albumin levels, and arterial calcification in hemodialysis patients. However, the study is observational and does not establish causality. Further research is needed to confirm these findings and understand the underlying mechanisms.",
      "expected_output": "yes",
      "question_values": [
        "Malnutrition, a new inducer for arterial calcification in hemodialysis patients?",
        "Arterial calcification is a significant cardiovascular risk factor in hemodialysis patients. A series of factors are involved in the process of arterial calcification; however, the relationship between malnutrition and arterial calcification is still unclear. 68 hemodialysis patients were enrolled in this study. Nutrition status was evaluated using modified quantitative subjective global assessment (MQSGA). Related serum biochemical parameters were measured. And the radial artery samples were collected during the arteriovenous fistula surgeries. Hematoxylin/eosin stain was used to observe the arterial structures while Alizarin red stain to observe calcified depositions and classify calcified degree. The expressions of bone morphogenetic protein 2 (BMP2) and matrix Gla protein (MGP) were detected by immunohistochemistry and western blot methods. 66.18% hemodialysis patients were malnutrition. In hemodialysis patients, the calcified depositions were mainly located in the medial layer of the radial arteries and the expressions of BMP2 and MGP were both increased in the calcified areas. The levels of serum albumin were negatively associated with calcification score and the expressions of BMP2 and MGP. While MQSGA score, serum phosphorus and calcium\u2009\u00d7\u2009phosphorus product showed positive relationships with calcification score and the expressions of BMP2 and MGP."
      ],
      "processing_time": 2.094599723815918,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Can the prognosis of polymyalgia rheumatica be predicted at disease onset?\n\nContext: To identify the features of PMR that may predict the duration of steroid therapy, the occurrence of relapses and the late development of GCA. Prospective cohort study of 176 patients with PMR, followed up for 5 years. Baseline factors associated with the duration of steroids therapy were identified using Cox regression. Predictors of relapse and the late development of GCA were identified using binary logistic regression. A total of 176 patients with PMR were included, of whom 124 stopped steroids within 5 years. The probability of stopping steroids within 5 years was independently reduced by an elevated plasma viscosity (PV) [hazard ratio (HR) = 0.49; 95% CI 0.29, 0.82 for a PV>or = 2.00 mPa s compared with a PV<or = 1.80 mPa s; overall P = 0.024] and by starting treatment at>15 mg prednisolone (HR = 0.63; 95% CI 0.41, 0.97; P = 0.036). Either of these independently reduced the chances of stopping steroids within a given time interval between 27 and 51%. No significant predictors of relapse were identified. Predictors of late GCA on univariable analysis were female sex [odds ratio (OR) = 8.16; 95% CI 1.06, 63.13; P = 0.044], HLA-DRB1*0101 or -*0401 alleles (OR = 4.95; 95% CI 1.05, 23.34; P = 0.043), PV>or = 2.00 mPa s compared with PV<or = 1.80 mPa s (OR = 10.64; 95% CI 1.28, 88.38; P = 0.029) and initial prednisolone dose>15 mg (OR = 4.53; 95% CI 1.61, 12.79; P = 0.004).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study identified some factors that may predict the duration of steroid therapy and the late development of giant cell arteritis (GCA) in patients with polymyalgia rheumatica (PMR) at disease onset, it's important to note that these predictions are not definitive. The study found that an elevated plasma viscosity (PV) and starting treatment at >15 mg prednisolone were associated with a reduced probability of stopping steroids within 5 years. However, no significant predictors of relapse were identified. Additionally, the predictors of late GCA were based on univariable analysis and may not hold up in a multivariable analysis. Therefore, while these factors may provide some insight into the prognosis of PMR, they cannot be used to definitively predict the course of the disease at disease onset. Further research is needed to identify more robust predictors of PMR prognosis.",
      "expected_output": "yes",
      "question_values": [
        "Can the prognosis of polymyalgia rheumatica be predicted at disease onset?",
        "To identify the features of PMR that may predict the duration of steroid therapy, the occurrence of relapses and the late development of GCA. Prospective cohort study of 176 patients with PMR, followed up for 5 years. Baseline factors associated with the duration of steroids therapy were identified using Cox regression. Predictors of relapse and the late development of GCA were identified using binary logistic regression. A total of 176 patients with PMR were included, of whom 124 stopped steroids within 5 years. The probability of stopping steroids within 5 years was independently reduced by an elevated plasma viscosity (PV) [hazard ratio (HR) = 0.49; 95% CI 0.29, 0.82 for a PV>or = 2.00 mPa s compared with a PV<or = 1.80 mPa s; overall P = 0.024] and by starting treatment at>15 mg prednisolone (HR = 0.63; 95% CI 0.41, 0.97; P = 0.036). Either of these independently reduced the chances of stopping steroids within a given time interval between 27 and 51%. No significant predictors of relapse were identified. Predictors of late GCA on univariable analysis were female sex [odds ratio (OR) = 8.16; 95% CI 1.06, 63.13; P = 0.044], HLA-DRB1*0101 or -*0401 alleles (OR = 4.95; 95% CI 1.05, 23.34; P = 0.043), PV>or = 2.00 mPa s compared with PV<or = 1.80 mPa s (OR = 10.64; 95% CI 1.28, 88.38; P = 0.029) and initial prednisolone dose>15 mg (OR = 4.53; 95% CI 1.61, 12.79; P = 0.004)."
      ],
      "processing_time": 6.48059868812561,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does open access publishing increase the impact of scientific articles?\n\nContext: Some studies suggest that open access articles are more often cited than non-open access articles. However, the relationship between open access and citations count in a discipline such as intensive care medicine has not been studied to date. The present article analyzes the effect of open access publishing of scientific articles in intensive care medicine journals in terms of citations count. We evaluated a total of 161 articles (76% being non-open access articles) published in Intensive Care Medicine in the year 2008. Citation data were compared between the two groups up until April 30, 2011. Potentially confounding variables for citation counts were adjusted for in a linear multiple regression model. The median number (interquartile range) of citations of non-open access articles was 8 (4-12) versus 9 (6-18) in the case of open access articles (p=0.084). In the highest citation range (>8), the citation count was 13 (10-16) and 18 (13-21) (p=0.008), respectively. The mean follow-up was 37.5 \u00b1 3 months in both groups. In the 30-35 months after publication, the average number (mean \u00b1 standard deviation) of citations per article per month of non-open access articles was 0.28 \u00b1 0.6 versus 0.38 \u00b1 0.7 in the case of open access articles (p=0.043). Independent factors for citation advantage were the Hirsch index of the first signing author (\u03b2=0.207; p=0.015) and open access status (\u03b2=3.618; p=0.006).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that open access articles in the intensive care medicine journal had a higher citation count and a higher average number of citations per article per month, the difference was not statistically significant for the overall median citation count (p=0.084). However, there was a significant difference in the highest citation range (>8) and in the 30-35 months after publication. Additionally, the linear multiple regression model showed that open access status was an independent factor for citation advantage. Therefore, while the evidence suggests that open access publishing may increase the impact of scientific articles in intensive care medicine, more research is needed to confirm this relationship.",
      "expected_output": "yes",
      "question_values": [
        "Does open access publishing increase the impact of scientific articles?",
        "Some studies suggest that open access articles are more often cited than non-open access articles. However, the relationship between open access and citations count in a discipline such as intensive care medicine has not been studied to date. The present article analyzes the effect of open access publishing of scientific articles in intensive care medicine journals in terms of citations count. We evaluated a total of 161 articles (76% being non-open access articles) published in Intensive Care Medicine in the year 2008. Citation data were compared between the two groups up until April 30, 2011. Potentially confounding variables for citation counts were adjusted for in a linear multiple regression model. The median number (interquartile range) of citations of non-open access articles was 8 (4-12) versus 9 (6-18) in the case of open access articles (p=0.084). In the highest citation range (>8), the citation count was 13 (10-16) and 18 (13-21) (p=0.008), respectively. The mean follow-up was 37.5 \u00b1 3 months in both groups. In the 30-35 months after publication, the average number (mean \u00b1 standard deviation) of citations per article per month of non-open access articles was 0.28 \u00b1 0.6 versus 0.38 \u00b1 0.7 in the case of open access articles (p=0.043). Independent factors for citation advantage were the Hirsch index of the first signing author (\u03b2=0.207; p=0.015) and open access status (\u03b2=3.618; p=0.006)."
      ],
      "processing_time": 4.919342041015625,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Are intraoperative precursor events associated with postoperative major adverse events?\n\nContext: Precursor events are undesirable events that can lead to a subsequent adverse event and have been associated with postoperative mortality. The purpose of the present study was to determine whether precursor events are associated with a composite endpoint of major adverse cardiac events (MACE) (death, acute renal failure, stroke, infection) in a low- to medium-risk coronary artery bypass grafting, valve, and valve plus coronary artery bypass grafting population. These events might be targets for strategies aimed at quality improvement. The present study was a retrospective cohort design performed at the Queen Elizabeth Health Science Centre. Low- to medium-risk patients who had experienced postoperative MACE were matched 1:1 with patients who had not experienced postoperative MACE. The operative notes, for both groups, were scored by 5 surgeons to determine the frequency of 4 precursor events: bleeding, difficulty weaning from cardiopulmonary bypass, repair or regrafting, and incomplete revascularization or repair. A univariate comparison of \u22651 precursor events in the matched groups was performed. A total of 311 MACE patients (98.4%) were matched. The primary outcome occurred more frequently in the MACE group than in the non-MACE group (33% vs 24%; P\u00a0=\u00a0.015). The incidence of the individual events of bleeding and difficulty weaning from cardiopulmonary bypass was significantly higher in the MACE group. Those patients with a precursor event in the absence of MACE also appeared to have a greater prevalence of other important postoperative outcomes.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. The study found an association between certain intraoperative precursor events (bleeding and difficulty weaning from cardiopulmonary bypass) and the occurrence of major adverse cardiac events (MACE) in a low- to medium-risk population undergoing coronary artery bypass grafting, valve, and valve plus coronary artery bypass grafting procedures. However, this is a retrospective study, and while it suggests an association, it does not prove causation. Therefore, while it's possible that these precursor events are associated with postoperative MACE, further research, such as prospective studies or randomized controlled trials, would be needed to confirm this relationship.",
      "expected_output": "yes",
      "question_values": [
        "Are intraoperative precursor events associated with postoperative major adverse events?",
        "Precursor events are undesirable events that can lead to a subsequent adverse event and have been associated with postoperative mortality. The purpose of the present study was to determine whether precursor events are associated with a composite endpoint of major adverse cardiac events (MACE) (death, acute renal failure, stroke, infection) in a low- to medium-risk coronary artery bypass grafting, valve, and valve plus coronary artery bypass grafting population. These events might be targets for strategies aimed at quality improvement. The present study was a retrospective cohort design performed at the Queen Elizabeth Health Science Centre. Low- to medium-risk patients who had experienced postoperative MACE were matched 1:1 with patients who had not experienced postoperative MACE. The operative notes, for both groups, were scored by 5 surgeons to determine the frequency of 4 precursor events: bleeding, difficulty weaning from cardiopulmonary bypass, repair or regrafting, and incomplete revascularization or repair. A univariate comparison of \u22651 precursor events in the matched groups was performed. A total of 311 MACE patients (98.4%) were matched. The primary outcome occurred more frequently in the MACE group than in the non-MACE group (33% vs 24%; P\u00a0=\u00a0.015). The incidence of the individual events of bleeding and difficulty weaning from cardiopulmonary bypass was significantly higher in the MACE group. Those patients with a precursor event in the absence of MACE also appeared to have a greater prevalence of other important postoperative outcomes."
      ],
      "processing_time": 4.46502161026001,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Is ultrasound equal to X-ray in pediatric fracture diagnosis?\n\nContext: Ultrasound is currently not established for the diagnosis of fractures. The aim of this study was to compare ultrasound and X-ray beyond their use solely for the identification of fractures, i. e., for the detection of fracture type and dislocation for pediatric fracture diagnosis. Limb bones of dead young pigs served as a model for pediatric bones. The fractured bones were examined with ultrasound, X-ray, and CT, which served as the gold standard. 162 of 248 bones were fractured. 130 fractures were identified using ultrasound, and 148 using X-ray. There were some advantages of X-ray over ultrasound in the detection of fracture type (80 correct results using X-ray, 66 correct results using ultrasound). Ultrasound, however, was superior to X-ray for dislocation identification (41 correct results using X-ray, 51 correct results using ultrasound). Both findings were not statistically significant after adjustment for multiple testing.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that ultrasound might be useful in detecting dislocations and could potentially be an alternative to X-ray in pediatric fracture diagnosis, the differences between ultrasound and X-ray were not statistically significant after adjusting for multiple testing. Therefore, more research is needed to confirm these findings and establish the role of ultrasound in pediatric fracture diagnosis.",
      "expected_output": "yes",
      "question_values": [
        "Is ultrasound equal to X-ray in pediatric fracture diagnosis?",
        "Ultrasound is currently not established for the diagnosis of fractures. The aim of this study was to compare ultrasound and X-ray beyond their use solely for the identification of fractures, i. e., for the detection of fracture type and dislocation for pediatric fracture diagnosis. Limb bones of dead young pigs served as a model for pediatric bones. The fractured bones were examined with ultrasound, X-ray, and CT, which served as the gold standard. 162 of 248 bones were fractured. 130 fractures were identified using ultrasound, and 148 using X-ray. There were some advantages of X-ray over ultrasound in the detection of fracture type (80 correct results using X-ray, 66 correct results using ultrasound). Ultrasound, however, was superior to X-ray for dislocation identification (41 correct results using X-ray, 51 correct results using ultrasound). Both findings were not statistically significant after adjustment for multiple testing."
      ],
      "processing_time": 2.4889719486236572,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Is an advance care planning model feasible in community palliative care?\n\nContext: An effective advance care planning programme involves an organizational wide commitment and preparedness for health service reform to embed advance care planning into routine practice. Internationally, such programmes have been implemented predominantly in aged and acute care with more recent work in primary care. A multi-site action research was conducted over a 16-month period in 2007-2009 with three Victorian community palliative care services. Using mixed method data collection strategies to assess feasibility, we conducted a baseline audit of staff and clients; analysed relevant documents (client records, policies, procedures and quality improvement strategies) pre-implementation and post-implementation and conducted key informant interviews (n\u2003=\u20039). Three community palliative care services: one regional and two metropolitan services in Victoria, Australia. The services demonstrated that it was feasible to embed the Model into their organizational structures. Advance care planning conversations and involvement of family was an important outcome measure rather than completion rate of advance care planning documents in community settings. Services adapted and applied their own concept of community, which widened the impact of the model. Changes to quality audit processes were essential to consolidate the model into routine palliative care practice.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that embedding an advance care planning model into community palliative care services was feasible, it's important to consider the specific context and resources of each community palliative care setting. The study was conducted in three services in Victoria, Australia, and the results may not be directly transferable to other settings. Additionally, the study focused on the feasibility of embedding the model, but it did not assess the effectiveness of the model in improving patient outcomes or satisfaction. Therefore, while it may be feasible to implement an advance care planning model in community palliative care, further research is needed to determine the best way to implement such a model and whether it leads to improved outcomes for patients and their families.",
      "expected_output": "yes",
      "question_values": [
        "Is an advance care planning model feasible in community palliative care?",
        "An effective advance care planning programme involves an organizational wide commitment and preparedness for health service reform to embed advance care planning into routine practice. Internationally, such programmes have been implemented predominantly in aged and acute care with more recent work in primary care. A multi-site action research was conducted over a 16-month period in 2007-2009 with three Victorian community palliative care services. Using mixed method data collection strategies to assess feasibility, we conducted a baseline audit of staff and clients; analysed relevant documents (client records, policies, procedures and quality improvement strategies) pre-implementation and post-implementation and conducted key informant interviews (n\u2003=\u20039). Three community palliative care services: one regional and two metropolitan services in Victoria, Australia. The services demonstrated that it was feasible to embed the Model into their organizational structures. Advance care planning conversations and involvement of family was an important outcome measure rather than completion rate of advance care planning documents in community settings. Services adapted and applied their own concept of community, which widened the impact of the model. Changes to quality audit processes were essential to consolidate the model into routine palliative care practice."
      ],
      "processing_time": 5.11191987991333,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Are 99mTc leukocyte scintigraphy and SBFT studies useful in children suspected of having inflammatory bowel disease?\n\nContext: The goal of this retrospective study was to assess whether 99mTc-white blood cell (WBC) scintigraphy and upper gastrointestinal small bowel follow-through (UGI-SBFT) could exclude inflammation in children suspected of having inflammatory bowel disease (IBD). Of a population of 313 children who had a 99mTc-WBC scan, 130 children were studied exclusively to rule out IBD. Sixty-nine colonoscopies with biopsies were done within a short time interval of the 99mTc-WBC scans. There were also 51 controls studied with 99mTc-WBC scintigraphy. Of the 130 children studied to exclude IBD, the final diagnosis was Crohn's disease in 27, ulcerative colitis in nine, miscellaneous colitis in 13, probably normal in 42, and normal in 39. The 99mTc-WBC scans were positive in all but three newly diagnosed Crohn's disease, ulcerative colitis, or miscellaneous colitis children. The false-negative 99mTc-WBC studies were seen in children with mild inflammation on biopsies and normal UGI-SBFT studies. In the 46 children with a true-positive 99mTc-WBC scan, 81% (17/21) of UGI-SBFT studies were normal. In five children with equivocal UGI-SBFT studies, the 99mTc-WBC scan correctly predicted if inflammation was present in the terminal ileum.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that 99mTc leukocyte scintigraphy can be useful in detecting inflammation in children suspected of having inflammatory bowel disease (IBD), it's not definitive in excluding the condition. The false-negative results in children with mild inflammation and normal UGI-SBFT studies indicate that the test may not be reliable in all cases. Therefore, it's important to consider other diagnostic tools and clinical judgment when evaluating children for IBD.",
      "expected_output": "yes",
      "question_values": [
        "Are 99mTc leukocyte scintigraphy and SBFT studies useful in children suspected of having inflammatory bowel disease?",
        "The goal of this retrospective study was to assess whether 99mTc-white blood cell (WBC) scintigraphy and upper gastrointestinal small bowel follow-through (UGI-SBFT) could exclude inflammation in children suspected of having inflammatory bowel disease (IBD). Of a population of 313 children who had a 99mTc-WBC scan, 130 children were studied exclusively to rule out IBD. Sixty-nine colonoscopies with biopsies were done within a short time interval of the 99mTc-WBC scans. There were also 51 controls studied with 99mTc-WBC scintigraphy. Of the 130 children studied to exclude IBD, the final diagnosis was Crohn's disease in 27, ulcerative colitis in nine, miscellaneous colitis in 13, probably normal in 42, and normal in 39. The 99mTc-WBC scans were positive in all but three newly diagnosed Crohn's disease, ulcerative colitis, or miscellaneous colitis children. The false-negative 99mTc-WBC studies were seen in children with mild inflammation on biopsies and normal UGI-SBFT studies. In the 46 children with a true-positive 99mTc-WBC scan, 81% (17/21) of UGI-SBFT studies were normal. In five children with equivocal UGI-SBFT studies, the 99mTc-WBC scan correctly predicted if inflammation was present in the terminal ileum."
      ],
      "processing_time": 3.3411552906036377,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Do European people with type 1 diabetes consume a high atherogenic diet?\n\nContext: Individuals with type 1 diabetes have a high risk of developing cardiovascular diseases, and it has been reported that they consume a high atherogenic diet. We examined how nutrient intake and adherence to current European nutritional recommendations evolved in a large cohort of European individuals with type 1 diabetes over a period of 7 years.SUBJECTS/ We analysed data from the EURODIAB Prospective Complications Study, a European multicentre prospective cohort study. Standardized 3-day dietary records were employed in individuals with type 1 diabetes. One thousand one hundred and two patients (553 men, 549 women, baseline age 33 \u00b1 10 years, duration 15 \u00b1 9 years) had complete nutritional data available at baseline and after 7 years. We calculated mean differences in reported nutrients over time and adjusted these for age, gender, HbA1c and BMI with ANOVA models. Compared to baseline, there were minor changes in nutrients. Reported protein (-0.35% energy (en), fat (-1.07% en), saturated fat (-0.25% en) and cholesterol (-7.42 mg/1000 kcal) intakes were lower, whereas carbohydrate (+1.23% en) and fibre (+0.46 g/1000 kcal) intakes were higher at the 7-year follow-up. European recommendations for adequate nutrient intakes were followed in individuals with type 1 diabetes for protein (76% at baseline and 78% at follow-up), moderately for fat (34, 40%), carbohydrate (34, 41%) and cholesterol (39, 47%), but poorly for fibre (1.4, 2.4%) and saturated fat (11, 13%).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that individuals with type 1 diabetes in Europe did not consume a high atherogenic diet (as they reduced their intake of protein, fat, saturated fat, and cholesterol over 7 years), they also did not fully adhere to European nutritional recommendations, particularly for fiber and saturated fat intake. Therefore, it's not accurate to say they consumed a high atherogenic diet, but it's also not accurate to say they consumed a fully healthy diet according to European guidelines.",
      "expected_output": "yes",
      "question_values": [
        "Do European people with type 1 diabetes consume a high atherogenic diet?",
        "Individuals with type 1 diabetes have a high risk of developing cardiovascular diseases, and it has been reported that they consume a high atherogenic diet. We examined how nutrient intake and adherence to current European nutritional recommendations evolved in a large cohort of European individuals with type 1 diabetes over a period of 7 years.SUBJECTS/ We analysed data from the EURODIAB Prospective Complications Study, a European multicentre prospective cohort study. Standardized 3-day dietary records were employed in individuals with type 1 diabetes. One thousand one hundred and two patients (553 men, 549 women, baseline age 33 \u00b1 10 years, duration 15 \u00b1 9 years) had complete nutritional data available at baseline and after 7 years. We calculated mean differences in reported nutrients over time and adjusted these for age, gender, HbA1c and BMI with ANOVA models. Compared to baseline, there were minor changes in nutrients. Reported protein (-0.35% energy (en), fat (-1.07% en), saturated fat (-0.25% en) and cholesterol (-7.42 mg/1000 kcal) intakes were lower, whereas carbohydrate (+1.23% en) and fibre (+0.46 g/1000 kcal) intakes were higher at the 7-year follow-up. European recommendations for adequate nutrient intakes were followed in individuals with type 1 diabetes for protein (76% at baseline and 78% at follow-up), moderately for fat (34, 40%), carbohydrate (34, 41%) and cholesterol (39, 47%), but poorly for fibre (1.4, 2.4%) and saturated fat (11, 13%)."
      ],
      "processing_time": 3.644167900085449,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Is digoxin use for cardiovascular disease associated with risk of prostate cancer?\n\nContext: Digoxin is a commonly used medication for heart failure and cardiac arrhythmias that has recently been suggested as a novel chemotherapeutic agent. Preclinical studies of prostate cancer (PCa) have shown anti-tumor activity with digoxin. We explore the relationship between use of digoxin and PCa risk. Data from a population-based case-control study of incident cases aged 35-74 years at PCa diagnosis in 2002-2005 in King County, Washington were available. Controls were identified by random digit dialing and frequency matched by age. Use of digoxin was determined from in-person questionnaires regarding medical and prescription history. The relationship of digoxin use with PCa risk was evaluated with logistic regression. One thousand one cases of PCa and 942 controls were analyzed. The prevalence of digoxin use in controls was 2.7%, and use was positively correlated with age. In multivariate analysis adjusting for age, race, PSA screening, and family history of PCa, digoxin use was associated with a reduction in the odds ratio of PCa (OR 0.58, 95% CI: 0.30-1.10). Among those with \u22653 PSA tests over the preceding 5 years (546 cases, 380 controls), digoxin use was associated with a stronger reduction of PCa risk (OR 0.44, 95% CI: 0.20-0.98).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. The study found a non-significant trend towards a reduced risk of prostate cancer with digoxin use in the overall population, and a significant reduction in risk among those who had multiple PSA tests, suggesting a potential protective effect. However, the results are not conclusive due to the small number of digoxin users in the study and the need for further research to confirm these findings. Therefore, it's not definitive to say that digoxin use is associated with a risk of prostate cancer, but it might be associated with a reduced risk.",
      "expected_output": "yes",
      "question_values": [
        "Is digoxin use for cardiovascular disease associated with risk of prostate cancer?",
        "Digoxin is a commonly used medication for heart failure and cardiac arrhythmias that has recently been suggested as a novel chemotherapeutic agent. Preclinical studies of prostate cancer (PCa) have shown anti-tumor activity with digoxin. We explore the relationship between use of digoxin and PCa risk. Data from a population-based case-control study of incident cases aged 35-74 years at PCa diagnosis in 2002-2005 in King County, Washington were available. Controls were identified by random digit dialing and frequency matched by age. Use of digoxin was determined from in-person questionnaires regarding medical and prescription history. The relationship of digoxin use with PCa risk was evaluated with logistic regression. One thousand one cases of PCa and 942 controls were analyzed. The prevalence of digoxin use in controls was 2.7%, and use was positively correlated with age. In multivariate analysis adjusting for age, race, PSA screening, and family history of PCa, digoxin use was associated with a reduction in the odds ratio of PCa (OR 0.58, 95% CI: 0.30-1.10). Among those with \u22653 PSA tests over the preceding 5 years (546 cases, 380 controls), digoxin use was associated with a stronger reduction of PCa risk (OR 0.44, 95% CI: 0.20-0.98)."
      ],
      "processing_time": 3.98988938331604,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages?\n\nContext: Studies examining predictors of survival among the oldest-old have primarily focused on objective measures, such as physical function and health status. Only a few studies have examined the effect of personality traits on survival, such as optimism. The aim of this study was to examine whether an optimistic outlook predicts survival among the oldest-old. The Danish 1905 Cohort Survey is a nationwide, longitudinal survey comprising all individuals born in Denmark in 1905. At baseline in 1998, a total of 2,262 persons aged 92 or 93 agreed to participate in the intake survey. The baseline in-person interview consisted of a comprehensive questionnaire including physical functioning and health, and a question about whether the respondent had an optimistic, neutral or pessimistic outlook on his or her own future. During the follow-up period of 12 years (1998-2010) there were 2,239 deaths (99 %) in the 1905 Cohort Survey. Univariable analyses revealed that optimistic women and men were at lower risk of death compared to their neutral counterparts [HR 0.82, 95 % CI (0.73-0.93) and 0.81, 95 % CI (0.66-0.99), respectively]. When confounding factors such as baseline physical and cognitive functioning and disease were taken into account the association between optimism and survival weakened in both sexes, but the general pattern persisted. Optimistic women were still at lower risk of death compared to neutral women [HR 0.85, 95 % CI (0.74-0.97)]. The risk of death was also decreased for optimistic men compared to their neutral counterparts, but the effect was non-significant [HR 0.91, 95 % CI (0.73-1.13)].\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found a trend towards optimistic individuals having better survival rates, especially among women, the association weakened when controlling for other factors like physical and cognitive functioning, and disease. Therefore, while optimism may play a role in longevity, it's not clear if it's a strong independent predictor of survival at advanced ages. More research is needed to fully understand the relationship between optimism and survival in the oldest-old.",
      "expected_output": "yes",
      "question_values": [
        "Optimism and survival: does an optimistic outlook predict better survival at advanced ages?",
        "Studies examining predictors of survival among the oldest-old have primarily focused on objective measures, such as physical function and health status. Only a few studies have examined the effect of personality traits on survival, such as optimism. The aim of this study was to examine whether an optimistic outlook predicts survival among the oldest-old. The Danish 1905 Cohort Survey is a nationwide, longitudinal survey comprising all individuals born in Denmark in 1905. At baseline in 1998, a total of 2,262 persons aged 92 or 93 agreed to participate in the intake survey. The baseline in-person interview consisted of a comprehensive questionnaire including physical functioning and health, and a question about whether the respondent had an optimistic, neutral or pessimistic outlook on his or her own future. During the follow-up period of 12 years (1998-2010) there were 2,239 deaths (99 %) in the 1905 Cohort Survey. Univariable analyses revealed that optimistic women and men were at lower risk of death compared to their neutral counterparts [HR 0.82, 95 % CI (0.73-0.93) and 0.81, 95 % CI (0.66-0.99), respectively]. When confounding factors such as baseline physical and cognitive functioning and disease were taken into account the association between optimism and survival weakened in both sexes, but the general pattern persisted. Optimistic women were still at lower risk of death compared to neutral women [HR 0.85, 95 % CI (0.74-0.97)]. The risk of death was also decreased for optimistic men compared to their neutral counterparts, but the effect was non-significant [HR 0.91, 95 % CI (0.73-1.13)]."
      ],
      "processing_time": 3.0988776683807373,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Do teleoncology models of care enable safe delivery of chemotherapy in rural towns?\n\nContext: To compare the dose intensity and toxicity profiles for patients undergoing chemotherapy at the Townsville Cancer Centre (TCC), a tertiary cancer centre in northern Queensland, with those for patients treated in Mount Isa, supervised by the same medical oncologists via teleoncology. A quasi-experimental design comparing two patient groups. TCC and Mount Isa Hospital, which both operate under the auspices of the Townsville Teleoncology Network (TTN). Eligible patients who received chemotherapy at TCC or Mt Isa Hospital between 1 May 2007 and 30 April 2012. Teleoncology model for managing cancer patients in rural towns. Dose intensity (doses, number of cycles and lines of treatment) and toxicity rates (rate of serious side effects, hospital admissions and mortality). Over 5 years, 89 patients received a total of 626 cycles of various chemotherapy regimens in Mount Isa. During the same period, 117 patients who received a total of 799 cycles of chemotherapy at TCC were eligible for inclusion in the comparison group. There were no significant differences between the Mount Isa and TCC patients in most demographic characteristics, mean numbers of treatment cycles, dose intensities, proportions of side effects, and hospital admissions. There were no toxicity-related deaths in either group.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found no significant differences in dose intensity and toxicity profiles between patients treated at the Townsville Cancer Centre and those treated in Mount Isa via teleoncology, it's important to consider a few factors:\n\n1. **Sample Size**: The study had a relatively small sample size, which might limit its power to detect subtle differences.\n\n2. **Follow-up Duration**: The study only looked at data up to 30 April 2012. Longer follow-up might be needed to capture late toxicities or differences in survival.\n\n3. **Patient Selection**: The study included patients who were deemed suitable for teleoncology care. Patients with more complex needs might have different outcomes.\n\n4. **Quality of Care**: The study didn't directly measure the quality of care or patient satisfaction. These aspects could still differ between the two settings.\n\nSo, while the study suggests that teleoncology models can enable safe delivery of chemotherapy in rural towns, more research with larger sample sizes, longer follow-up, and broader patient inclusion might be needed to confirm these findings.",
      "expected_output": "yes",
      "question_values": [
        "Do teleoncology models of care enable safe delivery of chemotherapy in rural towns?",
        "To compare the dose intensity and toxicity profiles for patients undergoing chemotherapy at the Townsville Cancer Centre (TCC), a tertiary cancer centre in northern Queensland, with those for patients treated in Mount Isa, supervised by the same medical oncologists via teleoncology. A quasi-experimental design comparing two patient groups. TCC and Mount Isa Hospital, which both operate under the auspices of the Townsville Teleoncology Network (TTN). Eligible patients who received chemotherapy at TCC or Mt Isa Hospital between 1 May 2007 and 30 April 2012. Teleoncology model for managing cancer patients in rural towns. Dose intensity (doses, number of cycles and lines of treatment) and toxicity rates (rate of serious side effects, hospital admissions and mortality). Over 5 years, 89 patients received a total of 626 cycles of various chemotherapy regimens in Mount Isa. During the same period, 117 patients who received a total of 799 cycles of chemotherapy at TCC were eligible for inclusion in the comparison group. There were no significant differences between the Mount Isa and TCC patients in most demographic characteristics, mean numbers of treatment cycles, dose intensities, proportions of side effects, and hospital admissions. There were no toxicity-related deaths in either group."
      ],
      "processing_time": 7.925393581390381,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR?\n\nContext: To examine the ability of various postoperative nomograms to predict prostate cancer-specific mortality (PCSM) and to validate that they could predict aggressive biochemical recurrence (BCR). Prostate-specific antigen (PSA), grade, and stage are the classic triad used to predict BCR after radical prostatectomy (RP). Multiple nomograms use these to predict risk of BCR. A previous study showed that several nomograms could predict aggressive BCR (prostate-specific antigen doubling time [PSADT]\u00a0<9 months) more accurately than BCR. However, it remains unknown if they can predict more definitive endpoints, such as PCSM. We performed Cox analyses to examine the ability of 4 postoperative nomograms, the Duke Prostate Center (DPC) nomogram, the Kattan postoperative nomogram, the Johns Hopkins Hospital (JHH) nomogram, and the joint Center for Prostate Disease Research(CPDR)/Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) nomogram to predict BCR and PCSM among 1778 men in the Shared Equal Access Regional Cancer Hospital (SEARCH) database who underwent RP between 1990 and 2009. We also compared their ability to predict BCR and aggressive BCR in a subset of men. We calculated the c-index for each nomogram to determine its predictive accuracy for estimating actual outcomes. We found that each nomogram could predict aggressive BCR and PCSM in a statistically significant manner and that they all predicted PCSM more accurately than they predicted BCR (ie, with higher c-index values).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that the nomograms do a better job of predicting prostate cancer-specific mortality (PCSM) than biochemical recurrence (BCR), it's important to note that the predictive accuracy for both outcomes was statistically significant. The difference in predictive accuracy between PCSM and BCR was not explicitly stated, so it's unclear whether the improvement is clinically significant. Additionally, the study only included men who underwent radical prostatectomy, so the results may not be generalizable to other treatment modalities or patient populations. Therefore, while the nomograms may have some advantage in predicting more clinically relevant outcomes, further research is needed to determine the clinical significance of this difference.",
      "expected_output": "yes",
      "question_values": [
        "Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR?",
        "To examine the ability of various postoperative nomograms to predict prostate cancer-specific mortality (PCSM) and to validate that they could predict aggressive biochemical recurrence (BCR). Prostate-specific antigen (PSA), grade, and stage are the classic triad used to predict BCR after radical prostatectomy (RP). Multiple nomograms use these to predict risk of BCR. A previous study showed that several nomograms could predict aggressive BCR (prostate-specific antigen doubling time [PSADT]\u00a0<9 months) more accurately than BCR. However, it remains unknown if they can predict more definitive endpoints, such as PCSM. We performed Cox analyses to examine the ability of 4 postoperative nomograms, the Duke Prostate Center (DPC) nomogram, the Kattan postoperative nomogram, the Johns Hopkins Hospital (JHH) nomogram, and the joint Center for Prostate Disease Research(CPDR)/Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) nomogram to predict BCR and PCSM among 1778 men in the Shared Equal Access Regional Cancer Hospital (SEARCH) database who underwent RP between 1990 and 2009. We also compared their ability to predict BCR and aggressive BCR in a subset of men. We calculated the c-index for each nomogram to determine its predictive accuracy for estimating actual outcomes. We found that each nomogram could predict aggressive BCR and PCSM in a statistically significant manner and that they all predicted PCSM more accurately than they predicted BCR (ie, with higher c-index values)."
      ],
      "processing_time": 4.91271185874939,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Necrotizing fasciitis: an indication for hyperbaric oxygenation therapy?\n\nContext: The accepted treatment protocol for necrotizing fasciitis (NF) consists of extensive surgery and wide spectrum antibiotics. Hyperbaric oxygenation (HBO) has been recommended as adjuvant therapy for NF, improving patient mortality and outcome. However, the beneficial effect of HBO for NF remains controversial. A retrospective evaluation of treatment outcome in 37 patients treated for NF between 1984 and 1993 was carried out. The mortality rate, morbidity criteria, and risk factors for grave prognosis were compared between a group of 25 patients who received HBO as part of their treatment protocol and a group of the remaining 12 patients treated by surgical excision and antibiotics alone. The two groups were found to be similar with regard to age, gender, the incidence of individual risk factors for ominous prognosis, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score for disease's severity on presentation. The mortality rate among the HBO-treated patients was 36%, as opposed to 25% in the non-HBO group. The mean number of surgical d\u00e9bridements required per patient was significantly higher in the HBO group: 3.3 compared with 1.5 in the non-HBO-treated patients. Although the average length of hospitalization for survivors was shorter for the HBO group, the difference between the groups did not reach statistical significance.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that the mortality rate was slightly higher in the HBO-treated group and the number of surgical debridements required was significantly higher, the average length of hospitalization for survivors was shorter. The study's retrospective nature and the small sample size make it difficult to draw definitive conclusions. More robust, prospective studies are needed to determine the true effectiveness of HBO as an adjuvant therapy for necrotizing fasciitis.",
      "expected_output": "no",
      "question_values": [
        "Necrotizing fasciitis: an indication for hyperbaric oxygenation therapy?",
        "The accepted treatment protocol for necrotizing fasciitis (NF) consists of extensive surgery and wide spectrum antibiotics. Hyperbaric oxygenation (HBO) has been recommended as adjuvant therapy for NF, improving patient mortality and outcome. However, the beneficial effect of HBO for NF remains controversial. A retrospective evaluation of treatment outcome in 37 patients treated for NF between 1984 and 1993 was carried out. The mortality rate, morbidity criteria, and risk factors for grave prognosis were compared between a group of 25 patients who received HBO as part of their treatment protocol and a group of the remaining 12 patients treated by surgical excision and antibiotics alone. The two groups were found to be similar with regard to age, gender, the incidence of individual risk factors for ominous prognosis, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score for disease's severity on presentation. The mortality rate among the HBO-treated patients was 36%, as opposed to 25% in the non-HBO group. The mean number of surgical d\u00e9bridements required per patient was significantly higher in the HBO group: 3.3 compared with 1.5 in the non-HBO-treated patients. Although the average length of hospitalization for survivors was shorter for the HBO group, the difference between the groups did not reach statistical significance."
      ],
      "processing_time": 3.14927339553833,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Has the use of complementary and alternative medicine therapies by U.S. adults with chronic disease-related functional limitations changed from 2002 to 2007?\n\nContext: This study examined changes in the use of complementary and alternative medicine (CAM) therapies by U.S. adults aged 18 years or older with chronic disease-related functional limitations between 2002 and 2007. The study was a cross-sectional survey.SETTING/ The study was conducted in the United States. The study comprised adults aged 18 years or older with chronic disease-related functional limitations. Data were obtained from the 2002 and 2007 U.S. National Health Interview Survey to compare the use of 22 CAM therapies (n=9313 and n=7014, respectively). Estimates were age adjusted to the year 2000 U.S. standard population. The unadjusted and age-standardized prevalence of overall CAM use (22 therapies comparable between both survey years) was higher in 2007 than in 2002 (30.6% versus 26.9%, p<0.001 and 34.4% versus 30.6%, p<0.001, respectively). Adults with functional limitations that included changing and maintaining body position experienced a significant increase in CAM use between 2002 and 2007 (31.1%-35.0%, p<0.01). The use of deep breathing exercises was the most prevalent CAM therapy in both 2002 and 2007 and increased significantly during this period (from 17.9% to 19.9%, p<0.05). The use of meditation, massage, and yoga also increased significantly from 2002 and 2007 (11.0%-13.5%, p<0.01; 7.0%-10.9%, p<0.0001; and 5.1% to 6.6%, p<0.05, respectively), while the use of the Atkins diet decreased (2.2%- 1.4%, p<0.01).\n\nAnswer (yes/no/maybe):",
      "response": "Yes, the use of complementary and alternative medicine therapies by U.S. adults with chronic disease-related functional limitations changed from 2002 to 2007. The overall prevalence of CAM use increased, and specific therapies such as deep breathing exercises, meditation, massage, and yoga also saw significant increases in usage during this period. Conversely, the use of the Atkins diet decreased.",
      "expected_output": "yes",
      "question_values": [
        "Has the use of complementary and alternative medicine therapies by U.S. adults with chronic disease-related functional limitations changed from 2002 to 2007?",
        "This study examined changes in the use of complementary and alternative medicine (CAM) therapies by U.S. adults aged 18 years or older with chronic disease-related functional limitations between 2002 and 2007. The study was a cross-sectional survey.SETTING/ The study was conducted in the United States. The study comprised adults aged 18 years or older with chronic disease-related functional limitations. Data were obtained from the 2002 and 2007 U.S. National Health Interview Survey to compare the use of 22 CAM therapies (n=9313 and n=7014, respectively). Estimates were age adjusted to the year 2000 U.S. standard population. The unadjusted and age-standardized prevalence of overall CAM use (22 therapies comparable between both survey years) was higher in 2007 than in 2002 (30.6% versus 26.9%, p<0.001 and 34.4% versus 30.6%, p<0.001, respectively). Adults with functional limitations that included changing and maintaining body position experienced a significant increase in CAM use between 2002 and 2007 (31.1%-35.0%, p<0.01). The use of deep breathing exercises was the most prevalent CAM therapy in both 2002 and 2007 and increased significantly during this period (from 17.9% to 19.9%, p<0.05). The use of meditation, massage, and yoga also increased significantly from 2002 and 2007 (11.0%-13.5%, p<0.01; 7.0%-10.9%, p<0.0001; and 5.1% to 6.6%, p<0.05, respectively), while the use of the Atkins diet decreased (2.2%- 1.4%, p<0.01)."
      ],
      "processing_time": 2.958831787109375,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Did Chile's traffic law reform push police enforcement?\n\nContext: The objective of the current study is to determine to what extent the reduction of Chile's traffic fatalities and injuries during 2000-2012 was related to the police traffic enforcement increment registered after the introduction of its 2005 traffic law reform. A unique dataset with assembled information from public institutions and analyses based on ordinary least square and robust random effects models was carried out. Dependent variables were traffic fatality and severe injury rates per population and vehicle fleet. Independent variables were: (1) presence of new national traffic law; (2) police officers per population; (3) number of traffic tickets per police officer; and (4) interaction effect of number of traffic tickets per police officer with traffic law reform. Oil prices, alcohol consumption, proportion of male population 15-24 years old, unemployment, road infrastructure investment, years' effects and regions' effects represented control variables. Empirical estimates from instrumental variables suggest that the enactment of the traffic law reform in interaction with number of traffic tickets per police officer is significantly associated with a decrease of 8% in traffic fatalities and 7% in severe injuries. Piecewise regression model results for the 2007-2012 period suggest that police traffic enforcement reduced traffic fatalities by 59% and severe injuries by 37%.\n\nAnswer (yes/no/maybe):",
      "response": "Yes, the study found that Chile's traffic law reform pushed police enforcement. The results showed that the enactment of the traffic law reform in interaction with the number of traffic tickets issued per police officer was significantly associated with a decrease in traffic fatalities and severe injuries. Additionally, the piecewise regression model results for the 2007-2012 period suggested that police traffic enforcement reduced traffic fatalities by 59% and severe injuries by 37%. Therefore, the traffic law reform did indeed push police enforcement, leading to a significant reduction in traffic fatalities and injuries.",
      "expected_output": "yes",
      "question_values": [
        "Did Chile's traffic law reform push police enforcement?",
        "The objective of the current study is to determine to what extent the reduction of Chile's traffic fatalities and injuries during 2000-2012 was related to the police traffic enforcement increment registered after the introduction of its 2005 traffic law reform. A unique dataset with assembled information from public institutions and analyses based on ordinary least square and robust random effects models was carried out. Dependent variables were traffic fatality and severe injury rates per population and vehicle fleet. Independent variables were: (1) presence of new national traffic law; (2) police officers per population; (3) number of traffic tickets per police officer; and (4) interaction effect of number of traffic tickets per police officer with traffic law reform. Oil prices, alcohol consumption, proportion of male population 15-24 years old, unemployment, road infrastructure investment, years' effects and regions' effects represented control variables. Empirical estimates from instrumental variables suggest that the enactment of the traffic law reform in interaction with number of traffic tickets per police officer is significantly associated with a decrease of 8% in traffic fatalities and 7% in severe injuries. Piecewise regression model results for the 2007-2012 period suggest that police traffic enforcement reduced traffic fatalities by 59% and severe injuries by 37%."
      ],
      "processing_time": 4.3132219314575195,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does the use of atypical antipsychotics as adjunctive therapy in depression result in cost savings?\n\nContext: Several atypical antipsychotics (AAPs) are used as second-line agents for treatment resistant depression. AAPs can be expensive compared to other treatment options and can cause several side effects. To estimate healthcare costs and utilization of AAPs compared to other second-line agents. Observational study using Medicaid claims data (2006-2011). Subjects were depression-diagnosed adult members with at least two prescriptions of antidepressant medications followed by a second-line agent. Gamma generalized linear models (GLM) produced estimates of the difference in mean expenditures among treatment groups after adjusting for individual baseline characteristics using propensity scores. Negative binomial models produced estimates of the difference in number of hospitalizations and emergency department (ED) visits. A total of 3910 members received second-line treatment. Treatment groups were AAPs (n\u2009=\u20092211), augmentation agents other than AAPs (n\u2009=\u20091008), and antidepressant switching (n\u2009=\u2009691). AAPs resulted in higher mean adjusted pharmacy costs and higher mean adjusted total mental health-related costs. Mean adjusted total healthcare costs and number of inpatient and ED visits were not different among treatments.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that the use of atypical antipsychotics (AAPs) as adjunctive therapy in depression resulted in higher mean adjusted pharmacy costs and higher mean adjusted total mental health-related costs compared to other second-line agents, there was no significant difference in mean adjusted total healthcare costs or the number of inpatient and emergency department visits. Therefore, while AAPs may increase pharmaceutical costs, they do not necessarily lead to overall cost savings or increased healthcare utilization. More research is needed to fully understand the cost-effectiveness of AAPs in treating depression.",
      "expected_output": "no",
      "question_values": [
        "Does the use of atypical antipsychotics as adjunctive therapy in depression result in cost savings?",
        "Several atypical antipsychotics (AAPs) are used as second-line agents for treatment resistant depression. AAPs can be expensive compared to other treatment options and can cause several side effects. To estimate healthcare costs and utilization of AAPs compared to other second-line agents. Observational study using Medicaid claims data (2006-2011). Subjects were depression-diagnosed adult members with at least two prescriptions of antidepressant medications followed by a second-line agent. Gamma generalized linear models (GLM) produced estimates of the difference in mean expenditures among treatment groups after adjusting for individual baseline characteristics using propensity scores. Negative binomial models produced estimates of the difference in number of hospitalizations and emergency department (ED) visits. A total of 3910 members received second-line treatment. Treatment groups were AAPs (n\u2009=\u20092211), augmentation agents other than AAPs (n\u2009=\u20091008), and antidepressant switching (n\u2009=\u2009691). AAPs resulted in higher mean adjusted pharmacy costs and higher mean adjusted total mental health-related costs. Mean adjusted total healthcare costs and number of inpatient and ED visits were not different among treatments."
      ],
      "processing_time": 4.095109939575195,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: The Omega-3 Index: a new risk factor for death from coronary heart disease?\n\nContext: Low intakes or blood levels of eicosapentaenoic and docosahexaenoic acids (EPA + DHA) are independently associated with increased risk of death from coronary heart disease (CHD). In randomized secondary prevention trials, fish or fish oil have been demonstrated to reduce total and CHD mortality at intakes of about 1 g/day. Red blood cell (RBC) fatty acid (FA) composition reflects long-term intake of EPA + DHA. We propose that the RBC EPA + DHA (hereafter called the Omega-3 Index) be considered a new risk factor for death from CHD. We conducted clinical and laboratory experiments to generate data necessary for the validation of the Omega-3 Index as a CHD risk predictor. The relationship between this putative marker and risk for CHD death, especially sudden cardiac death (SCD), was then evaluated in several published primary and secondary prevention studies. The Omega-3 Index was inversely associated with risk for CHD mortality. An Omega-3 Index of>or = 8% was associated with the greatest cardioprotection, whereas an index of<or = 4% was associated with the least.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the studies mentioned suggest a correlation between the Omega-3 Index and risk of death from coronary heart disease, more research is needed to establish a definitive causal relationship. Additionally, the optimal Omega-3 Index level for cardioprotection is still a topic of ongoing research and debate. Therefore, while the Omega-3 Index shows promise as a potential risk factor, it's not yet clear if it should be considered a definitive one.",
      "expected_output": "yes",
      "question_values": [
        "The Omega-3 Index: a new risk factor for death from coronary heart disease?",
        "Low intakes or blood levels of eicosapentaenoic and docosahexaenoic acids (EPA + DHA) are independently associated with increased risk of death from coronary heart disease (CHD). In randomized secondary prevention trials, fish or fish oil have been demonstrated to reduce total and CHD mortality at intakes of about 1 g/day. Red blood cell (RBC) fatty acid (FA) composition reflects long-term intake of EPA + DHA. We propose that the RBC EPA + DHA (hereafter called the Omega-3 Index) be considered a new risk factor for death from CHD. We conducted clinical and laboratory experiments to generate data necessary for the validation of the Omega-3 Index as a CHD risk predictor. The relationship between this putative marker and risk for CHD death, especially sudden cardiac death (SCD), was then evaluated in several published primary and secondary prevention studies. The Omega-3 Index was inversely associated with risk for CHD mortality. An Omega-3 Index of>or = 8% was associated with the greatest cardioprotection, whereas an index of<or = 4% was associated with the least."
      ],
      "processing_time": 3.2620227336883545,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: The nurse cystoscopist: a feasible option?\n\nContext: To compare the accuracy achieved by a trained urology nurse practitioner (UNP) and consultant urologist in detecting bladder tumours during flexible cystoscopy. Eighty-three patients underwent flexible cystoscopy by both the UNP and consultant urologist, each unaware of the other's findings. Before comparing the findings, each declared whether there was tumour or any suspicious lesion requiring biopsy. Of 83 patients examined by flexible cystoscopy, 26 were found to have a tumour or a suspicious lesion. One tumour was missed by the UNP and one by the urologist; each tumour was minute. Analysis using the chance-corrected proportional agreement (Kappa) was 0.94, indicating very close agreement.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study shows a high level of agreement between the UNP and the consultant urologist, with a Kappa value of 0.94 indicating very close agreement, it's important to consider the following:\n\n1. **Sample Size**: The study had a relatively small sample size (83 patients), which might limit its generalizability.\n2. **Tumour Size**: Both missed tumours were minute, which could suggest that even experienced professionals might miss small tumours.\n3. **Training**: The UNP in this study was trained, but the level and extent of this training are not specified. Without knowing the specifics of the UNP's training, it's difficult to conclude that all UNPs would perform at the same level.\n4. **Blinding**: The study was well-designed with each practitioner being unaware of the other's findings, but in real-world practice, there might be biases that could affect accuracy.\n\nTherefore, while the nurse cystoscopist could be a feasible option based on this study, more research with larger, more diverse samples and detailed training information would be needed to make a definitive conclusion.",
      "expected_output": "yes",
      "question_values": [
        "The nurse cystoscopist: a feasible option?",
        "To compare the accuracy achieved by a trained urology nurse practitioner (UNP) and consultant urologist in detecting bladder tumours during flexible cystoscopy. Eighty-three patients underwent flexible cystoscopy by both the UNP and consultant urologist, each unaware of the other's findings. Before comparing the findings, each declared whether there was tumour or any suspicious lesion requiring biopsy. Of 83 patients examined by flexible cystoscopy, 26 were found to have a tumour or a suspicious lesion. One tumour was missed by the UNP and one by the urologist; each tumour was minute. Analysis using the chance-corrected proportional agreement (Kappa) was 0.94, indicating very close agreement."
      ],
      "processing_time": 8.34883999824524,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Sternal fracture in growing children : A rare and often overlooked fracture?\n\nContext: Sternal fractures in childhood are rare. The aim of the study was to investigate the accident mechanism, the detection of radiological and sonographical criteria and consideration of associated injuries. In the period from January 2010 to December 2012 all inpatients and outpatients with sternal fractures were recorded according to the documentation. A total of 4 children aged 5-14\u00a0years with a sternal fracture were treated in 2\u00a0years, 2\u00a0children were hospitalized for pain management and 2 remained in outpatient care.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe\n\nExplanation: While the question states that sternal fractures in growing children are rare, the provided context only mentions that a total of 4 children with sternal fractures were treated over a period of 2 years in a single institution. This number, while not extremely high, does not necessarily confirm that these fractures are \"rare\" in the broader population of growing children. Therefore, the answer is \"maybe\" as the context does not provide definitive evidence to support the statement as either \"yes\" or \"no\".",
      "expected_output": "maybe",
      "question_values": [
        "Sternal fracture in growing children : A rare and often overlooked fracture?",
        "Sternal fractures in childhood are rare. The aim of the study was to investigate the accident mechanism, the detection of radiological and sonographical criteria and consideration of associated injuries. In the period from January 2010 to December 2012 all inpatients and outpatients with sternal fractures were recorded according to the documentation. A total of 4 children aged 5-14\u00a0years with a sternal fracture were treated in 2\u00a0years, 2\u00a0children were hospitalized for pain management and 2 remained in outpatient care."
      ],
      "processing_time": 3.868856906890869,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Could Adult European Pharmacoresistant Epilepsy Patients Be Treated With Higher Doses of Zonisamide?\n\nContext: To examine the clinical effect (efficacy and tolerability) of high doses of zonisamide (ZNS) (>500 mg/d) in adult patients with pharmacoresistant epilepsy. Between 2006 and 2013, all epileptic outpatients treated with high doses of ZNS were selected. Safety and efficacy were assessed based on patient and caregiver reports. Serum levels of ZNS and other concomitant antiepileptic drugs were evaluated if available. Nine patients (5 female): 8 focal/1 generalized pharmacoresistant epilepsy. Mean age: 34 years. Most frequent seizure type: complex partial seizures; other seizure types: generalized tonic-clonic, tonic, myoclonia. Zonisamide in polytherapy in all (100%), administered in tritherapy in 3 (33%) of 9 patients; mean dose: 633 (600-700) mg/d; efficacy (>50% seizure reduction) was observed in 5 (55%) of 9 patients. Five of 9 patients are still taking high doses of ZNS (more than 1 year). Adverse events were observed in 3 (37%) of 8 patients. Good tolerance to high doses of other antiepileptic drugs had been observed in 6 (66%) of 9 patients. Plasma levels of ZNS were only available in 2 patients; both were in the therapeutic range (34.95, 30.91) (10-40 mg/L).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that high doses of zonisamide (>500 mg/d) may be effective in reducing seizures in some adult patients with pharmacoresistant epilepsy, the evidence is limited due to the small sample size and lack of a control group. Additionally, the study did not provide long-term follow-up data or compare the high-dose ZNS group with a standard-dose ZNS group. Therefore, while high-dose ZNS may be an option for some patients, more research is needed to determine its safety and efficacy compared to standard doses. It's important for healthcare providers to consider individual patient factors and consult with a neurologist or epileptologist when considering high-dose ZNS therapy.",
      "expected_output": "yes",
      "question_values": [
        "Could Adult European Pharmacoresistant Epilepsy Patients Be Treated With Higher Doses of Zonisamide?",
        "To examine the clinical effect (efficacy and tolerability) of high doses of zonisamide (ZNS) (>500 mg/d) in adult patients with pharmacoresistant epilepsy. Between 2006 and 2013, all epileptic outpatients treated with high doses of ZNS were selected. Safety and efficacy were assessed based on patient and caregiver reports. Serum levels of ZNS and other concomitant antiepileptic drugs were evaluated if available. Nine patients (5 female): 8 focal/1 generalized pharmacoresistant epilepsy. Mean age: 34 years. Most frequent seizure type: complex partial seizures; other seizure types: generalized tonic-clonic, tonic, myoclonia. Zonisamide in polytherapy in all (100%), administered in tritherapy in 3 (33%) of 9 patients; mean dose: 633 (600-700) mg/d; efficacy (>50% seizure reduction) was observed in 5 (55%) of 9 patients. Five of 9 patients are still taking high doses of ZNS (more than 1 year). Adverse events were observed in 3 (37%) of 8 patients. Good tolerance to high doses of other antiepileptic drugs had been observed in 6 (66%) of 9 patients. Plasma levels of ZNS were only available in 2 patients; both were in the therapeutic range (34.95, 30.91) (10-40 mg/L)."
      ],
      "processing_time": 5.168395042419434,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Three-dimensional ultrasound-validated large-core needle biopsy: is it a reliable method for the histological assessment of breast lesions?\n\nContext: The use of three-dimensional (3D) ultrasound may help to determine the exact position of the needle during breast biopsy, thereby reducing the number of core samples that are needed to achieve a reliable histological diagnosis. The aim of this study was to demonstrate the efficacy of 3D ultrasound-validated large-core needle biopsy (LCNB) of the breast. A total of 360 core needle biopsies was obtained from 169 breast lesions in 146 patients. Additional open breast biopsy was performed in 111 women (127/169 breast lesions); the remaining 42 lesions were followed up for at least 24 months. 3D ultrasound visualization of the needle in the postfiring position was used to classify the biopsy as central, marginal or outside the lesion. Based on this classification it was decided whether another sample had to be obtained. A median of two core samples per lesion provided for all the lesions a sensitivity for malignancy of 96.9%, specificity of 100%, false-positive rate of 0% and false-negative rate of 3.1%, and for the excised lesions a sensitivity of 96.5%, specificity of 100%, false-positive rate of 0%, false-negative rate of 3.5% and an underestimation rate of 3.4%.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study shows promising results with high sensitivity and specificity, and a low false-positive and false-negative rate, it's important to consider a few points:\n\n1. **Sample Size**: The study had a relatively small number of lesions (169) and patients (146), which might limit the generalizability of the results.\n\n2. **Follow-up**: Only 42 lesions were followed up for at least 24 months without open biopsy. This is a relatively small number and longer follow-up is needed to confirm the accuracy of the method in benign lesions.\n\n3. **Operator Dependency**: The success of the technique depends on the skill and experience of the operator. The results might vary in different clinical settings.\n\n4. **Validation**: While 3D ultrasound visualization of the needle was used to guide the biopsy, the study did not compare this method with other guidance methods like 2D ultrasound or stereotactic guidance.\n\nSo, while the study suggests that 3D ultrasound-validated LCNB could be a reliable method for histological assessment of breast lesions, more studies with larger sample sizes, longer follow-up, and comparison with other guidance methods are needed to confirm these findings.",
      "expected_output": "yes",
      "question_values": [
        "Three-dimensional ultrasound-validated large-core needle biopsy: is it a reliable method for the histological assessment of breast lesions?",
        "The use of three-dimensional (3D) ultrasound may help to determine the exact position of the needle during breast biopsy, thereby reducing the number of core samples that are needed to achieve a reliable histological diagnosis. The aim of this study was to demonstrate the efficacy of 3D ultrasound-validated large-core needle biopsy (LCNB) of the breast. A total of 360 core needle biopsies was obtained from 169 breast lesions in 146 patients. Additional open breast biopsy was performed in 111 women (127/169 breast lesions); the remaining 42 lesions were followed up for at least 24 months. 3D ultrasound visualization of the needle in the postfiring position was used to classify the biopsy as central, marginal or outside the lesion. Based on this classification it was decided whether another sample had to be obtained. A median of two core samples per lesion provided for all the lesions a sensitivity for malignancy of 96.9%, specificity of 100%, false-positive rate of 0% and false-negative rate of 3.1%, and for the excised lesions a sensitivity of 96.5%, specificity of 100%, false-positive rate of 0%, false-negative rate of 3.5% and an underestimation rate of 3.4%."
      ],
      "processing_time": 8.954225301742554,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Is portable ultrasonography accurate in the evaluation of Schanz pin placement during extremity fracture fixation in austere environments?\n\nContext: The purpose of this study was to investigate the efficacy of ultrasonography to confirm Schanz pin placement in a cadaveric model, and the interobserver repeatability of the ultrasound methodology. This investigation is a repeated measures cadaveric study with multiple examiners. Cadaveric preparation and observations were done by an orthopaedic traumatologist and resident, and two general surgery traumatologists. A total of 16 Schanz pins were equally placed in bilateral femora and tibiae. Four examiners took measurements of pin protrusion beyond the distal cortices using first ultrasonography and then by direct measurement after gross dissection.MAIN OUTCOME MEASURE(S): Distal Schanz pin protrusion length measurements from both ultrasonography and direct measurement post dissection. Schanz pin protrusion measurements are underestimated by ultrasonography (p<0.01) by an average of 10 percent over the range of 5 to 18 mm, and they display a proportional bias that increases the under reporting as the magnitude of pin protrusion increases. Ultrasound data demonstrate good linear correlation and closely represent actual protrusion values in the 5 to 12 mm range. Interobserver repeatability analysis demonstrated that all examiners were not statistically different in their measurements despite minimal familiarity with the ultrasound methodology (p>0.8).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that portable ultrasonography can provide a reasonable estimate of Schanz pin placement in a cadaveric model, with good linear correlation in the 5 to 12 mm range, it also showed that ultrasonography underestimates the actual pin protrusion by an average of 10 percent, with a proportional bias that increases with the magnitude of pin protrusion. Therefore, while it may be useful in austere environments where other imaging modalities are not available, its accuracy should be considered with caution, especially for pins with greater protrusion. Further studies in live patients and clinical settings would be needed to confirm these findings.",
      "expected_output": "yes",
      "question_values": [
        "Is portable ultrasonography accurate in the evaluation of Schanz pin placement during extremity fracture fixation in austere environments?",
        "The purpose of this study was to investigate the efficacy of ultrasonography to confirm Schanz pin placement in a cadaveric model, and the interobserver repeatability of the ultrasound methodology. This investigation is a repeated measures cadaveric study with multiple examiners. Cadaveric preparation and observations were done by an orthopaedic traumatologist and resident, and two general surgery traumatologists. A total of 16 Schanz pins were equally placed in bilateral femora and tibiae. Four examiners took measurements of pin protrusion beyond the distal cortices using first ultrasonography and then by direct measurement after gross dissection.MAIN OUTCOME MEASURE(S): Distal Schanz pin protrusion length measurements from both ultrasonography and direct measurement post dissection. Schanz pin protrusion measurements are underestimated by ultrasonography (p<0.01) by an average of 10 percent over the range of 5 to 18 mm, and they display a proportional bias that increases the under reporting as the magnitude of pin protrusion increases. Ultrasound data demonstrate good linear correlation and closely represent actual protrusion values in the 5 to 12 mm range. Interobserver repeatability analysis demonstrated that all examiners were not statistically different in their measurements despite minimal familiarity with the ultrasound methodology (p>0.8)."
      ],
      "processing_time": 4.684101819992065,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does normothermic normokalemic simultaneous antegrade/retrograde perfusion improve myocardial oxygenation and energy metabolism for hypertrophied hearts?\n\nContext: Beating-heart valve surgery appears to be a promising technique for protection of hypertrophied hearts. Normothermic normokalemic simultaneous antegrade/retrograde perfusion (NNSP) may improve myocardial perfusion. However, its effects on myocardial oxygenation and energy metabolism remain unclear. The present study was to determine whether NNSP improved myocardial oxygenation and energy metabolism of hypertrophied hearts relative to normothermic normokalemic antegrade perfusion (NNAP). Twelve hypertrophied pig hearts underwent a protocol consisting of three 20-minute perfusion episodes (10 minutes NNAP and 10 minutes NNSP in a random order) with each conducted at a different blood flow in the left anterior descending coronary artery (LAD [100%, 50%, and 20% of its initial control]). Myocardial oxygenation was assessed using near-infrared spectroscopic imaging. Myocardial energy metabolism was monitored using localized phosphorus-31 magnetic resonance spectroscopy. With 100% LAD flow, both NNAP and NNSP maintained myocardial oxygenation, adenosine triphosphate, phosphocreatine, and inorganic phosphate at normal levels. When LAD flow was reduced to 50% of its control level, NNSP resulted in a small but significant decrease in myocardial oxygenation and phosphocreatine, whereas those measurements did not change significantly during NNAP. With LAD flow further reduced to 20% of its control level, both NNAP and NNSP caused a substantial decrease in myocardial oxygenation, adenosine triphosphate, and phosphocreatine with an increase in inorganic phosphate. However, the changes were significantly greater during NNSP than during NNAP.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that NNSP may not be as effective as NNAP in maintaining myocardial oxygenation and energy metabolism in hypertrophied hearts under reduced blood flow conditions, it's important to note that the differences were relatively small at 50% LAD flow and more pronounced at 20% LAD flow. Additionally, the study was conducted on hypertrophied pig hearts, which may not perfectly represent human hypertrophied hearts. Therefore, while the results suggest that NNSP might not be the optimal strategy for protecting hypertrophied hearts under reduced blood flow, further research is needed to confirm these findings in human subjects and under different clinical conditions.",
      "expected_output": "no",
      "question_values": [
        "Does normothermic normokalemic simultaneous antegrade/retrograde perfusion improve myocardial oxygenation and energy metabolism for hypertrophied hearts?",
        "Beating-heart valve surgery appears to be a promising technique for protection of hypertrophied hearts. Normothermic normokalemic simultaneous antegrade/retrograde perfusion (NNSP) may improve myocardial perfusion. However, its effects on myocardial oxygenation and energy metabolism remain unclear. The present study was to determine whether NNSP improved myocardial oxygenation and energy metabolism of hypertrophied hearts relative to normothermic normokalemic antegrade perfusion (NNAP). Twelve hypertrophied pig hearts underwent a protocol consisting of three 20-minute perfusion episodes (10 minutes NNAP and 10 minutes NNSP in a random order) with each conducted at a different blood flow in the left anterior descending coronary artery (LAD [100%, 50%, and 20% of its initial control]). Myocardial oxygenation was assessed using near-infrared spectroscopic imaging. Myocardial energy metabolism was monitored using localized phosphorus-31 magnetic resonance spectroscopy. With 100% LAD flow, both NNAP and NNSP maintained myocardial oxygenation, adenosine triphosphate, phosphocreatine, and inorganic phosphate at normal levels. When LAD flow was reduced to 50% of its control level, NNSP resulted in a small but significant decrease in myocardial oxygenation and phosphocreatine, whereas those measurements did not change significantly during NNAP. With LAD flow further reduced to 20% of its control level, both NNAP and NNSP caused a substantial decrease in myocardial oxygenation, adenosine triphosphate, and phosphocreatine with an increase in inorganic phosphate. However, the changes were significantly greater during NNSP than during NNAP."
      ],
      "processing_time": 4.995203971862793,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Endovenous laser ablation in the treatment of small saphenous varicose veins: does site of access influence early outcomes?\n\nContext: The study was performed to evaluate the clinical and technical efficacy of endovenous laser ablation (EVLA) of small saphenous varicosities, particularly in relation to the site of endovenous access. Totally 59 patients with unilateral saphenopopliteal junction incompetence and small saphenous vein reflux underwent EVLA (810 nm, 14 W diode laser) with ambulatory phlebectomies. Small saphenous vein access was gained at the lowest site of truncal reflux. Patients were divided into 2 groups: access gained above mid-calf (AMC, n = 33) and below mid-calf (BMC, n = 26) levels. Outcomes included Venous Clinical Severity Scores (VCSS), Aberdeen Varicose Vein Questionnaire (AVVQ), patient satisfaction, complications, and recurrence rates. Both groups demonstrated significant improvement in VCSS, AVVQ, generic quality of life Short Form 36, and EuroQol scores (P<.05) up to 1 year. No differences were seen between AMC and BMC groups for complications (phlebitis: 2 [6%] and 1 [3.8%], P>.05; paresthesia: 2 [6%] and 5 [19%], P = .223) and recurrence (3 [9%] and 1 [3.8%], P = .623), respectively.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found no significant differences in outcomes between the two access sites (above mid-calf and below mid-calf), the sample size was relatively small, and the study was not powered to detect small differences in outcomes. Therefore, it's possible that a larger study with more power might find subtle differences in outcomes based on the site of access. Additionally, the study only followed patients for one year, so long-term outcomes were not assessed. Therefore, while the current evidence suggests that the site of access does not influence early outcomes, further research is needed to determine if there are any long-term differences based on the site of access.",
      "expected_output": "no",
      "question_values": [
        "Endovenous laser ablation in the treatment of small saphenous varicose veins: does site of access influence early outcomes?",
        "The study was performed to evaluate the clinical and technical efficacy of endovenous laser ablation (EVLA) of small saphenous varicosities, particularly in relation to the site of endovenous access. Totally 59 patients with unilateral saphenopopliteal junction incompetence and small saphenous vein reflux underwent EVLA (810 nm, 14 W diode laser) with ambulatory phlebectomies. Small saphenous vein access was gained at the lowest site of truncal reflux. Patients were divided into 2 groups: access gained above mid-calf (AMC, n = 33) and below mid-calf (BMC, n = 26) levels. Outcomes included Venous Clinical Severity Scores (VCSS), Aberdeen Varicose Vein Questionnaire (AVVQ), patient satisfaction, complications, and recurrence rates. Both groups demonstrated significant improvement in VCSS, AVVQ, generic quality of life Short Form 36, and EuroQol scores (P<.05) up to 1 year. No differences were seen between AMC and BMC groups for complications (phlebitis: 2 [6%] and 1 [3.8%], P>.05; paresthesia: 2 [6%] and 5 [19%], P = .223) and recurrence (3 [9%] and 1 [3.8%], P = .623), respectively."
      ],
      "processing_time": 4.756770372390747,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Can gingival crevicular blood be relied upon for assessment of blood glucose level?\n\nContext: Diabetes mellitus (DM) is undiagnosed in approximately half of the patients actually suffering from the disease. In addition, the prevalence of DM is more than twice as high as in patients with periodontitis when compared to periodontally healthy subjects. Thus, a high number of patients with periodontitis may have undiagnosed DM. The purpose of the present study was to evaluate whether blood oozing from a gingival crevice during routine periodontal examination can be used for determining glucose levels. Observational cross-sectional studies were carried out in 75 patients (43 males and 32 females) with chronic periodontitis who were divided into two groups: Group I and Group II, respectively. Blood oozing from the gingival crevices of anterior teeth following periodontal probing was collected with the stick of glucose self-monitoring device, and the blood glucose levels were measured. At the same time, finger-prick blood was taken for glucometric analysis and subsequent readings were recorded. The patient's blood glucose values ranged from 74 to 256 mg/dl. The comparison between gingival crevicular blood and finger-prick blood showed a very strong correlation, with a t value of 3.97 (at P value = 0.001).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests a strong correlation between glucose levels in gingival crevicular blood and finger-prick blood, it's important to consider a few points:\n\n1. **Sample Size**: The study was conducted on 75 patients, which is a relatively small sample size. A larger, more diverse sample would provide more robust evidence.\n\n2. **Correlation vs. Agreement**: The strong correlation (t value of 3.97) indicates that the two methods are related, but it doesn't necessarily mean they agree perfectly. A more detailed analysis, such as a Bland-Altman plot, could provide more insight into the agreement between the two methods.\n\n3. **Clinical Significance**: Even if the methods agree, it's important to consider whether the difference in glucose levels is clinically significant. A small difference might not matter in practice, but a larger difference could lead to misdiagnosis or mistreatment.\n\n4. **Practicality**: Using blood from gingival crevices for glucose testing could be more convenient and less invasive than finger-prick tests, but it would need to be confirmed that the method is reliable and practical in a clinical setting.\n\nSo, while the study suggests that gingival crevicular blood could potentially be used for assessing blood glucose levels, more research is needed to confirm these findings and determine the clinical utility of this method.",
      "expected_output": "yes",
      "question_values": [
        "Can gingival crevicular blood be relied upon for assessment of blood glucose level?",
        "Diabetes mellitus (DM) is undiagnosed in approximately half of the patients actually suffering from the disease. In addition, the prevalence of DM is more than twice as high as in patients with periodontitis when compared to periodontally healthy subjects. Thus, a high number of patients with periodontitis may have undiagnosed DM. The purpose of the present study was to evaluate whether blood oozing from a gingival crevice during routine periodontal examination can be used for determining glucose levels. Observational cross-sectional studies were carried out in 75 patients (43 males and 32 females) with chronic periodontitis who were divided into two groups: Group I and Group II, respectively. Blood oozing from the gingival crevices of anterior teeth following periodontal probing was collected with the stick of glucose self-monitoring device, and the blood glucose levels were measured. At the same time, finger-prick blood was taken for glucometric analysis and subsequent readings were recorded. The patient's blood glucose values ranged from 74 to 256 mg/dl. The comparison between gingival crevicular blood and finger-prick blood showed a very strong correlation, with a t value of 3.97 (at P value = 0.001)."
      ],
      "processing_time": 10.150363206863403,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Is a specialised training of phonological awareness indicated in every preschool child?\n\nContext: In a prospective study 218 preschool children were enrolled (stratified in 2 training programs, one specialized for phonologic awareness in order to prevent dyslexia, the other consisting in training of general perception) during the last year of kindergarten. After finishing the first grade 131 children were compared in their reading and writing abilities. In the whole group only a slight difference was found between both training modalities concerning their writing abilities. However, children with a history of hearing loss, actual hearing loss or pathologic middle ear findings profited most from the specialized training program compared to the control in their reading abilities.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe.\n\nWhile the study suggests that specialized training in phonological awareness may be beneficial for children with a history of hearing loss, actual hearing loss, or pathologic middle ear findings, it does not provide conclusive evidence for the entire preschool population. The study found only a slight difference in writing abilities between the two training modalities for the whole group, and the significant difference in reading abilities was specific to children with certain hearing conditions. Therefore, while specialized training may be indicated for some preschool children, it may not be necessary or beneficial for all. Further research is needed to determine the most effective training methods for preventing dyslexia in the general preschool population.",
      "expected_output": "maybe",
      "question_values": [
        "Is a specialised training of phonological awareness indicated in every preschool child?",
        "In a prospective study 218 preschool children were enrolled (stratified in 2 training programs, one specialized for phonologic awareness in order to prevent dyslexia, the other consisting in training of general perception) during the last year of kindergarten. After finishing the first grade 131 children were compared in their reading and writing abilities. In the whole group only a slight difference was found between both training modalities concerning their writing abilities. However, children with a history of hearing loss, actual hearing loss or pathologic middle ear findings profited most from the specialized training program compared to the control in their reading abilities."
      ],
      "processing_time": 4.7413389682769775,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does early migraine treatment shorten time to headache peak and reduce its severity?\n\nContext: To explore whether early treatment would shorten the duration of headache from headache onset to its peak and reduce headache severity at peak. Prior clinical studies almost exclusively focused on headache relief after dosing. No data are available on whether early intervention affects the duration from headache onset to peak and headache severity at peak. Adult migraineurs were enrolled in this observational study from multi-site headache clinics. Patients recorded their migraine experiences via an electronic diary over 1 month. Patients reported the time and pain severity at onset, dosing, and peak. We used a linear mixed model to evaluate the impact of the timing of treatment and to adjust for covariates and correlation of observations within subjects. A total of 182 patients reported 970 migraine episodes, 620 of which were treated before headaches progressed to peak. Mean time from headache onset to peak varied from 1.9 hours to 8.9 hours for patients treated within 15 minutes of onset and those who waited for 4 or more hours, respectively. However, early intervention was not associated with reduced headache severity at peak. In multivariate analysis, early treatment, use of triptans, and mild migraine headache in the past 3 months were significantly associated with shorter time from onset to headache peak. A separate model indicated that the timing of medication was not associated with the duration between dosing and headache peak, but use of triptans shortened the time from dosing to headache peak.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that early treatment was associated with a shorter time from headache onset to peak, it did not find that early intervention reduced headache severity at peak. Therefore, while early treatment may help to reduce the duration of a migraine, it may not necessarily reduce its severity.",
      "expected_output": "yes",
      "question_values": [
        "Does early migraine treatment shorten time to headache peak and reduce its severity?",
        "To explore whether early treatment would shorten the duration of headache from headache onset to its peak and reduce headache severity at peak. Prior clinical studies almost exclusively focused on headache relief after dosing. No data are available on whether early intervention affects the duration from headache onset to peak and headache severity at peak. Adult migraineurs were enrolled in this observational study from multi-site headache clinics. Patients recorded their migraine experiences via an electronic diary over 1 month. Patients reported the time and pain severity at onset, dosing, and peak. We used a linear mixed model to evaluate the impact of the timing of treatment and to adjust for covariates and correlation of observations within subjects. A total of 182 patients reported 970 migraine episodes, 620 of which were treated before headaches progressed to peak. Mean time from headache onset to peak varied from 1.9 hours to 8.9 hours for patients treated within 15 minutes of onset and those who waited for 4 or more hours, respectively. However, early intervention was not associated with reduced headache severity at peak. In multivariate analysis, early treatment, use of triptans, and mild migraine headache in the past 3 months were significantly associated with shorter time from onset to headache peak. A separate model indicated that the timing of medication was not associated with the duration between dosing and headache peak, but use of triptans shortened the time from dosing to headache peak."
      ],
      "processing_time": 2.133474111557007,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Department of Transportation vs self-reported data on motor vehicle collisions and driving convictions for stroke survivors: do they agree?\n\nContext: Research on stroke survivors' driving safety has typically used either self-reports or government records, but the extent to which the 2 may differ is not known. We compared government records and self-reports of motor vehicle collisions and driving convictions in a sample of stroke survivors. The 56 participants were originally recruited for a prospective study on driving and community re-integration post-stroke; the study population consisted of moderately impaired stroke survivors without severe communication disorders who had been referred for a driving assessment. The driving records of the 56 participants for the 5 years before study entry and the 1-year study period were acquired with written consent from the Ministry of Transportation of Ontario (MTO), Canada. Self-reports of collisions and convictions were acquired via a semistructured interview and then compared with the MTO records. Forty-three participants completed the study. For 7 (13.5%) the MTO records did not match the self-reports regarding collision involvement, and for 9 (17.3%) the MTO records did not match self-reports regarding driving convictions. The kappa coefficient for the correlation between MTO records and self-reports was 0.52 for collisions and 0.47 for convictions (both in the moderate range of agreement). When both sources of data were consulted, up to 56 percent more accidents and up to 46 percent more convictions were identified in the study population in the 5 years before study entry compared to when either source was used alone.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found some disagreement between self-reported data and government records for motor vehicle collisions and driving convictions among stroke survivors, the level of agreement was in the moderate range (kappa coefficients of 0.52 and 0.47, respectively). Additionally, combining both sources of data led to the identification of more accidents and convictions than using either source alone. Therefore, it's not clear whether the two methods completely disagree or if they simply provide complementary information. Further research with larger and more diverse samples might provide more definitive answers.",
      "expected_output": "no",
      "question_values": [
        "Department of Transportation vs self-reported data on motor vehicle collisions and driving convictions for stroke survivors: do they agree?",
        "Research on stroke survivors' driving safety has typically used either self-reports or government records, but the extent to which the 2 may differ is not known. We compared government records and self-reports of motor vehicle collisions and driving convictions in a sample of stroke survivors. The 56 participants were originally recruited for a prospective study on driving and community re-integration post-stroke; the study population consisted of moderately impaired stroke survivors without severe communication disorders who had been referred for a driving assessment. The driving records of the 56 participants for the 5 years before study entry and the 1-year study period were acquired with written consent from the Ministry of Transportation of Ontario (MTO), Canada. Self-reports of collisions and convictions were acquired via a semistructured interview and then compared with the MTO records. Forty-three participants completed the study. For 7 (13.5%) the MTO records did not match the self-reports regarding collision involvement, and for 9 (17.3%) the MTO records did not match self-reports regarding driving convictions. The kappa coefficient for the correlation between MTO records and self-reports was 0.52 for collisions and 0.47 for convictions (both in the moderate range of agreement). When both sources of data were consulted, up to 56 percent more accidents and up to 46 percent more convictions were identified in the study population in the 5 years before study entry compared to when either source was used alone."
      ],
      "processing_time": 4.029798269271851,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Is amoxapine an atypical antipsychotic?\n\nContext: All currently available atypical antipsychotics have, at clinically relevant doses: i) high serotonin (5-HT)2 occupancy; ii) greater 5-HT2 than dopamine (D)2 occupancy; and iii) a higher incidence of extrapyramidal side effects when their D2 occupancy exceeds 80%. A review of pharmacologic and behavioral data suggested that amoxapine should also conform to this profile; therefore, we undertook a positron-emission tomography (PET) study of its 5-HT2 and D2 occupancy. Seven healthy volunteers received 50-250 mg/day of amoxapine for 5 days and then had [11C]-raclopride and [18F]-setoperone PET scans. 5-HT2 receptors showed near saturation at doses of 100 mg/day and above. The D2 receptor occupancies showed a dose-dependent increase, never exceeding 80%; at all doses 5-HT2 occupancy exceeded D2 occupancy.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe.\n\nWhile the study you've cited does show that amoxapine has a profile similar to atypical antipsychotics in terms of serotonin (5-HT)2 and dopamine (D)2 occupancy, it's important to note that amoxapine is not typically classified as an atypical antipsychotic by psychiatrists and pharmacologists. This is likely due to its tricyclic structure and its primary use as a tetracyclic antidepressant, rather than an antipsychotic.\n\nHowever, some sources do refer to amoxapine as an atypical antipsychotic due to its low extrapyramidal side effects and its serotonin-dopamine antagonism profile. The study you've cited supports this classification, but it's not universally accepted.\n\nSo, while amoxapine does share some properties with atypical antipsychotics, it's not typically classified as one. Therefore, the answer is maybe.",
      "expected_output": "yes",
      "question_values": [
        "Is amoxapine an atypical antipsychotic?",
        "All currently available atypical antipsychotics have, at clinically relevant doses: i) high serotonin (5-HT)2 occupancy; ii) greater 5-HT2 than dopamine (D)2 occupancy; and iii) a higher incidence of extrapyramidal side effects when their D2 occupancy exceeds 80%. A review of pharmacologic and behavioral data suggested that amoxapine should also conform to this profile; therefore, we undertook a positron-emission tomography (PET) study of its 5-HT2 and D2 occupancy. Seven healthy volunteers received 50-250 mg/day of amoxapine for 5 days and then had [11C]-raclopride and [18F]-setoperone PET scans. 5-HT2 receptors showed near saturation at doses of 100 mg/day and above. The D2 receptor occupancies showed a dose-dependent increase, never exceeding 80%; at all doses 5-HT2 occupancy exceeded D2 occupancy."
      ],
      "processing_time": 6.460195779800415,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Should all patients be optimized to the same preoperative hemoglobin level to avoid transfusion in primary knee arthroplasty?\n\nContext: Optimization of the preoperative hemoglobin (Hb) level is an effective way to reduce allogeneic transfusion in total knee arthroplasty (TKA) though the procedure is expensive, requires close monitoring and is often inconvenient for patients with reduced mobility. Our aim was to investigate the value of preoperative Hb levels to predict transfusion and thereby tailoring Hb optimization to patient characteristics. All consecutive patients who undergone primary TKA in our center over 2\u00a0years, and received tranexamic acid intraoperatively, were reviewed. The adjusted association between preoperative Hb levels and transfusion was assessed by multivariate logistic regression, and the estimated probability of transfusion for individual patients was derived from the logistic model. Out of the 784 patients who meet the inclusion criteria, risk of transfusion was associated with poorer performance status, as measured by the America Association of Anestesiology (ASA) score III/IV (OR: 3\u00b73, P\u00a0<\u00a00\u00b7001) and lower preoperative Hb level (OR 3\u00b78 for each g/dl below 13\u00a0g/dl; P\u00a0<\u00a00\u00b7001). According to the Hb level, the estimated probability of transfusion was 0\u00b703 (range: 0\u00b703-0\u00b764) for ASA I/II patients and 0\u00b710 (range: 0\u00b710-0\u00b784) for ASA III/IV.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that optimizing preoperative hemoglobin levels can help reduce the risk of transfusion in primary knee arthroplasty, it also highlights that the risk of transfusion is associated with other factors such as the patient's performance status (ASA score). Therefore, a one-size-fits-all approach to optimizing preoperative hemoglobin levels may not be the most effective strategy. Instead, a more personalized approach that considers the individual patient's characteristics and risk factors may be more appropriate. Further research is needed to determine the optimal preoperative hemoglobin level for different patient subgroups.",
      "expected_output": "no",
      "question_values": [
        "Should all patients be optimized to the same preoperative hemoglobin level to avoid transfusion in primary knee arthroplasty?",
        "Optimization of the preoperative hemoglobin (Hb) level is an effective way to reduce allogeneic transfusion in total knee arthroplasty (TKA) though the procedure is expensive, requires close monitoring and is often inconvenient for patients with reduced mobility. Our aim was to investigate the value of preoperative Hb levels to predict transfusion and thereby tailoring Hb optimization to patient characteristics. All consecutive patients who undergone primary TKA in our center over 2\u00a0years, and received tranexamic acid intraoperatively, were reviewed. The adjusted association between preoperative Hb levels and transfusion was assessed by multivariate logistic regression, and the estimated probability of transfusion for individual patients was derived from the logistic model. Out of the 784 patients who meet the inclusion criteria, risk of transfusion was associated with poorer performance status, as measured by the America Association of Anestesiology (ASA) score III/IV (OR: 3\u00b73, P\u00a0<\u00a00\u00b7001) and lower preoperative Hb level (OR 3\u00b78 for each g/dl below 13\u00a0g/dl; P\u00a0<\u00a00\u00b7001). According to the Hb level, the estimated probability of transfusion was 0\u00b703 (range: 0\u00b703-0\u00b764) for ASA I/II patients and 0\u00b710 (range: 0\u00b710-0\u00b784) for ASA III/IV."
      ],
      "processing_time": 3.954423189163208,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Can CT predict the level of CSF block in tuberculous hydrocephalus?\n\nContext: Treatment of obstructive hydrocephalus in children with tuberculous meningitis (TBM) depends on the level of the cerebrospinal fluid (CSF) block. Air-encephalography is regarded as the gold standard for differentiating communicating and non-communicating hydrocephalus. Since air-encephalography involves a lumbar puncture, it carries the risk of cerebral herniation. AIM. The aim of this study was to determine whether communicating and non-communicating hydrocephalus in TBM can be differentiated by means of cranial computerised tomography (CT). A number of CT indices were measured in 50 children with communicating and 34 children with non-communicating hydrocephalus according to air-encephalographic findings. The only CT finding that correlated with the type of hydrocephalus was the shape of the third ventricle. Significantly more children with non-communicating hydrocephalus had a rounded third ventricle than those with communicating hydrocephalus.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that the shape of the third ventricle on CT scan could potentially help differentiate between communicating and non-communicating hydrocephalus in children with tuberculous meningitis, it's not definitive. The study had a relatively small sample size, and further research with larger cohorts is needed to confirm these findings. Additionally, while CT scans are less invasive than air-encephalography, they still have limitations in detecting certain types of CSF block. Therefore, the use of CT to predict the level of CSF block in tuberculous hydrocephalus should be considered alongside other clinical and radiological findings.",
      "expected_output": "yes",
      "question_values": [
        "Can CT predict the level of CSF block in tuberculous hydrocephalus?",
        "Treatment of obstructive hydrocephalus in children with tuberculous meningitis (TBM) depends on the level of the cerebrospinal fluid (CSF) block. Air-encephalography is regarded as the gold standard for differentiating communicating and non-communicating hydrocephalus. Since air-encephalography involves a lumbar puncture, it carries the risk of cerebral herniation. AIM. The aim of this study was to determine whether communicating and non-communicating hydrocephalus in TBM can be differentiated by means of cranial computerised tomography (CT). A number of CT indices were measured in 50 children with communicating and 34 children with non-communicating hydrocephalus according to air-encephalographic findings. The only CT finding that correlated with the type of hydrocephalus was the shape of the third ventricle. Significantly more children with non-communicating hydrocephalus had a rounded third ventricle than those with communicating hydrocephalus."
      ],
      "processing_time": 4.379634857177734,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Prescriptions as a proxy for asthma in children: a good choice?\n\nContext: Stock et al. (Eur Respir J 25:47-53, 2005) recently estimated asthma prevalence in Germany using claims data on prescriptions and hospital diagnoses and found high prevalence peaks in infants. Our objective was to critically assess and discuss various aspects of identifying children with asthma using prescription data. We replicated the selection procedure of Stock et al. using data on 290,919 children aged 0-17 years insured in the Gm\u00fcnder ErsatzKasse (GEK) in 2005. Asthma prevalence was also estimated in a sample of 17,641 children aged 0-17 years participating in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) from 2003 to 2006. In children aged 0-4 years insured in the GEK, prevalences were found to range from 11.7 to 17.7% for boys and from 7.2 to 11.1% for girls when the criteria of Stock et al. were applied. A steady decline in prevalences was observed in older age groups. Asthma prevalence estimated in the KiGGS data showed a quite different distribution. In the age group 0-4 years, prevalences were found to range from 0 to 2.6% in boys and from 0 to 1.0% in girls; in children>4 years, prevalences were found to increase with increasing age.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While prescription data can be a useful indicator of asthma in children, it has its limitations. Here are a few points to consider:\n\n1. **Yes**: Prescription data can provide a good indication of asthma, especially in older children who are more likely to be prescribed medication. It's also a convenient and large-scale data source.\n\n2. **No**: The main issue is that prescription data may not capture all cases of asthma. Some children may have asthma but not be prescribed medication, either because they don't need it (mild asthma) or because their parents choose not to use medication. Conversely, some prescriptions may be for other conditions that cause similar symptoms. Also, prescription data doesn't provide information about asthma severity or control.\n\n3. **Maybe**: In infants, prescription data may be particularly unreliable due to the high rate of transient wheezing disorders that are not asthma. This could explain the high prevalence peaks found in infants in the Stock et al. study and the discrepancy with the KiGGS data.\n\nIn conclusion, while prescription data can be a useful tool for estimating asthma prevalence, it should be interpreted with caution, especially in young children. It's also important to consider using multiple data sources or methods to get a more comprehensive picture of asthma prevalence.",
      "expected_output": "no",
      "question_values": [
        "Prescriptions as a proxy for asthma in children: a good choice?",
        "Stock et al. (Eur Respir J 25:47-53, 2005) recently estimated asthma prevalence in Germany using claims data on prescriptions and hospital diagnoses and found high prevalence peaks in infants. Our objective was to critically assess and discuss various aspects of identifying children with asthma using prescription data. We replicated the selection procedure of Stock et al. using data on 290,919 children aged 0-17 years insured in the Gm\u00fcnder ErsatzKasse (GEK) in 2005. Asthma prevalence was also estimated in a sample of 17,641 children aged 0-17 years participating in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) from 2003 to 2006. In children aged 0-4 years insured in the GEK, prevalences were found to range from 11.7 to 17.7% for boys and from 7.2 to 11.1% for girls when the criteria of Stock et al. were applied. A steady decline in prevalences was observed in older age groups. Asthma prevalence estimated in the KiGGS data showed a quite different distribution. In the age group 0-4 years, prevalences were found to range from 0 to 2.6% in boys and from 0 to 1.0% in girls; in children>4 years, prevalences were found to increase with increasing age."
      ],
      "processing_time": 9.397298812866211,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Do approved doctors and medical referees in the UK agree when assessing a seafarer's fitness?\n\nContext: The seafaring industry remains a hazardous occupation that requires sophisticated systems of risk and fitness assessment. This study aims to investigate the extent of agreement between Approved Doctors (ADs) and Medical Referees (MRs) when they assess a seafarer's fitness. Between 2003 and 2009 a total of 232,878 seafarer medical examinations were carried out by ADs, of which 465 were considered by the MRs because the seafarer appealed against the AD's decision. The extent of agreement between ADs and MRs was studied. Two hundred and sixty-eight (58%) cases seen by the ADs were classed as category 4 \"permanently unfit\"; the referees only placed 85 (18%) of them in this category. On the other hand, 252 (54%) cases seen by the MRs were classed as category 2 \"fit with restrictions\", while the ADs had only placed 111 (24%) in this category. The overall agreement between the assessors (AD vs. MR) was poor (Kappa K = 0.18). For cardiovascular diseases and for mental ill-health, access to additional information by the MR was the commonest reason for changing the fitness category, but for all other conditions factors such as the experience and knowledge of the MRs or their different interpretation of the standards were the most frequent reasons for a change to fitness category or to restrictions.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study shows a poor overall agreement between Approved Doctors (ADs) and Medical Referees (MRs) in assessing a seafarer's fitness, it's important to consider the reasons behind these disagreements. In some cases, MRs had access to additional information that influenced their decisions, which could indicate that the disagreement is not necessarily due to a lack of agreement in medical standards, but rather a difference in the information available at the time of assessment. Additionally, the study suggests that the experience and knowledge of the MRs, or different interpretations of the standards, may also play a role in the disagreements. Therefore, while there is a lack of agreement in some cases, it's not clear whether this is due to a fundamental disagreement in assessing fitness or other factors.",
      "expected_output": "no",
      "question_values": [
        "Do approved doctors and medical referees in the UK agree when assessing a seafarer's fitness?",
        "The seafaring industry remains a hazardous occupation that requires sophisticated systems of risk and fitness assessment. This study aims to investigate the extent of agreement between Approved Doctors (ADs) and Medical Referees (MRs) when they assess a seafarer's fitness. Between 2003 and 2009 a total of 232,878 seafarer medical examinations were carried out by ADs, of which 465 were considered by the MRs because the seafarer appealed against the AD's decision. The extent of agreement between ADs and MRs was studied. Two hundred and sixty-eight (58%) cases seen by the ADs were classed as category 4 \"permanently unfit\"; the referees only placed 85 (18%) of them in this category. On the other hand, 252 (54%) cases seen by the MRs were classed as category 2 \"fit with restrictions\", while the ADs had only placed 111 (24%) in this category. The overall agreement between the assessors (AD vs. MR) was poor (Kappa K = 0.18). For cardiovascular diseases and for mental ill-health, access to additional information by the MR was the commonest reason for changing the fitness category, but for all other conditions factors such as the experience and knowledge of the MRs or their different interpretation of the standards were the most frequent reasons for a change to fitness category or to restrictions."
      ],
      "processing_time": 5.88735818862915,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Chemoradiation instead of surgery to treat mid and low rectal tumors: is it safe?\n\nContext: The main treatment for rectal carcinoma is surgery. Preoperative chemoradiation (CRT) is advocated to reduce local recurrence and improve resection of mid and low tethered rectal tumors. Fifty-two patients with mid or low rectal tumors underwent CRT (external beam radiation plus 5-fluorouracil plus folinic acid). Patients who had low rectal tumors with complete response (CR) were not submitted to surgical treatment. All other patients were submitted to surgery, independently of the response. Mean follow-up was 32.1 months. Five-year overall survival was 60.5%. Clinical evaluation after CRT showed CR in 10 cases (19.2%), all low tumors; incomplete response (>50%) in 21 (40.4%); and no response (<50%) in 19 (36.6%). Among the 10 cases with CR, 8 presented with local recurrence within 3.7 to 8.8 months. Two patients were not submitted to surgery and are still alive without cancer after 37 and 58 months. Thirty-nine patients had radical surgery. Seven had local recurrences after CRT plus surgery (17.9%). Overall survival was negatively affected by lymph node metastases (P =.017) and perineural invasion (P =.026).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that chemoradiation can be an alternative to surgery for some patients with mid and low rectal tumors, the high rate of local recurrence in patients who had a complete response to CRT (8 out of 10) raises significant concerns about the safety of this approach. The two patients who did not have surgery and are still alive without cancer after 37 and 58 months are notable, but the small number of such cases makes it difficult to draw definitive conclusions. Therefore, while chemoradiation may be a viable option for some patients, it should be used with caution and careful consideration of the potential risks and benefits, and further research is needed to determine its long-term safety and efficacy compared to surgery.",
      "expected_output": "no",
      "question_values": [
        "Chemoradiation instead of surgery to treat mid and low rectal tumors: is it safe?",
        "The main treatment for rectal carcinoma is surgery. Preoperative chemoradiation (CRT) is advocated to reduce local recurrence and improve resection of mid and low tethered rectal tumors. Fifty-two patients with mid or low rectal tumors underwent CRT (external beam radiation plus 5-fluorouracil plus folinic acid). Patients who had low rectal tumors with complete response (CR) were not submitted to surgical treatment. All other patients were submitted to surgery, independently of the response. Mean follow-up was 32.1 months. Five-year overall survival was 60.5%. Clinical evaluation after CRT showed CR in 10 cases (19.2%), all low tumors; incomplete response (>50%) in 21 (40.4%); and no response (<50%) in 19 (36.6%). Among the 10 cases with CR, 8 presented with local recurrence within 3.7 to 8.8 months. Two patients were not submitted to surgery and are still alive without cancer after 37 and 58 months. Thirty-nine patients had radical surgery. Seven had local recurrences after CRT plus surgery (17.9%). Overall survival was negatively affected by lymph node metastases (P =.017) and perineural invasion (P =.026)."
      ],
      "processing_time": 5.524287223815918,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer?\n\nContext: Compared with computed tomography (CT) and magnetic resonance imaging (MRI), positron emission tomography (PET) may have additional value in the assessment of primary and recurrent cervical cancer. However, the degree of tumour uptake of (18)F-2-fluoro-2-deoxy-D: -glucose (FDG) uptake is sometimes influenced by diabetes mellitus (DM). Therefore, we conducted this prospective study to compare the diagnostic ability of FDG-PET in patients with cervical cancer complicated by DM and those without DM. Patients with untreated locally advanced primary or clinically curable recurrent cervical carcinoma were enrolled. Both FDG-PET and MRI/CT scans were performed within 2 weeks. Patients were categorised into the following groups: hyperglycaemic DM (fasting blood sugar>126 mg/dl), euglycaemic DM and non-DM. The lesions were confirmed histologically or by clinical follow-up. The receiver operating characteristic curve method, with calculation of the area under the curve (AUC), was used to evaluate the discriminative power. From February 2001 to January 2003, 219 patients (75 with primary and 144 with recurrent cervical cancer) were eligible for analysis. Sixteen had hyperglycaemic DM, 12 had euglycaemic DM and 191 were in the non-DM group. The diagnostic power of PET in the hyperglycaemic DM, euglycaemic DM and non-DM groups did not differ significantly with regard to the identification of either metastatic lesions (AUC, 0.967/0.947/0.925, P>0.05) or primary tumours/local recurrence (AUC, 0.950/0.938/0.979, P>0.05). Considering all DM patients, PET showed a significantly higher detection power than MRI/CT scans in respect of metastatic lesions (AUC=0.956 vs 0.824, P=0.012).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that diabetes mellitus did not significantly affect the diagnostic ability of FDG-PET in detecting cervical cancer, it's important to note that the study had a relatively small number of patients with diabetes, particularly those with hyperglycaemic DM (n=16). Therefore, while the results suggest that diabetes mellitus may not significantly influence the efficacy of FDG-PET in diagnosing cervical cancer, further studies with larger sample sizes, especially in hyperglycaemic DM patients, would be needed to confirm these findings.",
      "expected_output": "no",
      "question_values": [
        "Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer?",
        "Compared with computed tomography (CT) and magnetic resonance imaging (MRI), positron emission tomography (PET) may have additional value in the assessment of primary and recurrent cervical cancer. However, the degree of tumour uptake of (18)F-2-fluoro-2-deoxy-D: -glucose (FDG) uptake is sometimes influenced by diabetes mellitus (DM). Therefore, we conducted this prospective study to compare the diagnostic ability of FDG-PET in patients with cervical cancer complicated by DM and those without DM. Patients with untreated locally advanced primary or clinically curable recurrent cervical carcinoma were enrolled. Both FDG-PET and MRI/CT scans were performed within 2 weeks. Patients were categorised into the following groups: hyperglycaemic DM (fasting blood sugar>126 mg/dl), euglycaemic DM and non-DM. The lesions were confirmed histologically or by clinical follow-up. The receiver operating characteristic curve method, with calculation of the area under the curve (AUC), was used to evaluate the discriminative power. From February 2001 to January 2003, 219 patients (75 with primary and 144 with recurrent cervical cancer) were eligible for analysis. Sixteen had hyperglycaemic DM, 12 had euglycaemic DM and 191 were in the non-DM group. The diagnostic power of PET in the hyperglycaemic DM, euglycaemic DM and non-DM groups did not differ significantly with regard to the identification of either metastatic lesions (AUC, 0.967/0.947/0.925, P>0.05) or primary tumours/local recurrence (AUC, 0.950/0.938/0.979, P>0.05). Considering all DM patients, PET showed a significantly higher detection power than MRI/CT scans in respect of metastatic lesions (AUC=0.956 vs 0.824, P=0.012)."
      ],
      "processing_time": 3.905918598175049,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Do microbiological factors account for poor pregnancy outcome among unmarried pregnant women in Poland?\n\nContext: Being unmarried is a well-known risk factor for poor pregnancy outcome such as preterm delivery and intrauterine growth restriction. The aim of this prospective study was to assess the prevalence and risk of bacterial vaginosis (BV) and selected bacteria isolated from the lower genital tract and to determine the socioeconomic and microbiological characteristics that might be responsible for poor pregnancy outcome observed among unmarried pregnant women. The study population comprised 196 pregnant women attending 10 randomly selected outpatient maternity units in the Lodz region, central Poland. Cervicovaginal samples were obtained between 8 and 16 weeks of gestation. Based on Spiegel's criteria, gram-stained vaginal smears were examined for BV and the BV-associated flora was sought by culture. To evaluate the risk factors, relative risk ratios were calculated using EPI INFO software. Among 196 pregnant women, 40 (20.4%) were unmarried. BV was diagnosed among 55 (28.1%) women studied. In the univariate analysis, unmarried pregnant women were characterized by younger age, primary educational level, poor economic situation and excessive smoking during pregnancy, as compared to married women. The unmarried status was a borderline risk factor for BV (OR = 1.83, 95% CI 0.94-4.9) after adjustment for age, smoking and education. An analysis of the microbiological culture from the lower genital tract revealed that unmarried pregnant women had a higher risk for several types of pathological microflora, as compared to married women. However, this finding was significant only for Mycoplasma hominis. The independent risk factors of M. hominis were the young age of the subject and a low concentration of Lactobacillus spp.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that unmarried pregnant women had a higher prevalence of bacterial vaginosis (BV) and were more likely to have certain types of pathological microflora, particularly Mycoplasma hominis, the association between marital status and poor pregnancy outcomes was not statistically significant after adjusting for other factors. Therefore, while microbiological factors may contribute to poor pregnancy outcomes among unmarried women, the study does not provide conclusive evidence that they are the primary cause. Socioeconomic factors such as younger age, lower education level, and poor economic situation were also associated with unmarried status and could potentially contribute to poor pregnancy outcomes. Thus, the relationship between marital status and pregnancy outcomes is likely complex and multifactorial, involving both microbiological and socioeconomic factors.",
      "expected_output": "yes",
      "question_values": [
        "Do microbiological factors account for poor pregnancy outcome among unmarried pregnant women in Poland?",
        "Being unmarried is a well-known risk factor for poor pregnancy outcome such as preterm delivery and intrauterine growth restriction. The aim of this prospective study was to assess the prevalence and risk of bacterial vaginosis (BV) and selected bacteria isolated from the lower genital tract and to determine the socioeconomic and microbiological characteristics that might be responsible for poor pregnancy outcome observed among unmarried pregnant women. The study population comprised 196 pregnant women attending 10 randomly selected outpatient maternity units in the Lodz region, central Poland. Cervicovaginal samples were obtained between 8 and 16 weeks of gestation. Based on Spiegel's criteria, gram-stained vaginal smears were examined for BV and the BV-associated flora was sought by culture. To evaluate the risk factors, relative risk ratios were calculated using EPI INFO software. Among 196 pregnant women, 40 (20.4%) were unmarried. BV was diagnosed among 55 (28.1%) women studied. In the univariate analysis, unmarried pregnant women were characterized by younger age, primary educational level, poor economic situation and excessive smoking during pregnancy, as compared to married women. The unmarried status was a borderline risk factor for BV (OR = 1.83, 95% CI 0.94-4.9) after adjustment for age, smoking and education. An analysis of the microbiological culture from the lower genital tract revealed that unmarried pregnant women had a higher risk for several types of pathological microflora, as compared to married women. However, this finding was significant only for Mycoplasma hominis. The independent risk factors of M. hominis were the young age of the subject and a low concentration of Lactobacillus spp."
      ],
      "processing_time": 5.53734016418457,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does lunar position influence the time of delivery?\n\nContext: To study the relationship between lunar position and the day of delivery; to investigate the synodic distribution of spontaneous deliveries, especially in relation to the presence of a full moon. Retrospective analysis of 1248 spontaneous full-term deliveries in three-year period (36 lunar months), setted at Department of Obstetrics and Gynaecology, Civil Hospital, Fano (Marche, Italy), using circular statistics techniques. A connection between the distribution of spontaneous full-term deliveries and the lunar month was found. The effect of the phases of the moon seems to be particularly relevant in multiparae and plurigravidae; in these cases, the mean day of delivery corresponds to the first or second day after the full moon.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study you mentioned found a correlation between the lunar cycle and the timing of deliveries, particularly in multiparous women, the relationship is not conclusive. Here's why:\n\n1. **Correlation does not imply causation**: The fact that there's a correlation between the lunar cycle and delivery times does not necessarily mean that the moon's position directly influences labor.\n\n2. **Small effect size**: The effect is relatively small, with deliveries peaking a couple of days after the full moon in multiparous women. This might not have a significant clinical impact.\n\n3. **Lack of biological mechanism**: There's no known biological mechanism by which the moon's position could directly influence human labor.\n\n4. **Other studies have found no effect**: Some other studies have found no significant relationship between the lunar cycle and delivery times.\n\nSo, while it's an interesting observation that warrants further study, it's not conclusive enough to say that lunar position definitively influences the time of delivery. Therefore, the answer is \"maybe\".",
      "expected_output": "yes",
      "question_values": [
        "Does lunar position influence the time of delivery?",
        "To study the relationship between lunar position and the day of delivery; to investigate the synodic distribution of spontaneous deliveries, especially in relation to the presence of a full moon. Retrospective analysis of 1248 spontaneous full-term deliveries in three-year period (36 lunar months), setted at Department of Obstetrics and Gynaecology, Civil Hospital, Fano (Marche, Italy), using circular statistics techniques. A connection between the distribution of spontaneous full-term deliveries and the lunar month was found. The effect of the phases of the moon seems to be particularly relevant in multiparae and plurigravidae; in these cases, the mean day of delivery corresponds to the first or second day after the full moon."
      ],
      "processing_time": 7.6204307079315186,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Inpatient Pediatric Tonsillectomy: Does Hospital Type Affect Cost and Outcomes of Care?\n\nContext: To ascertain whether hospital type is associated with differences in total cost and outcomes for inpatient tonsillectomy. Cross-sectional analysis of the 2006, 2009, and 2012 Kids' Inpatient Database (KID). Children \u226418 years of age undergoing tonsillectomy with/without adenoidectomy were included. Risk-adjusted generalized linear models assessed for differences in hospital cost and length of stay (LOS) among children managed by (1) non-children's teaching hospitals (NCTHs), (2) children's teaching hospitals (CTHs), and (3) nonteaching hospitals (NTHs). Risk-adjusted logistic regression compared the odds of major perioperative complications (hemorrhage, respiratory failure, death). Models accounted for clustering of patients within hospitals, were weighted to provide national estimates, and controlled for comorbidities. The 25,685 tonsillectomies recorded in the KID yielded a national estimate of 40,591 inpatient tonsillectomies performed in 2006, 2009, and 2012. The CTHs had significantly higher risk-adjusted total cost and LOS per tonsillectomy compared with NCTHs and NTHs ($9423.34/2.8 days, $6250.78/2.11 days, and $5905.10/2.08 days, respectively; P<.001). The CTHs had higher odds of complications compared with NCTHs (odds ratio [OR], 1.48; 95% CI, 1.15-1.91; P = .002) but not when compared with NTHs (OR, 1.19; 95% CI, 0.89-1.59; P = .23). The CTHs were significantly more likely to care for patients with comorbidities (P<.001).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that children's teaching hospitals (CTHs) had significantly higher risk-adjusted total cost and length of stay (LOS) compared to non-children's teaching hospitals (NCTHs) and non-teaching hospitals (NTHs), and higher odds of complications compared to NCTHs, it's not clear whether these differences are due to the hospital type itself or other factors. CTHs were also more likely to care for patients with comorbidities, which could contribute to higher costs and longer LOS. Therefore, while there are differences in cost and outcomes based on hospital type, it's not definitive that hospital type is the sole cause of these differences.",
      "expected_output": "yes",
      "question_values": [
        "Inpatient Pediatric Tonsillectomy: Does Hospital Type Affect Cost and Outcomes of Care?",
        "To ascertain whether hospital type is associated with differences in total cost and outcomes for inpatient tonsillectomy. Cross-sectional analysis of the 2006, 2009, and 2012 Kids' Inpatient Database (KID). Children \u226418 years of age undergoing tonsillectomy with/without adenoidectomy were included. Risk-adjusted generalized linear models assessed for differences in hospital cost and length of stay (LOS) among children managed by (1) non-children's teaching hospitals (NCTHs), (2) children's teaching hospitals (CTHs), and (3) nonteaching hospitals (NTHs). Risk-adjusted logistic regression compared the odds of major perioperative complications (hemorrhage, respiratory failure, death). Models accounted for clustering of patients within hospitals, were weighted to provide national estimates, and controlled for comorbidities. The 25,685 tonsillectomies recorded in the KID yielded a national estimate of 40,591 inpatient tonsillectomies performed in 2006, 2009, and 2012. The CTHs had significantly higher risk-adjusted total cost and LOS per tonsillectomy compared with NCTHs and NTHs ($9423.34/2.8 days, $6250.78/2.11 days, and $5905.10/2.08 days, respectively; P<.001). The CTHs had higher odds of complications compared with NCTHs (odds ratio [OR], 1.48; 95% CI, 1.15-1.91; P = .002) but not when compared with NTHs (OR, 1.19; 95% CI, 0.89-1.59; P = .23). The CTHs were significantly more likely to care for patients with comorbidities (P<.001)."
      ],
      "processing_time": 5.007879257202148,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does a colonoscopy after acute diverticulitis affect its management?\n\nContext: Medical records of 220 patients hospitalized for acute diverticulitis between June 1, 2002 and September 1, 2009 were reviewed. Acute diverticulitis was diagnosed by clinical criteria and characteristic CT findings. Fifteen patients were excluded either because of questionable CT or hematochezia. Mean age was 61.8\u00b114.3 years (61% females). Clinical parameters, laboratory results, imaging, endoscopic and histopathological reports, and long-term patients' outcome were analyzed. One hundred patients (aged 61.8\u00b113.3 y, 54.1% females), underwent an early (4 to 6 wk) colonoscopy after hospital discharge. There were no significant differences in patients' characteristics or survival between those with or without colonoscopy (4\u00b11.9 vs. 4.2\u00b12.1 y, P=0.62). No colonic malignancy was detected. However, in 32 patients (32%) at least 1 polyp was found. Only 1 was determined as an advanced adenoma. No new or different diagnosis was made after colonoscopy.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that performing a colonoscopy 4 to 6 weeks after an episode of acute diverticulitis did not reveal any new or different diagnoses, it also did not find any significant differences in patient outcomes or survival between those who underwent colonoscopy and those who did not. However, the study did find that 32% of patients who underwent colonoscopy had at least one polyp, with one being an advanced adenoma. Therefore, while colonoscopy may not significantly impact the immediate management of acute diverticulitis, it could potentially impact long-term management by detecting polyps or other lesions that may require further intervention.",
      "expected_output": "no",
      "question_values": [
        "Does a colonoscopy after acute diverticulitis affect its management?",
        "Medical records of 220 patients hospitalized for acute diverticulitis between June 1, 2002 and September 1, 2009 were reviewed. Acute diverticulitis was diagnosed by clinical criteria and characteristic CT findings. Fifteen patients were excluded either because of questionable CT or hematochezia. Mean age was 61.8\u00b114.3 years (61% females). Clinical parameters, laboratory results, imaging, endoscopic and histopathological reports, and long-term patients' outcome were analyzed. One hundred patients (aged 61.8\u00b113.3 y, 54.1% females), underwent an early (4 to 6 wk) colonoscopy after hospital discharge. There were no significant differences in patients' characteristics or survival between those with or without colonoscopy (4\u00b11.9 vs. 4.2\u00b12.1 y, P=0.62). No colonic malignancy was detected. However, in 32 patients (32%) at least 1 polyp was found. Only 1 was determined as an advanced adenoma. No new or different diagnosis was made after colonoscopy."
      ],
      "processing_time": 4.7491888999938965,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males?\n\nContext: To provide insight into the factors by which obesity in itself may directly lead to early arterial damage, we aimed to determine early sonographic markers of obesity-related vascular dysfunction in young obese males. Thirty-five young obese males and 23 age-matched healthy male volunteers were recruited into the study. Common carotid artery pulsatility index and resistance index were calculated from blood flow velocities curves obtained by pulsed Doppler ultrasonography. The mean pulsatility index, resistance index, body mass index, waist circumference, systolic and diastolic blood pressure, homeostasis model assessment for insulin resistance, plasma fasting glucose, insulin, C-peptide, triglycerides, low-density lipoprotein cholesterol, and high-sensitivity C-reactive protein were statistically higher in obese subjects than in healthy controls.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study does suggest that increased carotid artery pulsatility and resistance indexes may be associated with obesity in young males, it's not definitive evidence that these are early signs of vascular abnormalities. Here's why:\n\n1. **Correlation, not Causation**: The study shows a correlation between obesity and these indexes, but it doesn't prove that obesity directly causes these changes. Other factors could be at play.\n\n2. **Lack of Longitudinal Data**: The study is cross-sectional, meaning it provides a snapshot in time. Longitudinal studies are needed to determine if these changes progress to full-blown vascular abnormalities over time.\n\n3. **Other Factors**: Obesity is often associated with other factors like hypertension, dyslipidemia, and insulin resistance, which could also contribute to changes in carotid artery indexes.\n\nSo, while the study provides interesting data suggesting a link between obesity and early signs of vascular dysfunction in young males, more research is needed to confirm these findings and establish a causal relationship.",
      "expected_output": "yes",
      "question_values": [
        "Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males?",
        "To provide insight into the factors by which obesity in itself may directly lead to early arterial damage, we aimed to determine early sonographic markers of obesity-related vascular dysfunction in young obese males. Thirty-five young obese males and 23 age-matched healthy male volunteers were recruited into the study. Common carotid artery pulsatility index and resistance index were calculated from blood flow velocities curves obtained by pulsed Doppler ultrasonography. The mean pulsatility index, resistance index, body mass index, waist circumference, systolic and diastolic blood pressure, homeostasis model assessment for insulin resistance, plasma fasting glucose, insulin, C-peptide, triglycerides, low-density lipoprotein cholesterol, and high-sensitivity C-reactive protein were statistically higher in obese subjects than in healthy controls."
      ],
      "processing_time": 7.286107778549194,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up?\n\nContext: To investigate whether problems in instrumental activities of daily living (IADL) can add to conventionally used clinical measurements in helping to predict a diagnosis of dementia at 1- and 2-year follow-up. Multicenter prospective cohort study. Memory clinics in Europe. Individuals aged 55 and older without dementia. IADLs were measured using pooled activities from five informant-based questionnaires. Structural equation modeling (SEM) was used to investigate the relation between IADLs and dementia. Age, sex, education, depression, and cognitive measures (Mini-Mental State Examination and verbal memory) were included in the model. Five hundred thirty-one participants had baseline and 1-year follow-up assessments; 69 (13.0%) of these had developed dementia at 1-year follow-up. At 2-year follow-up, 481 participants were seen, of whom 100 (20.8%) had developed dementia. Participants with IADL disabilities at baseline had a higher conversion rate (24.4%) than participants without IADL disabilities (16.7%) (chi-square\u00a0=\u00a04.28, degrees of freedom\u00a0=\u00a01, P\u00a0=\u00a0.04). SEM showed that IADL disability could help predict dementia in addition to the measured variables at 1-year follow-up (odds ratio (OR)\u00a0=\u00a02.20, 95% confidence interval (CI)\u00a0= 1.51-3.13) and 2-year follow-up (OR\u00a0=\u00a02.11, 95% CI\u00a0=\u00a01.33-3.33).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that problems in instrumental activities of daily living (IADLs) at baseline could help predict a diagnosis of dementia at 1- and 2-year follow-up, even after accounting for other factors like age, sex, education, depression, and cognitive measures, the predictive power of IADLs was not extremely strong. The odds ratios for IADL disability predicting dementia were 2.20 at 1-year follow-up and 2.11 at 2-year follow-up, which means that individuals with IADL disabilities were about 2.1 to 2.2 times more likely to develop dementia compared to those without IADL disabilities. However, this does not mean that most individuals with IADL disabilities will develop dementia, and many individuals without IADL disabilities may still develop dementia. Therefore, while IADLs may be a useful additional factor to consider in predicting dementia, they should not be used in isolation and more research is needed to better understand their role in dementia prediction.",
      "expected_output": "yes",
      "question_values": [
        "Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up?",
        "To investigate whether problems in instrumental activities of daily living (IADL) can add to conventionally used clinical measurements in helping to predict a diagnosis of dementia at 1- and 2-year follow-up. Multicenter prospective cohort study. Memory clinics in Europe. Individuals aged 55 and older without dementia. IADLs were measured using pooled activities from five informant-based questionnaires. Structural equation modeling (SEM) was used to investigate the relation between IADLs and dementia. Age, sex, education, depression, and cognitive measures (Mini-Mental State Examination and verbal memory) were included in the model. Five hundred thirty-one participants had baseline and 1-year follow-up assessments; 69 (13.0%) of these had developed dementia at 1-year follow-up. At 2-year follow-up, 481 participants were seen, of whom 100 (20.8%) had developed dementia. Participants with IADL disabilities at baseline had a higher conversion rate (24.4%) than participants without IADL disabilities (16.7%) (chi-square\u00a0=\u00a04.28, degrees of freedom\u00a0=\u00a01, P\u00a0=\u00a0.04). SEM showed that IADL disability could help predict dementia in addition to the measured variables at 1-year follow-up (odds ratio (OR)\u00a0=\u00a02.20, 95% confidence interval (CI)\u00a0= 1.51-3.13) and 2-year follow-up (OR\u00a0=\u00a02.11, 95% CI\u00a0=\u00a01.33-3.33)."
      ],
      "processing_time": 7.724391222000122,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Do familiar teammates request and accept more backup?\n\nContext: The present study investigated factors that explain when and why different groups of teammates are more likely to request and accept backup from one another when needed in an environment characterized by extreme time pressure and severe consequences of error: commercial air traffic control (ATC). Transactive memory theory states that teammates develop consensus regarding the distribution of their relative expertise as well as confidence in that expertise over time and that this facilitates coordination processes. The present study investigated whether this theory could help to explain between-team differences in requesting and accepting backup when needed. The present study used cross-sectional data collected from 51 commercial ATC teams. Hypotheses were tested using multiple regression analysis. Teammates with greater experience working together requested and accepted backup from one another more than those with lesser experience working together. Teammate knowledge consensus and perceived team efficacy appear to have mediated this relationship.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. The study found that teammates with greater experience working together did request and accept backup more often, but it's not definitive that familiarity alone is the cause. The study also found that teammate knowledge consensus and perceived team efficacy mediated this relationship, suggesting that these factors might be more directly responsible for the increased backup requests and acceptance among familiar teammates. Therefore, while familiarity might play a role, it's not the only factor at work.",
      "expected_output": "yes",
      "question_values": [
        "Do familiar teammates request and accept more backup?",
        "The present study investigated factors that explain when and why different groups of teammates are more likely to request and accept backup from one another when needed in an environment characterized by extreme time pressure and severe consequences of error: commercial air traffic control (ATC). Transactive memory theory states that teammates develop consensus regarding the distribution of their relative expertise as well as confidence in that expertise over time and that this facilitates coordination processes. The present study investigated whether this theory could help to explain between-team differences in requesting and accepting backup when needed. The present study used cross-sectional data collected from 51 commercial ATC teams. Hypotheses were tested using multiple regression analysis. Teammates with greater experience working together requested and accepted backup from one another more than those with lesser experience working together. Teammate knowledge consensus and perceived team efficacy appear to have mediated this relationship."
      ],
      "processing_time": 3.1781504154205322,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer?\n\nContext: Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of Canada-Common Toxicity Criteria [version 2.0] was demonstrated. Phase 3 randomized clinical trials (RCTs) comparing AI with tamoxifen in early breast cancer were considered eligible for this review. The event-based risk ratios (RRs) with 95% confidence intervals (95% CIs) were derived, and a test of heterogeneity was applied. Finally, absolute differences (ADs) in event rates and the number of patients needed to harm 1 patient (NNH) were determined. Seven eligible RCTs (19,818 patients) reported CVAE results. When considering all RCTs, the AD of the primary endpoint (CVAE) between the 2 arms (0.52%), tamoxifen versus AI, was statistically significant (RR, 1.31; 95% CI, 1.07-1.60; P= .007). This translated into an NNH value of 189 patients; when only third-generation AIs were considered, the difference (0.57%) remained significant (RR, 1.34; 95% CI, 1.09-1.63; P= .0038). Thromboembolic events were significantly more frequent in the tamoxifen arm, regardless of the strategy adopted (RR, 0.53; 95% CI, 0.42-0.65; P<.0001), without significant heterogeneity (P= .21). An AD of 1.17% and an NNH value of 85 patients were observed.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the meta-analysis found a statistically significant increase in cardiovascular adverse events (CVAEs) with aromatase inhibitors compared to tamoxifen, the absolute difference was small (0.52% for all RCTs and 0.57% for third-generation AIs). The number needed to harm was 189 patients for all RCTs and 176 for third-generation AIs, indicating that for every 189 or 176 patients treated with AIs, one additional CVAE would occur compared to tamoxifen. However, the clinical significance of this small increase in risk is uncertain, and individual patient factors should be considered when deciding between AI and tamoxifen for early breast cancer treatment.",
      "expected_output": "yes",
      "question_values": [
        "Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer?",
        "Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of Canada-Common Toxicity Criteria [version 2.0] was demonstrated. Phase 3 randomized clinical trials (RCTs) comparing AI with tamoxifen in early breast cancer were considered eligible for this review. The event-based risk ratios (RRs) with 95% confidence intervals (95% CIs) were derived, and a test of heterogeneity was applied. Finally, absolute differences (ADs) in event rates and the number of patients needed to harm 1 patient (NNH) were determined. Seven eligible RCTs (19,818 patients) reported CVAE results. When considering all RCTs, the AD of the primary endpoint (CVAE) between the 2 arms (0.52%), tamoxifen versus AI, was statistically significant (RR, 1.31; 95% CI, 1.07-1.60; P= .007). This translated into an NNH value of 189 patients; when only third-generation AIs were considered, the difference (0.57%) remained significant (RR, 1.34; 95% CI, 1.09-1.63; P= .0038). Thromboembolic events were significantly more frequent in the tamoxifen arm, regardless of the strategy adopted (RR, 0.53; 95% CI, 0.42-0.65; P<.0001), without significant heterogeneity (P= .21). An AD of 1.17% and an NNH value of 85 patients were observed."
      ],
      "processing_time": 5.54439640045166,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Can autologous platelet-rich plasma gel enhance healing after surgical extraction of mandibular third molars?\n\nContext: This investigation assesses the effect of platelet-rich plasma (PRP) gel on postoperative pain, swelling, and trismus as well as healing and bone regeneration potential on mandibular third molar extraction sockets. A prospective randomized comparative clinical study was undertaken over a 2-year period. Patients requiring surgical extraction of a single impacted third molar and who fell within the inclusion criteria and indicated willingness to return for recall visits were recruited. The predictor variable was application of PRP gel to the socket of the third molar in the test group, whereas the control group had no PRP. The outcome variables were pain, swelling, and maximum mouth opening, which were measured using a 10-point visual analog scale, tape, and millimeter caliper, respectively. Socket healing was assessed radiographically by allocating scores for lamina dura, overall density, and trabecular pattern. Quantitative data were presented as mean. Mann-Whitney test was used to compare means between groups for continuous variables, whereas Fischer exact test was used for categorical variables. Statistical significance was inferred at P<.05. Sixty patients aged 19 to 35 years (mean: 24.7 \u00b1 3.6 years) were divided into both test and control groups of 30 patients each. The mean postoperative pain score (visual analog scale) was lower for the PRP group at all time points and this was statistically significant (P<.05). Although the figures for swelling and interincisal mouth opening were lower in the test group, this difference was not statistically significant. Similarly, the scores for lamina dura, trabecular pattern, and bone density were better among patients in the PRP group. This difference was also not statistically significant.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that autologous platelet-rich plasma gel may enhance healing after surgical extraction of mandibular third molars, the results were not statistically significant for all outcome variables. The mean postoperative pain score was significantly lower in the PRP group, but the differences in swelling, trismus, and radiographic healing scores were not statistically significant. Therefore, while PRP gel may have some potential benefits, more research with larger sample sizes and longer follow-up periods is needed to confirm these findings and determine the clinical significance of PRP gel in this context.",
      "expected_output": "yes",
      "question_values": [
        "Can autologous platelet-rich plasma gel enhance healing after surgical extraction of mandibular third molars?",
        "This investigation assesses the effect of platelet-rich plasma (PRP) gel on postoperative pain, swelling, and trismus as well as healing and bone regeneration potential on mandibular third molar extraction sockets. A prospective randomized comparative clinical study was undertaken over a 2-year period. Patients requiring surgical extraction of a single impacted third molar and who fell within the inclusion criteria and indicated willingness to return for recall visits were recruited. The predictor variable was application of PRP gel to the socket of the third molar in the test group, whereas the control group had no PRP. The outcome variables were pain, swelling, and maximum mouth opening, which were measured using a 10-point visual analog scale, tape, and millimeter caliper, respectively. Socket healing was assessed radiographically by allocating scores for lamina dura, overall density, and trabecular pattern. Quantitative data were presented as mean. Mann-Whitney test was used to compare means between groups for continuous variables, whereas Fischer exact test was used for categorical variables. Statistical significance was inferred at P<.05. Sixty patients aged 19 to 35 years (mean: 24.7 \u00b1 3.6 years) were divided into both test and control groups of 30 patients each. The mean postoperative pain score (visual analog scale) was lower for the PRP group at all time points and this was statistically significant (P<.05). Although the figures for swelling and interincisal mouth opening were lower in the test group, this difference was not statistically significant. Similarly, the scores for lamina dura, trabecular pattern, and bone density were better among patients in the PRP group. This difference was also not statistically significant."
      ],
      "processing_time": 4.039155006408691,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency?\n\nContext: Adults with GH deficiency (GHD) have a decreased life expectancy. The effect of GH treatment on mortality remains to be established. This nationwide cohort study investigates the effect of GH treatment on all-cause and cause-specific mortality and analyzes patient characteristics influencing mortality in GHD adults. Patients in the Dutch National Registry of Growth Hormone Treatment in Adults were retrospectively monitored (1985-2009) and subdivided into treatment (n = 2229), primary (untreated, n = 109), and secondary control (partly treated, n = 356) groups. Standardized mortality ratios (SMR) were calculated for all-cause, malignancy, and cardiovascular disease (CVD) mortality. Expected mortality was obtained from cause, sex, calendar year, and age-specific death rates from national death and population counts. In the treatment group, 95 patients died compared to 74.6 expected [SMR 1.27 (95% confidence interval, 1.04-1.56)]. Mortality was higher in women than in men. After exclusion of high-risk patients, the SMR for CVD mortality remained increased in women. Mortality due to malignancies was not elevated. In the control groups mortality was not different from the background population. Univariate analyses demonstrated sex, GHD onset, age, and underlying diagnosis as influencing factors.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. The study found a slightly increased all-cause mortality in adults with growth hormone deficiency who were treated with growth hormone replacement therapy, with a standardized mortality ratio (SMR) of 1.27. However, the increase was not significant for cause-specific mortality, such as malignancies. The study also found that certain patient characteristics, such as sex, age, and underlying diagnosis, influenced mortality. Therefore, while the study suggests a possible association between growth hormone replacement therapy and increased mortality, the evidence is not conclusive, and further research is needed to establish a clear causal relationship.",
      "expected_output": "no",
      "question_values": [
        "Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency?",
        "Adults with GH deficiency (GHD) have a decreased life expectancy. The effect of GH treatment on mortality remains to be established. This nationwide cohort study investigates the effect of GH treatment on all-cause and cause-specific mortality and analyzes patient characteristics influencing mortality in GHD adults. Patients in the Dutch National Registry of Growth Hormone Treatment in Adults were retrospectively monitored (1985-2009) and subdivided into treatment (n = 2229), primary (untreated, n = 109), and secondary control (partly treated, n = 356) groups. Standardized mortality ratios (SMR) were calculated for all-cause, malignancy, and cardiovascular disease (CVD) mortality. Expected mortality was obtained from cause, sex, calendar year, and age-specific death rates from national death and population counts. In the treatment group, 95 patients died compared to 74.6 expected [SMR 1.27 (95% confidence interval, 1.04-1.56)]. Mortality was higher in women than in men. After exclusion of high-risk patients, the SMR for CVD mortality remained increased in women. Mortality due to malignancies was not elevated. In the control groups mortality was not different from the background population. Univariate analyses demonstrated sex, GHD onset, age, and underlying diagnosis as influencing factors."
      ],
      "processing_time": 4.31804347038269,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity?\n\nContext: To investigate the influence of laparoscopic procedures on perisinusoidal cell function. In 31 patients who underwent laparoscopic cholecystectomy for symptomatic cholelithiasis, the serum levels of beta-N-acetyl hexosaminidase (beta-NAH) and hyaluronic acid (HA) were measured. Six female patients, who underwent other laparoscopic procedures, not involving the hepatobiliary system, served as controls. HA serum levels increased significantly in both study and control groups, while beta-NAH serum levels remained within normal values. Post-operative AST and ALT serum levels increased significantly only in the study group. No elevation of serum ALP was noted in any of our patients, and post-operative bilirubin levels did not increase in patients with normal pre-operative levels.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. The study suggests that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity, as indicated by the significant increase in post-operative AST and ALT serum levels in the study group compared to the control group. However, the study also found that beta-NAH serum levels remained within normal values, and there was no elevation of serum ALP or increase in bilirubin levels in patients with normal pre-operative levels. Therefore, while there is some evidence to suggest an influence on peri-sinusoidal cell activity, the results are not conclusive. Further research would be needed to fully understand the impact of laparoscopic cholecystectomy on peri-sinusoidal cell function.",
      "expected_output": "yes",
      "question_values": [
        "Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity?",
        "To investigate the influence of laparoscopic procedures on perisinusoidal cell function. In 31 patients who underwent laparoscopic cholecystectomy for symptomatic cholelithiasis, the serum levels of beta-N-acetyl hexosaminidase (beta-NAH) and hyaluronic acid (HA) were measured. Six female patients, who underwent other laparoscopic procedures, not involving the hepatobiliary system, served as controls. HA serum levels increased significantly in both study and control groups, while beta-NAH serum levels remained within normal values. Post-operative AST and ALT serum levels increased significantly only in the study group. No elevation of serum ALP was noted in any of our patients, and post-operative bilirubin levels did not increase in patients with normal pre-operative levels."
      ],
      "processing_time": 5.069885492324829,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Can routinely collected ambulance data about assaults contribute to reduction in community violence?\n\nContext: The 'law of spatiotemporal concentrations of events' introduced major preventative shifts in policing communities. 'Hotspots' are at the forefront of these developments yet somewhat understudied in emergency medicine. Furthermore, little is known about interagency 'data-crossover', despite some developments through the Cardiff Model. Can police-ED interagency data-sharing be used to reduce community-violence using a hotspots methodology? 12-month (2012) descriptive study and analysis of spatiotemporal clusters of police and emergency calls for service using hotspots methodology and assessing the degree of incident overlap. 3775 violent crime incidents and 775 assault incidents analysed using spatiotemporal clustering with k-means++ algorithm and Spearman's rho. Spatiotemporal location of calls for services to the police and the ambulance service are equally highly concentrated in a small number of geographical areas, primarily within intra-agency hotspots (33% and 53%, respectively) but across agencies' hotspots as well (25% and 15%, respectively). Datasets are statistically correlated with one another at the 0.57 and 0.34 levels, with 50% overlap when adjusted for the number of hotspots. At least one in every two police hotspots does not have an ambulance hotspot overlapping with it, suggesting half of assault spatiotemporal concentrations are unknown to the police. Data further suggest that more severely injured patients, as estimated by transfer to hospital, tend to be injured in the places with the highest number of police-recorded crimes.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that there is a significant overlap between police and ambulance data, indicating that routinely collected ambulance data about assaults could potentially contribute to reducing community violence, there are a few reasons why the answer is not a definitive \"yes\":\n\n1. **Data Limitations**: The study is based on a single year of data (2012) from a single city, which may not be representative of other areas or time periods.\n\n2. **Severity Bias**: The study found that more severely injured patients tend to be injured in areas with high police-recorded crimes. This could mean that ambulance data might not capture less severe assaults that are still important to track for violence reduction strategies.\n\n3. **Interagency Coordination**: While the study suggests that there is overlap between police and ambulance hotspots, it also indicates that there are many police hotspots without ambulance hotspots, suggesting that there are assaults that the police are aware of but the ambulance service is not. This highlights the need for better interagency coordination and data-sharing.\n\n4. **Prevention Strategies**: The study does not provide evidence that using this data to inform prevention strategies would actually reduce violence. More research is needed to understand how this data could be used to inform targeted interventions.\n\nSo, while the study suggests that ambulance data could potentially contribute to reducing community violence, more research is needed to understand how this data could be used effectively and whether it would actually lead to a reduction in violence. Therefore, the answer is \"maybe\".",
      "expected_output": "maybe",
      "question_values": [
        "Can routinely collected ambulance data about assaults contribute to reduction in community violence?",
        "The 'law of spatiotemporal concentrations of events' introduced major preventative shifts in policing communities. 'Hotspots' are at the forefront of these developments yet somewhat understudied in emergency medicine. Furthermore, little is known about interagency 'data-crossover', despite some developments through the Cardiff Model. Can police-ED interagency data-sharing be used to reduce community-violence using a hotspots methodology? 12-month (2012) descriptive study and analysis of spatiotemporal clusters of police and emergency calls for service using hotspots methodology and assessing the degree of incident overlap. 3775 violent crime incidents and 775 assault incidents analysed using spatiotemporal clustering with k-means++ algorithm and Spearman's rho. Spatiotemporal location of calls for services to the police and the ambulance service are equally highly concentrated in a small number of geographical areas, primarily within intra-agency hotspots (33% and 53%, respectively) but across agencies' hotspots as well (25% and 15%, respectively). Datasets are statistically correlated with one another at the 0.57 and 0.34 levels, with 50% overlap when adjusted for the number of hotspots. At least one in every two police hotspots does not have an ambulance hotspot overlapping with it, suggesting half of assault spatiotemporal concentrations are unknown to the police. Data further suggest that more severely injured patients, as estimated by transfer to hospital, tend to be injured in the places with the highest number of police-recorded crimes."
      ],
      "processing_time": 11.33626127243042,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Clinical identifiers for early-stage primary/idiopathic adhesive capsulitis: are we seeing the real picture?\n\nContext: Adhesive capsulitis is often difficult to diagnose in its early stage and to differentiate from other common shoulder disorders. The aim of this study was to validate any or all of the 8 clinical identifiers of early-stage primary/idiopathic adhesive capsulitis established in an earlier Delphi study. This was a cross-sectional study. Sixty-four patients diagnosed with early-stage adhesive capsulitis by a physical therapist or medical practitioner were included in the study. Eight active and 8 passive shoulder movements and visual analog scale pain scores for each movement were recorded prior to and immediately following an intra-articular injection of corticosteroid and local anesthetic. Using the local anesthetic as the reference standard, pain relief of \u226570% for passive external rotation was deemed a positive anesthetic response (PAR). Sixteen participants (25%) demonstrated a PAR. Univariate logistic regression identified that of the proposed identifiers, global loss of passive range of movement (odds ratio [OR]=0.26, P=.03), pain at the end of range of all measured active movements (OR=0.06, P=.02), and global loss of passive glenohumeral movements (OR=0.23, P=.02) were associated with a PAR. Following stepwise removal of the variables, pain at the end of range of all measured active movements remained the only identifier but was associated with reduced odds of a PAR. The lack of a recognized reference standard for diagnosing early-stage adhesive capsulitis remains problematic in all related research.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study provides some evidence for certain clinical identifiers of early-stage adhesive capsulitis, the lack of a recognized reference standard for diagnosis makes it difficult to definitively conclude that we are seeing the real picture. The use of a corticosteroid and local anesthetic injection as a reference standard is not universally accepted, and the 70% pain relief threshold for passive external rotation as a positive anesthetic response is arbitrary. Therefore, while the study provides some useful information, it does not provide a definitive answer to the question. Further research with a more robust reference standard is needed to confirm these findings.",
      "expected_output": "no",
      "question_values": [
        "Clinical identifiers for early-stage primary/idiopathic adhesive capsulitis: are we seeing the real picture?",
        "Adhesive capsulitis is often difficult to diagnose in its early stage and to differentiate from other common shoulder disorders. The aim of this study was to validate any or all of the 8 clinical identifiers of early-stage primary/idiopathic adhesive capsulitis established in an earlier Delphi study. This was a cross-sectional study. Sixty-four patients diagnosed with early-stage adhesive capsulitis by a physical therapist or medical practitioner were included in the study. Eight active and 8 passive shoulder movements and visual analog scale pain scores for each movement were recorded prior to and immediately following an intra-articular injection of corticosteroid and local anesthetic. Using the local anesthetic as the reference standard, pain relief of \u226570% for passive external rotation was deemed a positive anesthetic response (PAR). Sixteen participants (25%) demonstrated a PAR. Univariate logistic regression identified that of the proposed identifiers, global loss of passive range of movement (odds ratio [OR]=0.26, P=.03), pain at the end of range of all measured active movements (OR=0.06, P=.02), and global loss of passive glenohumeral movements (OR=0.23, P=.02) were associated with a PAR. Following stepwise removal of the variables, pain at the end of range of all measured active movements remained the only identifier but was associated with reduced odds of a PAR. The lack of a recognized reference standard for diagnosing early-stage adhesive capsulitis remains problematic in all related research."
      ],
      "processing_time": 4.426929950714111,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Lloyd-Davies position with Trendelenburg--a disaster waiting to happen?\n\nContext: Lower limb compartment syndrome has been reported to occur after colorectal, urological, and gynecological procedures during which the patient's lower limbs are elevated for prolonged periods of time. We investigated lower limb perfusion in a group of patients undergoing prolonged pelvic surgery both during and immediately after surgery, using intra-arterial blood pressure monitoring, laser doppler flowmetry, and pulse oximetry. Use of the modified lithotomy position was not associated with any demonstrable decrease in lower limb perfusion. The addition of 15 degrees head-down tilt, however, during pelvic dissection, led to an immediate and significant drop in lower limb perfusion (P<0.05; Mann-Whitney U test). The subgroup of patients analyzed postoperatively showed a ten-fold increase (P<0.01) in perfusion that was confined to the muscle compartment with no demonstrable increase in skin perfusion or intra-arterial pedal blood pressure.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that the addition of 15 degrees head-down tilt in the modified lithotomy position can lead to a decrease in lower limb perfusion, it's not accurate to label it as a \"disaster waiting to happen.\" Here's why:\n\n1. **Context Matters**: The study was conducted during and immediately after prolonged pelvic surgery. The impact of this position on lower limb perfusion in shorter procedures or in other types of surgeries might be different.\n\n2. **No Long-term Data**: The study only looked at immediate effects. Long-term effects or the risk of compartment syndrome were not assessed.\n\n3. **Individual Variation**: Patient factors like obesity, comorbidities, and the specific surgical procedure can also influence the risk of compartment syndrome.\n\n4. **Monitoring and Prevention**: With proper monitoring (like the methods used in this study) and preventive measures (like frequent position changes, leg elevation, and early detection of signs of compartment syndrome), the risk can be mitigated.\n\nSo, while the study suggests a potential risk, it's not accurate to label it as a \"disaster waiting to happen\" without more context and long-term data. It's important for healthcare providers to be aware of this potential risk and take appropriate precautions.",
      "expected_output": "yes",
      "question_values": [
        "Lloyd-Davies position with Trendelenburg--a disaster waiting to happen?",
        "Lower limb compartment syndrome has been reported to occur after colorectal, urological, and gynecological procedures during which the patient's lower limbs are elevated for prolonged periods of time. We investigated lower limb perfusion in a group of patients undergoing prolonged pelvic surgery both during and immediately after surgery, using intra-arterial blood pressure monitoring, laser doppler flowmetry, and pulse oximetry. Use of the modified lithotomy position was not associated with any demonstrable decrease in lower limb perfusion. The addition of 15 degrees head-down tilt, however, during pelvic dissection, led to an immediate and significant drop in lower limb perfusion (P<0.05; Mann-Whitney U test). The subgroup of patients analyzed postoperatively showed a ten-fold increase (P<0.01) in perfusion that was confined to the muscle compartment with no demonstrable increase in skin perfusion or intra-arterial pedal blood pressure."
      ],
      "processing_time": 9.18722677230835,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: The HELPP syndrome--evidence of a possible systemic inflammatory response in pre-eclampsia?\n\nContext: The principal causes of morbidity and mortality during pregnancy in Mexico, are preeclampsia/eclampsia, obstetric hemorrhage and puerperium complications; this is, 62% of maternal deaths in last years. HELLP syndrome was observed between 5 to 25% of the mortality in pregnancies of 36 weeks or less. To analyze patients with HELLP syndrome in ICU's (Intensive Care Unit) of a Gynecology and Obstetric Hospital, related to the abnormal hematological, hepatic and renal results with the obstetric case history and the clinical complications. A transversal study in patients with HELLP syndrome during 1998 and 1999 were carry out. Peripheral blood with Microangiopathic hemolysis, elevated liver enzymes: AST, ALT over 40 UI/L, even when were LDH lower than 600 UI/L. It was evaluated the hepatic and renal function, platelets count, microangiopathic hemolysis, arterial pressure, seizures, icteric skin color, blindness, visual disturbances, nausea, vomiting and upper quadrant right abdominal pain. In newborn we analyzed gestational age, sex, weight and APGAR. We studied for an association between maternal and biochemical variables with Correlation Pearson Test, and dependence between variables with lineal regression model. 2878 patients with hypertensives disorders in pregnancy (11.64%). The 1.15% (n = 33) had HELLP syndrome with specific maternal mortality of 0.4 per 10,000 live birth, perinatal mortality of 1.62 per 10,000 live birth; and renal damage in 84.5%. Coefficient beta was higher between number of pregnancies to platelets count (-0.33) and creatinine clearance (-0.401).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. The study suggests a possible association between the number of pregnancies and platelet count, as well as creatinine clearance, in patients with HELLP syndrome. However, it's important to note that correlation does not imply causation, and further research would be needed to establish a definitive link. Additionally, the study found a high prevalence of renal damage in these patients, which could indicate a systemic inflammatory response, but more research is needed to confirm this.",
      "expected_output": "yes",
      "question_values": [
        "The HELPP syndrome--evidence of a possible systemic inflammatory response in pre-eclampsia?",
        "The principal causes of morbidity and mortality during pregnancy in Mexico, are preeclampsia/eclampsia, obstetric hemorrhage and puerperium complications; this is, 62% of maternal deaths in last years. HELLP syndrome was observed between 5 to 25% of the mortality in pregnancies of 36 weeks or less. To analyze patients with HELLP syndrome in ICU's (Intensive Care Unit) of a Gynecology and Obstetric Hospital, related to the abnormal hematological, hepatic and renal results with the obstetric case history and the clinical complications. A transversal study in patients with HELLP syndrome during 1998 and 1999 were carry out. Peripheral blood with Microangiopathic hemolysis, elevated liver enzymes: AST, ALT over 40 UI/L, even when were LDH lower than 600 UI/L. It was evaluated the hepatic and renal function, platelets count, microangiopathic hemolysis, arterial pressure, seizures, icteric skin color, blindness, visual disturbances, nausea, vomiting and upper quadrant right abdominal pain. In newborn we analyzed gestational age, sex, weight and APGAR. We studied for an association between maternal and biochemical variables with Correlation Pearson Test, and dependence between variables with lineal regression model. 2878 patients with hypertensives disorders in pregnancy (11.64%). The 1.15% (n = 33) had HELLP syndrome with specific maternal mortality of 0.4 per 10,000 live birth, perinatal mortality of 1.62 per 10,000 live birth; and renal damage in 84.5%. Coefficient beta was higher between number of pregnancies to platelets count (-0.33) and creatinine clearance (-0.401)."
      ],
      "processing_time": 3.355832099914551,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does topical ropivacaine reduce the post-tonsillectomy morbidity in pediatric patients?\n\nContext: To determine whether post-operative administration of topical ropivacaine hydrochloride decreases morbidity following adenotonsillectomy. Prospective, randomized, double-blind clinical trial. University referral center; ENT Department. Fourty one children, aged 4-16 years, undergoing tonsillectomy. Patients received 1.0% ropivacaine hydrochloride soaked swabs packed in their tonsillar fossae while the control group received saline-soaked swabs. Mc Grath's face scale was used to compare the two groups in respect of pain control. Chi-square and two-tailed unpaired Student's t-tests or Mann-Whitney-U-tests were used to compare the two independent groups. As 10 we made 11 comparison between groups, for Bonferroni correction, p<0.005 was accepted as statistically significant. Only first hour there was no significant pain-relieving effect seen in the ropivacaine group (p>0.05). The other hours and days there were statistically significance between the two groups (p<0.001). Also, the other post-operative parameters such as nausea, fever, vomiting, odor, bleeding, otalgia and trismus were not statistically different between the two groups. There were no complications associated with ropivacaine hydrochloride. No patients in this study suffered systemic side effects related to the use of this medication.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that topical ropivacaine reduced pain in pediatric patients after tonsillectomy for most of the post-operative period, it did not significantly reduce other morbidities such as nausea, fever, vomiting, odor, bleeding, otalgia, and trismus. Therefore, while it may help with pain management, it does not appear to significantly reduce overall post-tonsillectomy morbidity in pediatric patients.",
      "expected_output": "yes",
      "question_values": [
        "Does topical ropivacaine reduce the post-tonsillectomy morbidity in pediatric patients?",
        "To determine whether post-operative administration of topical ropivacaine hydrochloride decreases morbidity following adenotonsillectomy. Prospective, randomized, double-blind clinical trial. University referral center; ENT Department. Fourty one children, aged 4-16 years, undergoing tonsillectomy. Patients received 1.0% ropivacaine hydrochloride soaked swabs packed in their tonsillar fossae while the control group received saline-soaked swabs. Mc Grath's face scale was used to compare the two groups in respect of pain control. Chi-square and two-tailed unpaired Student's t-tests or Mann-Whitney-U-tests were used to compare the two independent groups. As 10 we made 11 comparison between groups, for Bonferroni correction, p<0.005 was accepted as statistically significant. Only first hour there was no significant pain-relieving effect seen in the ropivacaine group (p>0.05). The other hours and days there were statistically significance between the two groups (p<0.001). Also, the other post-operative parameters such as nausea, fever, vomiting, odor, bleeding, otalgia and trismus were not statistically different between the two groups. There were no complications associated with ropivacaine hydrochloride. No patients in this study suffered systemic side effects related to the use of this medication."
      ],
      "processing_time": 3.2987139225006104,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does base deficit predict mortality in patients with severe traumatic brain injury?\n\nContext: Base Deficit (BD) is a marker of tissue hypoxia in polytrauma patients. It guides resuscitative measures, and predicts outcomes, complications and mortality. The aim of this study was to examine the presence of BD in patients with isolated severe traumatic brain injury (TBI), and to assess if it correlates with the outcomes in these patients. This was a retrospective observational study. All patients over the age of 16 years presenting to Aga Khan University Hospital from 2009 to 2013 with isolated TBI, were included. Data was extracted from 2009 to 2013. Glasgow Outcome Scale (GOS) of 4 and 5 at last follow up was categorized as favorable outcome. Data was analyzed using SPSS version 19 and receiver operative curve (ROC) was generated for BD as a predictor of mortality and unfavorable outcome. One hundred and eight patients were analyzed. Ninety-eight (90.7%) were males. Mean age was 36.69 \u00b1 17.65. Eighty-eight (81.5%) patients had BD, while 20 (18.5%) patients had base excess. 62 (58.5%) of the patients had unfavorable outcomes. BD on admission had a statistically significant negative correlation with Glasgow Coma Scale (GCS) on presentation (r = -0.239, p = 0.025) and Revised Trauma Score (RTS) (r = -0.214, p = 0.046). However, there was no statistically significant difference in means of BD between survivors and non survivors. Area under receiver operator curve (ROC) for BD as a predictor of mortality statistically non-significant.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found a significant negative correlation between Base Deficit (BD) and both Glasgow Coma Scale (GCS) and Revised Trauma Score (RTS) on presentation, indicating that a higher BD (more severe acidosis) was associated with worse initial neurological status and overall injury severity, it did not find a statistically significant difference in BD means between survivors and non-survivors. Additionally, the area under the receiver operator curve (ROC) for BD as a predictor of mortality was statistically non-significant. Therefore, while BD may be a marker of severity in isolated severe traumatic brain injury, it may not be a reliable predictor of mortality in these patients. Further studies with larger sample sizes and prospective designs are needed to confirm these findings.",
      "expected_output": "no",
      "question_values": [
        "Does base deficit predict mortality in patients with severe traumatic brain injury?",
        "Base Deficit (BD) is a marker of tissue hypoxia in polytrauma patients. It guides resuscitative measures, and predicts outcomes, complications and mortality. The aim of this study was to examine the presence of BD in patients with isolated severe traumatic brain injury (TBI), and to assess if it correlates with the outcomes in these patients. This was a retrospective observational study. All patients over the age of 16 years presenting to Aga Khan University Hospital from 2009 to 2013 with isolated TBI, were included. Data was extracted from 2009 to 2013. Glasgow Outcome Scale (GOS) of 4 and 5 at last follow up was categorized as favorable outcome. Data was analyzed using SPSS version 19 and receiver operative curve (ROC) was generated for BD as a predictor of mortality and unfavorable outcome. One hundred and eight patients were analyzed. Ninety-eight (90.7%) were males. Mean age was 36.69 \u00b1 17.65. Eighty-eight (81.5%) patients had BD, while 20 (18.5%) patients had base excess. 62 (58.5%) of the patients had unfavorable outcomes. BD on admission had a statistically significant negative correlation with Glasgow Coma Scale (GCS) on presentation (r = -0.239, p = 0.025) and Revised Trauma Score (RTS) (r = -0.214, p = 0.046). However, there was no statistically significant difference in means of BD between survivors and non survivors. Area under receiver operator curve (ROC) for BD as a predictor of mortality statistically non-significant."
      ],
      "processing_time": 5.652371406555176,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does having a regular primary care clinician improve quality of preventive care for young children?\n\nContext: This study examines whether having a regular clinician for preventive care is associated with quality of care for young children, as measured by interpersonal quality ratings and content of anticipatory guidance. The National Survey of Early Childhood Health (NSECH), a nationally representative parent survey of health care quality for 2068 young US children fielded by the National Center for Health Statistics (NCHS). Bivariate and multivariate analyses evaluate associations between having a regular clinician for well child care and interpersonal quality, the content of anticipatory guidance, and timely access to care. In bivariate analysis, parents of children with a regular clinician for preventive care reported slightly higher interpersonal quality (69 vs. 65 on a 0-100 scale, P = 0.01). Content of anticipatory guidance received was slightly greater for children with a regular clinician (82 vs. 80 on a 0-100 scale, P = 0.03). In bivariate analysis, a regular clinician was associated with interpersonal quality only among African American and Hispanic children. In multivariate analyses, controlling for factors that could independently influence self-reports of experiences with care, interpersonal quality but not anticipatory guidance content was higher for children with a regular clinician.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found some associations between having a regular primary care clinician and improved quality of preventive care for young children, the differences were small and not consistent across all measures. The association between a regular clinician and interpersonal quality was only significant in bivariate analysis and not in multivariate analysis, which controls for other factors. Additionally, there was no significant association between a regular clinician and the content of anticipatory guidance in multivariate analysis. Therefore, while having a regular clinician may have some benefits for the quality of preventive care, the evidence from this study is not conclusive. Further research with larger samples and more objective measures of care quality may be needed to draw more definitive conclusions.",
      "expected_output": "yes",
      "question_values": [
        "Does having a regular primary care clinician improve quality of preventive care for young children?",
        "This study examines whether having a regular clinician for preventive care is associated with quality of care for young children, as measured by interpersonal quality ratings and content of anticipatory guidance. The National Survey of Early Childhood Health (NSECH), a nationally representative parent survey of health care quality for 2068 young US children fielded by the National Center for Health Statistics (NCHS). Bivariate and multivariate analyses evaluate associations between having a regular clinician for well child care and interpersonal quality, the content of anticipatory guidance, and timely access to care. In bivariate analysis, parents of children with a regular clinician for preventive care reported slightly higher interpersonal quality (69 vs. 65 on a 0-100 scale, P = 0.01). Content of anticipatory guidance received was slightly greater for children with a regular clinician (82 vs. 80 on a 0-100 scale, P = 0.03). In bivariate analysis, a regular clinician was associated with interpersonal quality only among African American and Hispanic children. In multivariate analyses, controlling for factors that could independently influence self-reports of experiences with care, interpersonal quality but not anticipatory guidance content was higher for children with a regular clinician."
      ],
      "processing_time": 4.971669435501099,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants?\n\nContext: Noise exposure in the neonatal intensive care unit is believed to be a risk factor for hearing loss in preterm neonates. Continuous positive airway pressure (CPAP) devices exceed recommended noise levels. High flow nasal cannulae (HFNC) are an increasingly popular alternative to CPAP for treating preterm infants, but there are no in vivo studies assessing noise production by HFNC. To study whether HFNC are noisier than bubble CPAP (BCPAP) for preterm infants. An observational study of preterm infants receiving HFNC or BCPAP. Noise levels within the external auditory meatus (EAM) were measured using a microphone probe tube connected to a calibrated digital dosimeter. Noise was measured across a range of frequencies and reported as decibels A-weighted (dBA). A total of 21 HFNC and 13 BCPAP noise measurements were performed in 21 infants. HFNC gas flows were 2-5 L/min, and BCPAP gas flows were 6-10 L/min with set pressures of 5-7 cm of water. There was no evidence of a difference in average noise levels measured at the EAM: mean difference (95% CI) of -1.6 (-4.0 to 0.9) dBA for HFNC compared to BCPAP. At low frequency (500 Hz), HFNC was mean (95% CI) 3.0 (0.3 to 5.7) dBA quieter than BCPAP. Noise increased with increasing BCPAP gas flow (p=0.007), but not with increasing set pressure. There was a trend to noise increasing with increasing HFNC gas flows.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found no significant difference in overall noise levels between HFNC and BCPAP, there was a significant difference at low frequencies, with HFNC being quieter. However, the clinical significance of this finding is not clear, and more research is needed to determine the impact of these noise levels on preterm infant hearing development. Additionally, the study had a relatively small sample size, and further studies with larger sample sizes are needed to confirm these findings.",
      "expected_output": "no",
      "question_values": [
        "Are high flow nasal cannulae noisier than bubble CPAP for preterm infants?",
        "Noise exposure in the neonatal intensive care unit is believed to be a risk factor for hearing loss in preterm neonates. Continuous positive airway pressure (CPAP) devices exceed recommended noise levels. High flow nasal cannulae (HFNC) are an increasingly popular alternative to CPAP for treating preterm infants, but there are no in vivo studies assessing noise production by HFNC. To study whether HFNC are noisier than bubble CPAP (BCPAP) for preterm infants. An observational study of preterm infants receiving HFNC or BCPAP. Noise levels within the external auditory meatus (EAM) were measured using a microphone probe tube connected to a calibrated digital dosimeter. Noise was measured across a range of frequencies and reported as decibels A-weighted (dBA). A total of 21 HFNC and 13 BCPAP noise measurements were performed in 21 infants. HFNC gas flows were 2-5 L/min, and BCPAP gas flows were 6-10 L/min with set pressures of 5-7 cm of water. There was no evidence of a difference in average noise levels measured at the EAM: mean difference (95% CI) of -1.6 (-4.0 to 0.9) dBA for HFNC compared to BCPAP. At low frequency (500 Hz), HFNC was mean (95% CI) 3.0 (0.3 to 5.7) dBA quieter than BCPAP. Noise increased with increasing BCPAP gas flow (p=0.007), but not with increasing set pressure. There was a trend to noise increasing with increasing HFNC gas flows."
      ],
      "processing_time": 3.4570651054382324,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does multi-modal cervical physical therapy improve tinnitus in patients with cervicogenic somatic tinnitus?\n\nContext: Tinnitus can be related to many different aetiologies such as hearing loss or a noise trauma, but it can also be related to the somatosensory system of the cervical spine, called cervicogenic somatic tinnitus (CST). Case studies suggest a positive effect of cervical spine treatment on tinnitus complaints in patients with CST, but no experimental studies are available. To investigate the effect of a multimodal cervical physical therapy treatment on tinnitus complaints in patients with CST. Randomized controlled trial. Patients with a combination of severe subjective tinnitus (Tinnitus Functional Index (TFI): 25-90 points) and neck complaints (Neck Bournemouth Questionnaire (NBQ)\u00a0>\u00a014 points). All patients received cervical physical therapy for 6 weeks (12 sessions). Patients were randomized in an immediate-start therapy group (n\u00a0=\u00a019) and a 6-week delayed-start therapy group (n\u00a0=\u00a019). TFI and NBQ-scores were documented at baseline, after the wait-and-see period in the delayed-start group, after treatment and after 6 weeks follow-up. The Global Perceived Effect (GPE) was documented at all measuring moments, except at baseline. In all patients (n\u00a0=\u00a038) TFI and NBQ-scores decreased significantly after treatment (p\u00a0=\u00a00.04 and p\u00a0<\u00a00.001). NBQ-scores remained significantly lower after follow-up (p\u00a0=\u00a00.001). Immediately after treatment, 53% (n\u00a0=\u00a038) experienced substantial improvement of tinnitus. This effect was maintained in 24% of patients after follow-up at six weeks.\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found significant improvements in both tinnitus (TFI) and neck (NBQ) symptoms after multimodal cervical physical therapy, the improvements were not maintained in all patients at the 6-week follow-up. Additionally, the study had a relatively small sample size and a wait-list control group, which could introduce biases. Therefore, while the results suggest that multimodal cervical physical therapy may improve tinnitus in patients with cervicogenic somatic tinnitus, more research with larger, placebo-controlled studies is needed to confirm these findings.",
      "expected_output": "yes",
      "question_values": [
        "Does multi-modal cervical physical therapy improve tinnitus in patients with cervicogenic somatic tinnitus?",
        "Tinnitus can be related to many different aetiologies such as hearing loss or a noise trauma, but it can also be related to the somatosensory system of the cervical spine, called cervicogenic somatic tinnitus (CST). Case studies suggest a positive effect of cervical spine treatment on tinnitus complaints in patients with CST, but no experimental studies are available. To investigate the effect of a multimodal cervical physical therapy treatment on tinnitus complaints in patients with CST. Randomized controlled trial. Patients with a combination of severe subjective tinnitus (Tinnitus Functional Index (TFI): 25-90 points) and neck complaints (Neck Bournemouth Questionnaire (NBQ)\u00a0>\u00a014 points). All patients received cervical physical therapy for 6 weeks (12 sessions). Patients were randomized in an immediate-start therapy group (n\u00a0=\u00a019) and a 6-week delayed-start therapy group (n\u00a0=\u00a019). TFI and NBQ-scores were documented at baseline, after the wait-and-see period in the delayed-start group, after treatment and after 6 weeks follow-up. The Global Perceived Effect (GPE) was documented at all measuring moments, except at baseline. In all patients (n\u00a0=\u00a038) TFI and NBQ-scores decreased significantly after treatment (p\u00a0=\u00a00.04 and p\u00a0<\u00a00.001). NBQ-scores remained significantly lower after follow-up (p\u00a0=\u00a00.001). Immediately after treatment, 53% (n\u00a0=\u00a038) experienced substantial improvement of tinnitus. This effect was maintained in 24% of patients after follow-up at six weeks."
      ],
      "processing_time": 4.154926538467407,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does a 4 diagram manual enable laypersons to operate the Laryngeal Mask Supreme\u00ae?\n\nContext: Bystander resuscitation plays an important role in lifesaving cardiopulmonary resuscitation (CPR). A significant reduction in the \"no-flow-time\", quantitatively better chest compressions and an improved quality of ventilation can be demonstrated during CPR using supraglottic airway devices (SADs). Previous studies have demonstrated the ability of inexperienced persons to operate SADs after brief instruction. The aim of this pilot study was to determine whether an instruction manual consisting of four diagrams enables laypersons to operate a Laryngeal Mask Supreme\u00ae (LMAS) in the manikin. An instruction manual of four illustrations with speech bubbles displaying the correct use of the LMAS was designed. Laypersons were handed a bag containing a LMAS, a bag mask valve device (BMV), a syringe prefilled with air and the instruction sheet, and were asked to perform and ventilate the manikin as displayed. Time to ventilation was recorded and degree of success evaluated. A total of 150 laypersons took part. Overall 145 participants (96.7%) inserted the LMAS in the manikin in the right direction. The device was inserted inverted or twisted in 13 (8.7%) attempts. Eight (5.3%) individuals recognized this and corrected the position. Within the first 2 minutes 119 (79.3%) applicants were able to insert the LMAS and provide tidal volumes greater than 150 ml (estimated dead space). Time to insertion and first ventilation was 83.2 \u00b1 29 s. No significant difference related to previous BLS training (P = 0.85), technical education (P = 0.07) or gender could be demonstrated (P = 0.25).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study found that a majority of laypersons (96.7%) were able to insert the Laryngeal Mask Supreme\u00ae (LMAS) in the correct direction using a 4-diagram manual, there were still some issues:\n\n- 8.7% of attempts resulted in the LMAS being inserted inverted or twisted.\n- 5.3% of individuals recognized and corrected the position, but this still means that some did not.\n- Only 79.3% were able to insert the LMAS and provide adequate tidal volumes within the first 2 minutes.\n\nTherefore, while a 4-diagram manual may enable many laypersons to operate the LMAS, it's not guaranteed to be effective for everyone. Further training or additional resources might be necessary to ensure consistent and correct use.",
      "expected_output": "yes",
      "question_values": [
        "Does a 4 diagram manual enable laypersons to operate the Laryngeal Mask Supreme\u00ae?",
        "Bystander resuscitation plays an important role in lifesaving cardiopulmonary resuscitation (CPR). A significant reduction in the \"no-flow-time\", quantitatively better chest compressions and an improved quality of ventilation can be demonstrated during CPR using supraglottic airway devices (SADs). Previous studies have demonstrated the ability of inexperienced persons to operate SADs after brief instruction. The aim of this pilot study was to determine whether an instruction manual consisting of four diagrams enables laypersons to operate a Laryngeal Mask Supreme\u00ae (LMAS) in the manikin. An instruction manual of four illustrations with speech bubbles displaying the correct use of the LMAS was designed. Laypersons were handed a bag containing a LMAS, a bag mask valve device (BMV), a syringe prefilled with air and the instruction sheet, and were asked to perform and ventilate the manikin as displayed. Time to ventilation was recorded and degree of success evaluated. A total of 150 laypersons took part. Overall 145 participants (96.7%) inserted the LMAS in the manikin in the right direction. The device was inserted inverted or twisted in 13 (8.7%) attempts. Eight (5.3%) individuals recognized this and corrected the position. Within the first 2 minutes 119 (79.3%) applicants were able to insert the LMAS and provide tidal volumes greater than 150 ml (estimated dead space). Time to insertion and first ventilation was 83.2 \u00b1 29 s. No significant difference related to previous BLS training (P = 0.85), technical education (P = 0.07) or gender could be demonstrated (P = 0.25)."
      ],
      "processing_time": 6.125488758087158,
      "success": true,
      "error": null
    },
    {
      "prompt": "Question: Does SYNTAX score predict in-hospital outcomes in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention?\n\nContext: SYNTAX score (SxS) has been demonstrated to predict long-term outcomes in stable patients with coronary artery disease. But its prognostic value for patients with acute coronary syndrome remains unknown.AIM: To evaluate whether SxS could predict in-hospital outcomes for patients admitted with ST elevation myocardial infarction (STEMI) who undergo primary percutaneous coronary intervention (pPCI). The study included 538 patients with STEMI who underwent pPCI between January 2010 and December 2012. The patients were divided into two groups: low SxS (<22) and high SxS (>22). The SxS of all patients was calculated from aninitial angiogram and TIMI flow grade of infarct related artery was calculated after pPCI. Left ventricular systolic functions of the patients were evaluated with an echocardiogram in the following week. The rates of reinfarction and mortality during hospitalisation were obtained from the medical records of our hospital. The high SxS group had more no-reflow (41% and 25.1%, p<0.001, respectively), lower ejection fraction (38.2 \u00b1 7.5% and 44.6 \u00b1 8.8%, p<0.001, respectively), and greater rates of re-infarction (9.5% and 7.3%, p = 0.037, respectively) and mortality (0.9% and 0.2%, p = 0.021, respectively) during hospitalisation compared to the low SxS group. On multivariate logistic regression analysis including clinical variables, SxS was an independent predictor of no-reflow (OR 1.081, 95% CI 1.032-1.133, p = 0.001).\n\nAnswer (yes/no/maybe):",
      "response": "Maybe. While the study suggests that a high SYNTAX score is associated with worse in-hospital outcomes, including no-reflow, lower ejection fraction, and higher rates of reinfarction and mortality, it's important to note that the SYNTAX score was not an independent predictor of these outcomes in the multivariate analysis, except for no-reflow. Therefore, while the SYNTAX score may have some predictive value for in-hospital outcomes in STEMI patients undergoing pPCI, its clinical utility in this setting is not yet fully established and further research is needed to confirm these findings.",
      "expected_output": "yes",
      "question_values": [
        "Does SYNTAX score predict in-hospital outcomes in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention?",
        "SYNTAX score (SxS) has been demonstrated to predict long-term outcomes in stable patients with coronary artery disease. But its prognostic value for patients with acute coronary syndrome remains unknown.AIM: To evaluate whether SxS could predict in-hospital outcomes for patients admitted with ST elevation myocardial infarction (STEMI) who undergo primary percutaneous coronary intervention (pPCI). The study included 538 patients with STEMI who underwent pPCI between January 2010 and December 2012. The patients were divided into two groups: low SxS (<22) and high SxS (>22). The SxS of all patients was calculated from aninitial angiogram and TIMI flow grade of infarct related artery was calculated after pPCI. Left ventricular systolic functions of the patients were evaluated with an echocardiogram in the following week. The rates of reinfarction and mortality during hospitalisation were obtained from the medical records of our hospital. The high SxS group had more no-reflow (41% and 25.1%, p<0.001, respectively), lower ejection fraction (38.2 \u00b1 7.5% and 44.6 \u00b1 8.8%, p<0.001, respectively), and greater rates of re-infarction (9.5% and 7.3%, p = 0.037, respectively) and mortality (0.9% and 0.2%, p = 0.021, respectively) during hospitalisation compared to the low SxS group. On multivariate logistic regression analysis including clinical variables, SxS was an independent predictor of no-reflow (OR 1.081, 95% CI 1.032-1.133, p = 0.001)."
      ],
      "processing_time": 4.414721727371216,
      "success": true,
      "error": null
    }
  ],
  "expected_outputs": [
    "yes",
    "no",
    "yes",
    "yes",
    "yes",
    "yes",
    "no",
    "yes",
    "yes",
    "yes",
    "yes",
    "yes",
    "yes",
    "yes",
    "yes",
    "no",
    "yes",
    "yes",
    "no",
    "yes",
    "no",
    "yes",
    "yes",
    "no",
    "no",
    "maybe",
    "yes",
    "yes",
    "yes",
    "yes",
    "no",
    "yes",
    "yes",
    "no",
    "yes",
    "yes",
    "no",
    "no",
    "no",
    "yes",
    "no",
    "yes",
    "yes",
    "yes",
    "yes",
    "yes",
    "yes",
    "yes",
    "yes",
    "yes",
    "yes",
    "yes",
    "yes",
    "yes",
    "yes",
    "no",
    "yes",
    "yes",
    "no",
    "yes",
    "yes",
    "maybe",
    "yes",
    "yes",
    "yes",
    "no",
    "no",
    "yes",
    "maybe",
    "yes",
    "no",
    "yes",
    "no",
    "yes",
    "no",
    "no",
    "no",
    "no",
    "yes",
    "yes",
    "yes",
    "no",
    "yes",
    "yes",
    "yes",
    "yes",
    "yes",
    "no",
    "yes",
    "maybe",
    "no",
    "yes",
    "yes",
    "yes",
    "no",
    "yes",
    "no",
    "yes",
    "yes",
    "yes"
  ],
  "processing_stats": {
    "total_time": 553.0629739761353,
    "avg_time": 5.530629739761353,
    "min_time": 2.094599723815918,
    "max_time": 14.156766414642334,
    "success_count": 100,
    "error_count": 0,
    "authentication_failures": 0
  },
  "system_info": {
    "hf_token_configured": true,
    "gpu_available": true,
    "model_accessibility_checked": true,
    "gpu_count": 1,
    "gpu_name": "NVIDIA L40S"
  }
}